Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,-0.137090156298715,0.00285639780995265,-0.142688696006222,-0.131491616591208,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,40332,0.163561580624552,0.00385748063839656,0.156000918573295,0.17112224267581,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,-0.124584100700656,0.00286434696400207,-0.1301982207501,-0.118969980651212,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,-0.101009316605256,0.00252295701384584,-0.105954312352394,-0.0960643208581178,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,0.162684634835845,0.00384256235838395,0.155153212613412,0.170216057058277,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,0.187012331335339,0.00483618146457835,0.177533415664765,0.196491247005912,1.11258681022723e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37990,0.281501759177165,0.00730344385358369,0.267187009224141,0.295816509130189,1.98983075555549e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39980,0.439351024682336,0.0115019188642042,0.416807263708496,0.461894785656176,3.27934113703765e-305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,40293,0.141449140678622,0.00373049676241631,0.134137367024286,0.148760914332958,3.26557275471284e-301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,0.0954313887995325,0.00272694991252342,0.0900865669709866,0.100776210628078,1.78674428603044e-258
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,38013,-0.209956371074429,0.00617765210070734,-0.222064569191815,-0.197848172957042,4.76238234153081e-243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40489,0.205899894862279,0.0062191012522959,0.193710456407779,0.218089333316779,1.4411788109207e-232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40516,0.158576475973563,0.00500221843568858,0.148772127839613,0.168380824107512,5.51753663052058e-214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37987,-0.0711218771846924,0.00225882477686887,-0.0755491737473554,-0.0666945806220294,4.58926406351914e-210
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,0.379921185940847,0.0123985358584342,0.355620055658315,0.404222316223378,1.93753958296616e-200
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.334271563608341,0.0110192497536669,-0.355869293125528,-0.312673834091153,1.33696589365926e-196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,40359,-0.129952215707861,0.00430759313232828,-0.138395098247225,-0.121509333168498,1.78287626420524e-194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37562,0.265055019433297,0.00889494908099666,0.247620919234543,0.28248911963205,7.51866237581191e-189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,40332,0.118758880436477,0.00399906193331572,0.110920719047179,0.126597041825776,1.17026188793155e-188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,40305,0.255478357881003,0.00865330719688381,0.238517875775111,0.272438839986896,1.53477439879746e-186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,0.151204222867224,0.00511256404562998,0.141183597337789,0.161224848396659,2.6964565582032e-186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,0.179025867135659,0.00633035979171691,0.166618361943893,0.191433372327424,1.2506031299542e-171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,0.141845278194155,0.00504238005897283,0.131962213278568,0.151728343109741,5.87897830311318e-170
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,40372,-0.0705315064107213,0.0025256223878641,-0.075481726290935,-0.0655812865305077,1.36029198781022e-167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,0.0886827334064465,0.00322132584230151,0.0823689347555356,0.0949965320573575,4.87309409674547e-163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,40461,-0.0880334874273714,0.00322968855597134,-0.0943636769970753,-0.0817032978576676,5.92173172684976e-160
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,0.0660746457033512,0.00244595907535414,0.0612805659156571,0.0708687254910453,1.59262945763026e-156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,-0.0549705115182945,0.00206128479161134,-0.0590106297098528,-0.0509303933267363,2.41256395868875e-153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,40352,0.190679079337503,0.00719148838748491,0.176583762098032,0.204774396576973,1.27852247775051e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FURIN,Furin,40411,0.0841687638750364,0.00317894666322737,0.0779380284151107,0.090399499334962,3.23656512830499e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,40415,0.0854730905562694,0.0032319257066161,0.0791385161713019,0.091807664941237,6.99753382824293e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40489,-0.0858026255643208,0.00326242151831417,-0.0921969717402165,-0.079408279388425,2.73944402749667e-149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,-0.0840410684163621,0.00322098740686007,-0.0903542037338078,-0.0777279330989164,5.40246090661038e-147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40489,0.0827646506917698,0.00319998235396428,0.0764926852779999,0.0890366161055398,1.52909919851591e-144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0744201099788505,0.00288274400663516,-0.0800702882318554,-0.0687699317258456,2.0507513360505e-143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40453,0.282203699918149,0.011065372972229,0.26051556889258,0.303891830943718,1.15254363930298e-140
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,-0.128621089379892,0.00505436289508232,-0.138527640654254,-0.118714538105531,5.15324306613126e-140
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37987,-0.116307720758627,0.00460965249475407,-0.125342639648345,-0.107272801868909,2.63923592375991e-137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,0.10961261485924,0.0043700676165272,0.101047282330847,0.118177947387634,3.28886570193215e-136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,40338,-0.107985130617843,0.00431273546087913,-0.116438092121167,-0.0995321691145204,9.80748274364188e-136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37671,0.0677742872719456,0.00273078222611952,0.0624219541087513,0.0731266204351399,6.08219533617867e-133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,-0.0877935062561804,0.00356941479423135,-0.0947895592528738,-0.080797453259487,3.91135687455774e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,40280,0.181229234975283,0.00738815352250371,0.166748454071175,0.19571001587939,1.91885226716173e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.127094211450166,0.005220448404957,0.116862132576451,0.137326290323882,1.46465565180774e-128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.073535084038315,0.00303479864924049,0.0675868786858037,0.0794832893908264,2.22667199825954e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.061464718261485,0.00255133523471106,-0.0664653353215187,-0.0564641012014514,5.52932450160046e-126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,40332,-0.061498364962907,0.00255318653784547,-0.0665026105770841,-0.0564941193487299,6.16290339166851e-126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,40372,0.04109287302012,0.00170629111174403,0.0377485424411017,0.0444372035991383,6.64018219778778e-126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,40359,0.135371844034037,0.00564202362575159,0.124313477727564,0.14643021034051,5.35527935893167e-125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.077992282296771,0.00328585357609241,-0.0844325553059121,-0.0715520092876299,1.9460668881042e-122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,40424,-0.0632168987719674,0.00267612350598658,-0.0684621008437011,-0.0579716967002337,2.69342832027285e-121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40470,0.0444893760710337,0.00189779688865162,0.0407696941692766,0.0482090579727909,1.60334719624924e-119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40536,0.117139110416786,0.00502655969007007,0.107287053424249,0.126991167409323,3.63291798833197e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,0.0704439023836258,0.0030345814760651,0.0644961226905382,0.0763916820767134,8.00875635196658e-117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,40375,-0.0438070074900399,0.0019129240019796,-0.0475563385339199,-0.0400576764461598,3.19031550216158e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.13724626703457,0.00604097999988053,-0.149086587834336,-0.125405946234804,1.71175941221166e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,40357,0.11378021339873,0.00502564051469264,0.103929957989932,0.123630468807527,1.0149120516155e-111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.11800084673309,0.00529930276354043,0.10761421331655,0.128387480149629,3.70313842489029e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0623243021373381,0.00282597862028653,-0.0678632202330997,-0.0567853840415765,3.38007555075211e-106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,40044,0.159659591833771,0.00729415808602032,0.145363041985172,0.173956141682371,1.24553095492801e-104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37987,-0.112490292645336,0.00513383745129818,-0.12255261404988,-0.102427971240791,1.31411030172451e-104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37572,0.162697954318349,0.00750067236854646,0.147996636475998,0.1773992721607,1.55934300145096e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,37345,-0.0919302894815168,0.00424333020301366,-0.100247216679424,-0.08361336228361,2.91535446654831e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37990,0.187384569506381,0.00868196010561628,0.170367927699373,0.204401211313389,1.32092469122211e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.070249649703218,0.0032846839997067,0.0638116690637929,0.0766876303426431,4.46111227903715e-100
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,40419,0.118464242189013,0.00556380254070534,0.10755918920923,0.129369295168795,3.21616631546576e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37642,0.0730164294927943,0.00344760709221891,0.0662591195920453,0.0797737393935434,6.33291603879463e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.149745021399563,0.0071699731583316,0.135691874009233,0.163798168789893,2.34914083648774e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40502,-0.107692250485839,0.00516457447814799,-0.117814816463009,-0.0975696845086694,2.66708417850709e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,40376,0.0594826335160739,0.00285391877912884,0.0538889527089813,0.0650763143231664,3.32059095785515e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0748521155967672,0.00358720908677726,0.0678211857866838,0.0818830454068506,3.67252863599228e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37998,-0.119477938033201,0.00576002229016768,-0.130767581721929,-0.108188294344472,4.12095716473128e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0835576614880684,0.00403828355791512,0.0756426257145547,0.091472697261582,7.49981023192102e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.164842068986783,0.00802268789091646,0.149117600720587,0.180566537252979,1.37512944376929e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.131607277774199,0.00643428190893061,0.118996085232695,0.144218470315703,8.43628867056512e-92
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.154036858844063,0.00753863007130498,0.139261143904306,0.168812573783821,1.28484107563618e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,0.0593904717030678,0.00290805781597822,0.0536906783837505,0.0650902650223851,1.5761724296123e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,39243,0.0772826243793462,0.00380186655521226,0.0698309659311301,0.0847342828275622,1.26478802666693e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,-0.0521309795623975,0.0025747731484068,-0.0571775349332748,-0.0470844241915202,5.17126293724929e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,0.159309189172981,0.00788483352148274,0.143854915470875,0.174763462875088,1.19334965916545e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40516,0.0653745913321274,0.00326600498797823,0.0589732215556901,0.0717759611085647,4.65854345663336e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFM,Afamin,38013,0.0356496061507559,0.0017793891083985,0.0321620034982948,0.0391372088032169,5.12265329280409e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,40305,0.105315400625478,0.00527674240175907,0.09497298551803,0.115657815732926,1.50285428611224e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,0.104004755667625,0.00522233876742671,0.0937689716834684,0.114240539651781,3.67036409101463e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37671,0.0789257229229281,0.00398558260398952,0.0711139810191087,0.0867374648267475,4.94946050073204e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.0618007794239402,0.00314277483859541,0.0556409407402933,0.0679606181075872,4.36815094862363e-85
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37959,0.086476021376287,0.00439609537029942,0.0778596744505002,0.0950923683020739,5.86993895573538e-85
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,0.0558172805567557,0.00285132714523127,0.0502286793521024,0.061405881761409,2.43542929658874e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.0855604779827761,0.00438222897022234,0.0769713092011403,0.0941496467644119,6.70994136624353e-84
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,0.091002972668824,0.00467026955984716,0.0818492443315236,0.100156701006124,1.43225750540245e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0777786736689965,0.00399947600117245,0.0699397007066985,0.0856176466312945,2.8098133106635e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,40353,-0.100262115253681,0.00515914540814925,-0.110374040253653,-0.0901501902537084,3.67325448204884e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.108552607549421,0.00558867893945374,0.0975987968280922,0.119506418270751,4.6997947338083e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,40337,0.186453749273912,0.00962218163140231,0.167594273276364,0.205313225271461,1.07472137961909e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0766579629490762,0.00396237449627356,0.0688917089363801,0.0844242169617724,1.94398584206623e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,40332,0.0435656942164659,0.00225753127992201,0.0391409329078188,0.0479904555251131,4.85388707959267e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.272275211705582,0.0141342919753373,0.244571999433921,0.299978423977243,9.55407333194654e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,40422,-0.0811366573058987,0.00423663751260243,-0.0894404668305994,-0.0728328477811979,7.61334941204721e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0695719264756524,0.00364356242848722,0.0624305441158174,0.0767133088354874,2.17831021220877e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,40332,0.102800851487369,0.0053904033775937,0.092235660867285,0.113366042107452,3.45391654599476e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,0.137262411740019,0.00722037174955679,0.123110483110888,0.15141434036915,1.12138017377814e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37981,-0.0658806226617426,0.00346574210036072,-0.0726734771784497,-0.0590877681450356,1.55541664952898e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0559146964608346,0.00294710170232741,0.0501383771242728,0.0616910157973963,2.13092416826255e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40536,-0.0499744929589547,0.00264096695019415,-0.0551507881813352,-0.0447981977365741,5.33290092963093e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39961,0.0904177827746312,0.00479907415234125,0.0810115974360424,0.0998239681132201,2.62097057361544e-78
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40516,0.0470413634552554,0.00250851598358874,0.0421246721274215,0.0519580547830894,1.2406317908094e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,40372,0.060550870824226,0.00323137462318731,0.0542173765627789,0.0668843650856732,1.63978622017259e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.186753522827674,0.0100119018718977,0.167130195158755,0.206376850496594,7.89995127727947e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39963,0.105840169051353,0.00568083955279768,0.0947057235278691,0.116974614574836,1.23245083042717e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40516,0.0534104990486481,0.00287371208097047,0.047778023369946,0.0590429747273503,2.63579854052465e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,40422,0.0727745918928983,0.00391577295924844,0.0650996768927713,0.0804495068930252,2.70838031848262e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0562947954467134,0.00303232863546827,-0.0622381595722312,-0.0503514313211955,3.92765087582815e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,0.049872116296984,0.00270105507104986,0.0445780483577263,0.0551661842362417,3.36743432650914e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.107992319123192,0.00588538517836972,0.0964569641735872,0.119527674072797,2.04548629750881e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37901,0.19380939074836,0.0105717300892681,0.173088799773395,0.214529981723326,3.61771834080199e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37871,0.0447798327124546,0.00244258144357652,0.0399923730830446,0.0495672923418645,3.62147503673407e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,0.0474851980220702,0.00259086656394712,0.0424070995567339,0.0525632964874066,3.99817798594734e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0657501415939265,0.00359273512020195,-0.0727919024295223,-0.0587083807583307,4.66031722421639e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,-0.0544786492580307,0.00297727571793806,-0.0603141096651893,-0.0486431888508721,4.94272287578199e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,-0.107308306055422,0.00589223878214753,-0.118857094068431,-0.095759518042413,2.33715473808702e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.0948722028067548,0.00520937071691989,0.0846618362015918,0.105082569411918,2.39241562550509e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,0.0642181883605328,0.00353428769724999,0.0572909844739228,0.0711453922471428,4.81220264974609e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,0.0898853387857084,0.00494466939999695,0.0801937867617144,0.0995768908097024,5.96494993185393e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.144261795291065,0.00794758696190391,0.128684524845733,0.159839065736397,9.16059100467626e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,40345,0.0537139982639856,0.00297308662027154,0.0478867484882534,0.0595412480397178,3.07423014327832e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0527812928655702,0.00294153531524932,0.0470158836476815,0.0585467020834589,2.73662938808343e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,0.131521153366108,0.00736418800920772,0.117087344868061,0.145954961864156,1.19808406373992e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.135708547879983,0.00768132819119927,0.120653144625233,0.150763951134734,3.55462386974933e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,0.125644853817305,0.0071216297475348,0.111686459512137,0.139603248122473,5.41096732830405e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,40434,0.0798859485090756,0.0045510619724792,0.0709658670430164,0.0888060299751348,2.45696866892877e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37981,0.0458555414568657,0.002620602440332,0.040719160673815,0.0509919222399164,8.2555431176457e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.146240973476824,0.00839639826334873,0.129784032880661,0.162697914072988,2.58905835603174e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40536,0.0712576952489434,0.00412146025004732,0.0631796331588506,0.0793357573390361,2.24867844889126e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,40309,0.0882469386952167,0.00512062081945424,0.0782105218890864,0.0982833555013471,5.91952877094445e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0380968835069296,0.00221703921799759,0.0337514866396543,0.0424422803742049,1.37110367647522e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.089686443575182,0.00524099450990793,0.0794140943357625,0.0999587928146015,4.59742655782671e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,40330,0.0473407937368558,0.00276790425363965,0.0419157013997221,0.0527658860739895,5.33989776431026e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0717560244098534,0.00420131153698936,0.0635214537973542,0.0799905950223525,8.201094233741e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.0850808581772576,0.00498713225981657,0.0753060789480172,0.0948556374064981,1.09590628628916e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.118257369863031,0.00694749538096074,0.104640278916348,0.131874460809714,2.64745162377957e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0601468394350016,0.00357393410007699,0.0531419285988507,0.0671517502711525,5.15656198370026e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,-0.0445964372261662,0.00265045530755607,-0.0497913296289761,-0.0394015448233564,5.49940542910925e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37998,-0.0608754799841154,0.00362408128771934,-0.0679786793080453,-0.0537722806601855,1.09564610475385e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0556779059970911,0.00331764895127516,0.0491753140525918,0.0621804979415905,1.12546491041631e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,40392,0.0516307485022507,0.00308347608283529,0.0455871353798935,0.0576743616246078,2.12522050599531e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MME,Neprilysin,40305,0.129675788735761,0.007787881508987,0.114411540978147,0.144940036493376,9.95387396092289e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0321753002969994,0.00194766335249201,0.028357880126115,0.0359927204678837,8.48722098429006e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0903652270096804,0.00548145905988561,0.0796215672523046,0.101108886767056,1.87400721095906e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0611043191181295,0.00371102285090991,-0.0683779239059129,-0.0538307143303461,2.05017813737819e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0383744226829296,0.00233171052425501,-0.0429445753104694,-0.0338042700553897,2.32309219990212e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.0544855188616251,0.0033264646952879,0.0479656480588609,0.0610053896643894,8.25219128663617e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,0.0334733749578235,0.00204584514519902,0.0294635184732334,0.0374832314424135,1.09972166480693e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0759537102847422,0.00464011796531454,-0.0850483414967587,-0.0668590790727257,1.19391336971947e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,40398,0.099953433033416,0.00613829027525162,0.0879223840939229,0.111984481972909,3.87109037159281e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,40359,0.0923800820626847,0.00569627848869101,0.0812153762248504,0.103544787900519,1.11873428653418e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,0.050478380275512,0.00311774018957908,0.044367609503937,0.056589151047087,1.70340933385222e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37628,0.0843909316136728,0.00521748253240762,0.0741646658501538,0.0946171973771917,2.77004626503666e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37901,0.105517395425628,0.00655653268090246,0.0926665913710588,0.118368199480196,9.80237004700128e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,38013,0.0308968887848054,0.00192765107524748,0.0271186926773204,0.0346750848922905,2.7230843657518e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0532627621758549,0.00332817398884005,0.0467395411577284,0.0597859831939814,3.34720601501684e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0451015839210734,0.00285228451574766,0.039511106270208,0.0506920615719388,6.79696083080364e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40536,0.085115540612418,0.00540245389552996,0.0745267309771793,0.0957043502476567,1.65063025309381e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0429633026708902,0.00273075035102328,0.0376110319828845,0.0483155733588958,2.33422465902973e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,0.0987276096042862,0.00627692710400928,0.086424832480428,0.111030386728144,2.4960541536191e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.11031654530061,0.0070208048671872,0.096555767760923,0.124077322840297,3.24687287555351e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40489,-0.0246237832650422,0.00156859986835087,-0.0276982390070099,-0.0215493275230745,4.0183965203625e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,40367,-0.0556482949307781,0.0035503997309665,-0.0626070784034725,-0.0486895114580838,5.88401855361423e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0384503316050847,0.00245396473307802,0.0336405607282518,0.0432601024819176,6.40607491379433e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40489,0.0677881481427039,0.00432799345816753,0.0593052809646955,0.0762710153207123,6.93770938663195e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,0.0494505906727708,0.00315978913842109,0.0432574039614655,0.0556437773840761,1.01482898410827e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,0.0541131684171505,0.00346077783141906,0.0473300438675691,0.0608962929667318,1.06305413068563e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,-0.0368478598659348,0.00235725400105517,-0.0414680777080029,-0.0322276420238666,1.13250062184845e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40536,0.0666600331820602,0.00426894170106973,0.0582929074479636,0.0750271589161569,1.44472958812798e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,0.0858125635316915,0.0054967943685898,0.0750388465692555,0.0965862804941275,1.82093544938996e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0820445813715273,0.00526515562560009,0.0717248763453511,0.0923642863977034,2.43031498275258e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,40465,0.0394500009040537,0.00253392050645439,0.0344835167114031,0.0444164850967043,2.96503993652511e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,0.0874959685874586,0.00562657023253695,0.0764678909316862,0.098524046243231,3.92932679933796e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.136878906581492,0.00880357502440344,0.119623899533661,0.154133913629323,4.17548198944207e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40536,-0.0244214133534561,0.00157095138142558,-0.0275004780610502,-0.0213423486458619,4.21648377522987e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,-0.060416314328021,0.00389301965440368,-0.0680466328506522,-0.0527859958053898,6.40671526525263e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40536,0.0742344475309542,0.00479350244651589,0.064839182735783,0.0836297123261253,1.04532915280952e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,40341,-0.0503729809953108,0.0032668408082296,-0.0567759889794408,-0.0439699730111808,2.94278560697594e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0507877367278112,0.00329424720665161,-0.0572444612528483,-0.044331012202774,3.04514403305279e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,40224,-0.0419973472830626,0.00272490624052042,-0.0473381635144826,-0.0366565310516426,3.29964173832775e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,0.0456477388535504,0.00296157505202015,0.0398430517515909,0.0514524259555098,3.76109350536616e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0407956826200934,0.00265025169077001,0.0356011893061842,0.0459901759340026,4.39691724947221e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,40341,0.0635759054396461,0.00413074805742566,0.0554796392470918,0.0716721716322004,4.54958526756423e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,0.114332493505236,0.00744688756620315,0.0997365938754774,0.128928393134994,8.01343591141512e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,0.072073078002286,0.00469812807483224,0.0628647469756148,0.0812814090289572,9.66554461631053e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0464997865583495,0.00303219448684543,-0.0524428877525666,-0.0405566853641325,1.04736030506033e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,40359,0.0377995945821484,0.00247957863984637,0.0329396204480495,0.0426595687162473,4.19001992065555e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,40414,0.0865221182645035,0.00568947854219949,0.0753707403217925,0.0976734962072145,7.29406257072368e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,40332,0.0508346232369362,0.00334890843625037,0.0442707627018855,0.0573984837719869,1.11495565282113e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0547578573233894,0.00361729800950653,0.0476679532247566,0.0618477614220222,2.08310960302812e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,40359,0.0927367574859658,0.00612975996829444,0.0807224279481087,0.104751087023823,2.37596309144316e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,-0.043304047945571,0.00286877838902861,-0.0489268535880671,-0.0376812423030749,4.01122923319941e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.0981748888391469,0.00652519722244867,0.0853855022831475,0.110964275395146,9.79213547085655e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0700729949617899,0.00466460055471596,0.0609303778745466,0.0792156120490332,1.37116538540551e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0706448823959155,0.00470836586577665,0.0614164852989932,0.0798732794928377,1.51643010377296e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,-0.0342127135118061,0.0022808619155061,-0.0386832028661981,-0.0297422241574141,1.63284857813415e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0301262497613044,0.00201095635337043,0.0261847753086983,0.0340677242139104,2.14062320424288e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37990,-0.0391173194697649,0.00262010348372888,-0.0442527222978735,-0.0339819166416563,5.27822805329252e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37628,0.0922049809055607,0.00618579008180682,0.0800808323452194,0.104329129465902,7.67863330669943e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,40228,-0.0476352016039164,0.00321760523953266,-0.0539417078734004,-0.0413286953344323,2.93061746149387e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37987,0.0368794942563823,0.00249300632511565,0.0319932018591556,0.0417657866536089,3.92054774829625e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.0723396703934667,0.00489833747274073,0.0627389289468948,0.0819404118400385,5.67880217805255e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37959,0.0615751619241915,0.00418562005852671,0.0533713466094791,0.0697789772389038,1.29985777006215e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,40305,0.050873474293409,0.00346635024266562,0.0440794278177844,0.0576675207690336,1.89879348122746e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,40382,-0.054480698902094,0.00373346320511779,-0.0617982867841249,-0.0471631110200632,6.38557220768734e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,40305,0.069303504608878,0.00475643199564179,0.0599808978974201,0.078626111320336,8.81353659545104e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,40350,0.0448636024917637,0.00308503926228245,0.0388169255376901,0.0509102794458373,1.32082811528318e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0528119761167591,0.00363410088375833,0.0456891383845928,0.0599348138489255,1.51505876173617e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0310118844959999,0.00213567532533447,0.0268259608583443,0.0351978081336554,2.02982305077978e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,0.0555077800831498,0.00383175776433779,0.0479975348650477,0.0630180253012519,2.96108557692092e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,0.0824770142358082,0.00569430052288215,0.0713161852109592,0.0936378432606572,3.05697463412919e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REN,Renin,40359,0.0991100895992435,0.00684908183524361,0.085685889202166,0.112534289996321,3.70575602425345e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,0.0463188463442222,0.00320239892888898,0.0400421444435998,0.0525955482448446,4.0644449371221e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0883455107826057,0.00610914973708139,-0.100319444267285,-0.0763715772979262,4.8823788849563e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37671,-0.0300691951547223,0.00208532486081889,-0.0341564318819273,-0.0259819584275172,8.84012306556076e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37928,-0.02639032929795,0.0018325525664013,-0.0299821323280965,-0.0227985262678034,1.13440771458649e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,40330,0.0409992699229816,0.00284919589697698,0.0354148459649067,0.0465836938810565,1.17921489475779e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,40447,0.0510468282579905,0.00355794497242239,0.0440732561120426,0.0580204004039383,2.15023623705031e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,40228,0.0560934029588534,0.00391396759600802,0.0484220264706777,0.0637647794470291,2.71219411137437e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0584049210467213,0.00407718189299212,-0.0663961975569858,-0.0504136445364567,2.96353732302797e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,0.0868354606795998,0.00607643099545693,0.0749256559285043,0.0987452654306954,4.80993061763448e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0513916413579861,0.00359848623847865,0.0443386083305679,0.0584446743854042,5.52484733848466e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.039602750512536,0.00277525641480691,0.0341632479395145,0.0450422530855576,6.47602106727816e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0723810413070048,0.00509521375039777,0.0623944223562252,0.0823676602577845,1.60451779518485e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0481297441965072,0.00338996358084387,0.0414854155780532,0.0547740728149612,1.79409648302145e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40516,0.0606935818399204,0.00427782287363864,0.0523090490075887,0.0690781146722522,2.04569088159155e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40516,0.036803076894678,0.00261413531729635,0.0316793716727772,0.0419267821165789,9.50183033574454e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,40332,-0.0392108582163557,0.00278882402478388,-0.0446769533049321,-0.0337447631277793,1.2388620697709e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,40341,0.0715042565915214,0.00509109646867737,0.0615257075129138,0.0814828056701291,1.52742335929211e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,40203,0.0396621768614516,0.00282755035581492,0.0341201781640544,0.0452041755588489,1.97098433100294e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,40305,0.0923872190537215,0.00658703053106238,0.0794766392128392,0.105297798894604,2.0024730892738e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0610946866559986,0.00437442554996263,0.0525208125780718,0.0696685607339253,5.1413007960951e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0586538826333751,0.00420941904739604,0.0504034213004788,0.0669043439662713,7.1465156391385e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0828927014811137,0.00594906311382198,0.0712325377780226,0.0945528651842048,7.1588052437717e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,40359,-0.0696059141221745,0.00499680470666286,-0.0793996513472337,-0.0598121768971153,7.52512026243838e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,0.0818487407556606,0.00587743552474445,0.0703289671271615,0.0933685143841597,7.97580436009869e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.0520897461835671,0.00374435362828939,0.0447508130721199,0.0594286792950143,9.74126912814529e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,0.135390702891047,0.00974076970097158,0.116298794277142,0.154482611504951,1.17301282888162e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,40341,0.0638996828803968,0.00460070635818552,0.0548822984183532,0.0729170673424404,1.32630761189191e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,40403,0.0669623501222965,0.00482303528599518,0.0575092009617459,0.076415499282847,1.42251693107498e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,0.0501414128800558,0.00361665816933776,0.0430527628681538,0.0572300628919578,1.88263885107705e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40469,0.081800280465617,0.00591863851464478,0.0701997489769132,0.0934008119543208,3.3796770004783e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,0.172547866109544,0.0125011430311828,0.148045625768426,0.197050106450662,4.33681884745042e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40471,-0.0493185316056964,0.00357833438282172,-0.0563320669960269,-0.0423049962153658,5.70987430691832e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0415489130117399,0.00301397932480625,-0.0474563124883601,-0.0356415135351197,5.94356082401129e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40489,0.0355676766808334,0.00258367252369711,0.030503678534387,0.0406316748272797,7.12375662414301e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,40372,0.0371565768247128,0.0026992854924703,0.031865977259471,0.0424471763899546,7.25022676017975e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,40341,-0.0564282387087964,0.00410080535194874,-0.0644658171986159,-0.0483906602189768,7.77759698327632e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0445184043505965,0.00325285332915385,0.038142811825455,0.050893996875738,2.14124967114084e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,40360,-0.0501433066657466,0.00366883637854383,-0.0573342259676925,-0.0429523873638007,2.75674393978287e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0550702608126542,0.00403039806029193,-0.0629698410108264,-0.047170680614482,2.90159936071298e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.113180348452337,0.00828611738087383,0.0969395583858239,0.129421138518849,3.40259677431802e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0885021992708903,0.00648562934667458,0.0757903657514081,0.101214032790373,3.66720311409519e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,37301,0.0304009140581275,0.002230920246989,0.0260283103740291,0.034773517742226,5.41157859750576e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0316278459085175,0.00232805320356144,-0.0361908301874979,-0.027064861629537,8.29971784888854e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,40228,0.116158821187142,0.00855161958069171,0.0993976468089859,0.132919995565297,8.64766469456935e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40536,0.0745883771409947,0.00549755583448297,0.0638131677054081,0.0853635865765813,1.05790750504824e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,0.0583493060335901,0.00431197015673499,0.0498978445263895,0.0668007675407906,1.91898892899833e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLN,Promotilin,40341,0.114822808333517,0.00851623600555313,0.098130985762633,0.131514630904401,3.32656806771198e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.087038854848583,0.00646485601477828,0.0743677370596176,0.0997099726375485,4.3670294382985e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,0.117653227623389,0.00874493456528817,0.100513155875424,0.134793299371354,4.88988055537458e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.0875157114393278,0.00651445513256914,0.0747473793794923,0.100284043499163,7.0039050860654e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,0.121244031889852,0.00903025221612615,0.103544737546245,0.138943326233459,7.75537791086069e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0463497050318508,0.00345467573623012,0.0395785405888398,0.0531208694748619,8.16791485404992e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.0841296851380335,0.00626852399959689,0.0718433780988236,0.0964159921772434,8.30715239742832e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0352044396163171,0.00262439177642358,0.0300606317345268,0.0403482474981073,8.31380352004606e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.0951764515899569,0.00709921347569209,0.0812619931776004,0.109090910002313,9.24401780224199e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,0.0868952541981679,0.00652453039938733,0.0741071746153687,0.0996833337809671,2.98382436736277e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0358614756841911,0.00269646319482293,0.0305764078223382,0.0411465435460441,3.82012258173375e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,40311,0.116532734211791,0.00876267654683345,0.0993578881799975,0.133707580243585,3.86058356446188e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,0.0224277651697997,0.00168621660547243,0.0191227806230738,0.0257327497165257,4.09234004687668e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37628,0.0777852076066285,0.00586334281127151,0.0662930556965364,0.0892773595167207,6.5390309851947e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRN,Agrin,40422,0.0422493495290951,0.00318802672744544,0.0360008171433021,0.0484978819148882,7.08610991702084e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0698429579004808,0.00527719215443698,0.0594996612777843,0.0801862545231773,9.08933186122639e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,40192,0.0697505078597563,0.00528205309024899,0.0593976838028683,0.0801033319166443,1.32999750669375e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37598,0.105663081244462,0.00800741586314688,0.0899685461526937,0.121357616336229,1.65692125302445e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,40333,-0.0277495896436828,0.00210598741942875,-0.0318773249857632,-0.0236218543016025,1.92912798701102e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37781,0.0303757295004924,0.00230721175983693,0.025853594451212,0.0348978645497728,2.43730177867631e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37942,0.16473154385986,0.0125157545077879,0.140200665024596,0.189262422695124,2.53846499948006e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0729760173341489,0.00554993740412341,0.062098140022067,0.0838538946462308,3.0115763658231e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,40305,0.0674619455824911,0.00514263011941561,0.0573823905484365,0.0775415006165457,4.14133618519214e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,40042,-0.0297252672140934,0.00227284892110504,-0.0341800510994593,-0.0252704833287275,7.00754908086558e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,0.136440146312446,0.0104330488725234,0.1159913705223,0.156888922102592,7.08770797925736e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,40145,0.0451260074237741,0.00345277019273753,0.0383585778460085,0.0518934370015396,7.84450179288929e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0338670653961348,0.00259013148032024,0.0287904076947071,0.0389437230975624,7.8480023582773e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.0607080297433323,0.00464791009176361,0.0515981259634756,0.069817933523189,8.68082415760112e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37998,0.140811692471689,0.0107777164418905,0.119687368245584,0.161936016697795,8.94154378433957e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,40417,0.0837044167213821,0.00640999556463465,0.0711408254146982,0.0962680080280661,8.98952826552771e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39961,0.0649545829045006,0.00497477427720987,0.0552040253211692,0.0747051404878319,9.30537228977572e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0388925603758502,0.00298006641716341,0.0330516301982099,0.0447334905534905,1.0824708020021e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,0.105550058000385,0.00809542034953979,0.0896830341152873,0.121417081885483,1.28678846501227e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0657924317472085,0.00506329858370071,-0.0757164969712619,-0.0558683665231551,2.07757923267523e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,0.119669644505625,0.00923923472607679,0.101560744442514,0.137778544568735,3.54384862197063e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,40042,0.0667669050861264,0.00515922185287783,0.0566548302544858,0.0768789799177669,4.13612706143323e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,0.0319033936381299,0.00247092702320242,0.0270603766726532,0.0367464106036067,6.00397057340743e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.104858129702131,0.00811894279276098,0.0889450018283197,0.120771257575943,6.27225031247405e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,40268,0.0899043280153077,0.00696686600931375,0.0762492706370527,0.103559385393563,6.59061542038357e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40516,0.049807050281009,0.00387673870056706,0.0422086424278975,0.0574054581341204,1.35754152695995e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.0891541386635571,0.00694158326110689,0.0755486354717876,0.102759641855327,1.43521041908978e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.119899086271586,0.00933710212615454,0.101598366104323,0.138199806438849,1.48396408715023e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0325669030193309,0.00254124848070183,-0.0375477500415065,-0.0275860559971554,2.06395505046341e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0329521360040202,0.00257155576128377,0.0279118867119041,0.0379923852961364,2.11644841316971e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40516,0.0433070048745181,0.0033820761500247,0.0366781356204697,0.0499358741285665,2.34541152359493e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37671,0.0558820343855222,0.0043635325548708,0.0473295105779754,0.064434558193069,2.50936577926407e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,0.057361554781064,0.00447976786211359,0.0485812097713213,0.0661418997908066,2.54872165511937e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,0.0684406177485829,0.00535673439761449,0.0579414183292585,0.0789398171679073,3.6333593648581e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0479786784018405,0.00376022798486725,0.0406086315515006,0.0553487252521803,4.17531134194169e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,40044,0.0581915797303227,0.0045807752107641,0.0492132603172251,0.0671698991434203,8.61142536780624e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,0.0961481211964489,0.00759304679383629,0.0812657494805298,0.111030492912368,1.55598245086615e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,0.0880899890630739,0.00697228287885907,0.0744243146205101,0.101755663505638,2.04421110411509e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,0.148379476020383,0.0117464952517269,0.125356345326998,0.171402606713767,2.11153452474027e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,40341,0.0746594655627015,0.00591212484801856,0.0630717008605852,0.0862472302648179,2.2077363983507e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,40374,0.0567473358070303,0.0044953471747438,0.0479364553445325,0.0655582162695282,2.33800134897276e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40489,0.0795737733592091,0.00630860332672351,0.067208910838831,0.0919386358795872,2.64493716305921e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37998,-0.0485490949460389,0.00385148525312662,-0.0560980060421671,-0.0410001838499107,3.15321167729074e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0524833012452033,0.00416602781627189,0.0443178867253104,0.0606487157650962,3.23027084861891e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,-0.0354876055593284,0.00282279626721938,-0.0410202862430784,-0.0299549248755784,4.4826908598749e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,-0.0345615150242924,0.00275227692310241,-0.0399559777935731,-0.0291670522550117,5.36584366758596e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,0.136574842380638,0.010904615501523,0.115201795997653,0.157947888763624,8.10253386859213e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0699788555311901,0.00558944852089575,0.0590235364302344,0.0809341746321457,8.56758804234376e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.069199458927591,0.00552858106658094,0.0583634400370923,0.0800354778180896,8.95005169170137e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,-0.0443057246806125,0.00353852005857364,-0.0512412239954169,-0.0373702253658082,9.06046160390377e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.106819995175476,0.00853597967568237,0.0900894750111391,0.123550515339814,9.24941105569341e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37917,0.0355343157891921,0.00284308501105704,0.0299618691675203,0.0411067624108639,1.19936568086557e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,0.032525309659086,0.00260402099153908,0.0274214285156694,0.0376291908025026,1.23558816744747e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0464718759794185,0.00372085123028061,0.0391790075680685,0.0537647443907685,1.33894109502369e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEP,Leptin,40359,0.0764463786160946,0.00613851317681733,0.0644148927895326,0.0884778644426565,1.95640364983615e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,0.065511997839172,0.00526561286875942,0.0551913966164035,0.0758325990619405,2.27394972376598e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37628,0.0678323481490761,0.00546387129154709,0.0571231604176438,0.0785415358805084,3.42123342946145e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.059035125373852,0.00476407165403848,0.0496975449319366,0.0683727058157674,4.24487574371617e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0808925083981424,0.00653869050294436,0.0680766750123714,0.0937083417839133,5.41560560273579e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,-0.0307994197523992,0.00248968939905116,-0.0356792109745394,-0.0259196285302589,5.42831861519725e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,40305,0.0932350844792632,0.00753971755129661,0.0784572380787219,0.108012930879805,5.79648568759027e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,0.12490719259037,0.0101004848650642,0.105110242254844,0.144704142925896,6.14579043690401e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,-0.0342321137359649,0.00276864129223049,-0.0396586506687366,-0.0288055768031931,6.36432177068911e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,40305,0.0910583835191421,0.00738624538190534,0.0765813425706076,0.105535424467677,9.22568945121937e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,0.128794040363078,0.010443736944882,0.108324315951109,0.149263764775047,9.35633529298497e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,40305,0.0604299750454779,0.00490453667131829,0.0508170831696941,0.0700428669212618,1.00371837689331e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,0.0744802034578491,0.00605024244304378,0.0626217282694833,0.0863386786462149,1.15698655261565e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,0.109930815535732,0.00894378829835067,0.0924009904709644,0.127460640600499,1.44750079486116e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0217976435593689,0.00177484925868082,0.0183189390123545,0.0252763481063833,1.65199640909836e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0496630622518336,0.0040445155821539,0.0417358117108119,0.0575903127928552,1.68055229226572e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,0.0814393402475214,0.00663654472171435,0.0684317125929613,0.0944469679020815,1.84512558653684e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37990,0.0508332951728782,0.00414749699477371,0.0427042010631217,0.0589623892826347,2.36137797610568e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.05794828133686,0.004748367190131,0.0486414816442033,0.0672550810295168,4.21336908070536e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0823533128264587,0.006745372523959,0.069132382679499,0.0955742429734183,4.2597609393733e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,0.0329542680351018,0.00270495353536087,0.0276525591057945,0.0382559769644091,5.45459305199689e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,0.088420990256323,0.00725892972617948,0.0741934879930112,0.102648492519635,5.54213825247666e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,40292,0.0554026107015997,0.00455175254268723,0.0464811757179327,0.0643240456852667,6.23385175722978e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,0.101629856013198,0.00835496648541672,0.0852541217017814,0.118005590324615,6.83485761045069e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0672358981790589,0.00553876107560749,0.0563799264708683,0.0780918698872496,9.83151421052057e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,0.0432071143147759,0.00356116895251639,0.0362272231678438,0.050187005461708,1.0015110696502e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,0.0632863813817322,0.00521804688925268,0.053059009478797,0.0735137532846675,1.04906236560194e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,0.0359729285774716,0.00296633265029432,0.0301589165828947,0.0417869405720485,1.07733596055451e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,-0.0394955443719331,0.003259295066558,-0.0458837627023868,-0.0331073260414795,1.19580468405326e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,40332,-0.0296482566102989,0.00244971291579577,-0.0344496939252587,-0.0248468192953392,1.43535065588502e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39757,0.108538628980272,0.00896825986837036,0.090960839638266,0.126116418322278,1.45753033422201e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.0992182780268753,0.00820072168972406,0.0831448635150162,0.115291692538734,1.50762632797535e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.121164474568556,0.0100220634284027,0.101521230248887,0.140807718888225,1.68057129155338e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.109985143149661,0.00914995602916404,0.0920512293324995,0.127919056966822,3.87062096905555e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,0.0516613945469291,0.00430509395845902,0.0432234103883495,0.0600993787055088,4.94125704313194e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,0.0977604486183089,0.00815040683188419,0.0817856512278159,0.113735246008802,5.30187189013011e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,40332,-0.0279924873533218,0.00233750126976933,-0.0325739898420697,-0.0234109848645739,6.62703501151531e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0595328214874003,0.00498051581627007,0.049771010487511,0.0692946324872896,8.63181520617559e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,40293,0.0359822431373162,0.00301027429665197,0.0300821055158784,0.0418823807587541,8.64977422486997e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37671,0.0304182056693871,0.00254574957424472,0.0254285365038675,0.0354078748349068,9.73075395410406e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0394487441366572,0.00330821909183612,-0.045932853556656,-0.0329646347166584,1.21612430974772e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0700215055712353,0.0058828566720693,0.0584911064939795,0.0815519046484911,1.57676431673912e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.0829217764645543,0.00696431246728453,0.0692717240286766,0.096571828900432,1.60393175745891e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39960,0.0450518573554073,0.00379252510577791,0.0376185081480826,0.052485206562732,2.10021744278534e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37990,0.104631045733642,0.00881135880041418,0.0873607824848306,0.121901308982454,2.32267500408055e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,40332,0.0507993852137941,0.00428219134325238,0.0424062901810195,0.0591924802465688,2.52487837095458e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,40330,-0.199731482672489,0.0168370527251783,-0.232732106013838,-0.166730859331139,2.53474204807528e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,40097,0.0476645540121432,0.00402358778161304,0.0397783219601816,0.0555507860641047,3.08946469534477e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0441045858843063,0.00372403205244821,0.0368054830615079,0.0514036887071048,3.40062763470739e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.0953951545822328,0.00806402382417394,0.0795896678868519,0.111200641277614,3.9521692822933e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.0935730431326749,0.00791377194272967,0.0780620501249248,0.109084036140425,4.02555402099501e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,0.135315912056913,0.0114481906022301,0.112877458476542,0.157754365637284,4.48283676559198e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0336082242119758,0.00284525488367559,0.0280315246399717,0.03918492378398,4.61700369371467e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,0.0323851555207014,0.00274368862923569,0.0270075258073995,0.0377627852340034,5.07955752728756e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.116854278527204,0.00991177726161904,0.0974271950944306,0.136281361959977,6.01339329083891e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37967,0.0641215932201383,0.00543907420979342,0.0534610077689432,0.0747821786713334,6.37032021562967e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.0792295911048522,0.00672483331384481,0.0660489178097163,0.092410264399988,6.63624747217858e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,-0.0374619845251609,0.00317966183368061,-0.0436941217191749,-0.0312298473311469,6.93759882484968e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,40359,-0.0346880656157739,0.00295036650157828,-0.0404707839588673,-0.0289053472726804,8.77851469214116e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.0838626534190497,0.00713496185432358,0.0698781281845755,0.0978471786535239,9.74552950549225e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,40192,0.0905161317344591,0.00771177010092987,0.0754010623366366,0.105631201132282,1.11093649449928e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37990,0.0781744849723231,0.00666155671993499,0.0651178338012505,0.0912311361433957,1.19775590064176e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,40228,0.0753148606399271,0.00643425135203589,0.0627037279899367,0.0879259932899174,1.61634221203655e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,40203,0.058588432969378,0.00501109225348798,0.0487666921525416,0.0684101737862145,1.89451982332596e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,-0.0430252786263975,0.00368016548673265,-0.0502384029803935,-0.0358121542724015,1.90286062468838e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40471,0.0412578863496177,0.00353200560363162,0.0343351553664997,0.0481806173327357,2.13335421434761e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37575,0.0308131262847181,0.00263671200169656,0.0256451707613928,0.0359810818080433,2.14513740126476e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,-0.0374114853295908,0.00320417283018484,-0.0436916640767531,-0.0311313065824285,2.26852912844478e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.121763673382423,0.0104245221830342,0.101331609903676,0.14219573686117,2.2748642463343e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.0933543503861138,0.00800537732967967,0.0776638108199416,0.109044889952286,2.85345055808784e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0482360302804217,0.00414361448814133,-0.0563575146771787,-0.0401145458836647,3.41175042375731e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,0.0680605435336985,0.00585115674477262,0.0565922763139442,0.0795288107534529,3.81599363733455e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0553286808524712,0.00475954350806746,0.045999975576659,0.0646573861282834,4.37999051934892e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39806,0.044773864840041,0.00385865674243678,0.0372108976248649,0.0523368320552171,5.3287840082002e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,0.0575736806532179,0.0049645906355478,0.0478430830075442,0.0673042782988916,5.70827245519048e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.0775861727458087,0.00670528821146238,0.0644438078513424,0.0907285376402749,7.73514375420932e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,38013,0.0242113843662288,0.00210404333727746,0.0200874594251649,0.0283353093072926,1.68367266549306e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39980,0.0811871151735427,0.00707570228801217,0.0673187386890388,0.0950554916580465,2.36021255839535e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,40346,-0.030478921055379,0.00266047111555604,-0.0356934444418689,-0.0252643976688892,2.87745665576646e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,0.0347538057110729,0.00303562984098805,0.0288039712227363,0.0407036401994095,3.13478015358311e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0500164759752821,0.00437247873397388,0.0414464176566933,0.0585865342938709,3.5089115132155e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0497401960549488,0.00434905502361223,-0.0582643439012288,-0.0412160482086688,3.57659182506857e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,40341,0.0895001196718768,0.00785218751430506,0.0741098321438389,0.104890407199915,5.5870770901286e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40471,0.0652925987928893,0.00572948317763299,0.0540628117647287,0.07652238582105,5.71752192984366e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.0897113460247866,0.007886470122085,0.0742538645855,0.105168827464073,7.22376072126051e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,40341,0.102734509110135,0.0090323393474594,0.0850311239891143,0.120437894231155,7.34482874338983e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0332170265552192,0.00292157593515992,0.0274907377223058,0.0389433153881327,8.16343362828477e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0283188476834862,0.00249283828381171,-0.0332048107197572,-0.0234328846472153,9.01120609993343e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,0.0868182013049577,0.00765139421715467,0.0718214686393346,0.101814933970581,1.04867598521053e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0359994420110289,0.00317535157070037,-0.0422231310896016,-0.0297757529324562,1.16839932106128e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,-0.0520735083611325,0.0045959790006732,-0.0610816272024519,-0.043065389519813,1.20791741779953e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,0.100113791383343,0.00883812598694251,0.0827910644489356,0.11743651831775,1.24600106221606e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.0866400000254278,0.00766241738730462,0.0716216619463108,0.101658338104545,1.64390391468242e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,0.047116667354676,0.00417512134311249,0.0389334295221756,0.0552999051871765,2.12409515642677e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,40228,-0.0272992266692009,0.00242123277861316,-0.0320448429152827,-0.0225536104231191,2.26051803692703e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,0.0892231913613677,0.00792884905779943,0.0736826472080808,0.104763735514655,2.88581696680194e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0544407174091515,0.00483767943827109,0.0449588657101402,0.0639225691081629,2.89085140215303e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,0.0234378800806291,0.00208354122707413,0.0193541392755638,0.0275216208856944,3.01006935849972e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0528876638298038,0.00470583014177078,0.0436642367519331,0.0621110909076745,3.41126272611038e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,0.0371256228691705,0.0033038025788467,0.0306501698146309,0.04360107592371,3.43784770587963e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0608423737899139,0.00541510398253086,0.0502287699841534,0.0714559775956744,3.70173725131494e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0479548096885094,0.00427005678862655,-0.0563241209942174,-0.0395854983828013,3.71655886974105e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,0.085261125297753,0.00759337875028767,0.0703781029471892,0.100144147648317,3.83394012808943e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40471,0.0628743094132985,0.00560391596790511,0.0518906341162044,0.0738579847103925,4.18993968568756e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,0.0686561082035461,0.00612072629866332,0.056659484658166,0.0806527317489262,4.5643519417248e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0569510074383016,0.00508065400559511,0.0469929255873352,0.066909089289268,4.74124114139195e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40489,-0.0494475324815702,0.00441948656706879,-0.0581097261530251,-0.0407853388101154,5.94063802412851e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37598,0.0984885859792699,0.00880087560418653,0.0812388697950643,0.115738302163476,6.11454547316581e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.150073497049965,0.0134259108038367,0.123758711874445,0.176388282225485,7.01235754382368e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.113821017485819,0.0101891450809003,0.0938502931272543,0.133791741844383,7.25818987464765e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.0347193882383791,0.00310740564871016,-0.040809903309851,-0.0286288731669072,7.44711181827725e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0547588224871231,0.00490301989951435,0.045148903484075,0.0643687414901712,7.79768555722703e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,40411,0.0436378031543321,0.00391470054521871,0.0359649900857034,0.0513106162229608,9.44016935944027e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,40305,0.0352744644789365,0.00317908326694881,0.0290434612757169,0.0415054676821562,1.67423679966772e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40471,0.0439926768043661,0.00397856822430256,0.0361946830847331,0.0517906705239991,2.55531787893003e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,0.0367421289545925,0.00332352964046121,0.0302280108592886,0.0432562470498965,2.62647424406977e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.0945171193042095,0.00855073243416311,0.0777576837332498,0.111276554875169,2.68802122673732e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,40341,0.0832889045280277,0.00753652666868053,0.0685173122574139,0.0980604967986415,2.73736296593284e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.0796638283990806,0.00721074901870325,0.0655307603224222,0.093796896475739,2.98470505433354e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0459148545828026,0.00416281398289923,0.0377557391763202,0.0540739699892851,3.64885208566845e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37748,0.0300754837930693,0.00272749915633156,0.0247295854466594,0.0354213821394791,3.75953161009382e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,-0.0780846037259436,0.00709140564411255,-0.0919837587884042,-0.064185448663483,4.44337431578423e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0678186455856855,0.00616953122971572,0.0557263643754427,0.0799109267959283,5.26632656499704e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37990,0.0265538768062471,0.00241535308910196,0.0218197847516073,0.031287968860887,5.37666436260366e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,40422,0.0449816266294621,0.0040938750208629,0.0369576315885708,0.0530056216703534,5.52580988854568e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40489,0.0593804546221362,0.00541982327377817,0.0487576010055309,0.0700033082387414,7.79137533517647e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,40341,0.0639641564931978,0.00585049132403342,0.0524971934980923,0.0754311194883032,1.00482925960034e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0404316391852278,0.00369846705387341,0.033182643759636,0.0476806346108197,1.0170561358868e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,0.0342296293158726,0.00313216282643617,0.0280905901760578,0.0403686684556875,1.10807546479079e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,0.0312262127870318,0.00285762062286841,0.0256252763662097,0.0368271492078539,1.11266209942466e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,-0.0297526071424631,0.00272382938843605,-0.0350913127437978,-0.0244139015411285,1.12039729488255e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0686755561435786,0.00628931259080726,0.0563485034655963,0.0810026088215608,1.16746233661943e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,0.0554026601225919,0.00507722685579658,0.0454512954852306,0.0653540247599532,1.26610362482786e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0567512286253042,0.00520697930391702,0.0465455491896269,0.0669569080609816,1.45769707048476e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,0.0368375339978897,0.00338392775840038,0.0302050355914249,0.0434700324043544,1.68484175548575e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,40359,0.0407449201202681,0.00374594415420327,0.0334028695780297,0.0480869706625065,1.85200455737228e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37987,0.0758720368272553,0.00698255067624826,0.0621862375018087,0.0895578361527019,2.17271648058392e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,38013,0.0216279185157768,0.00199232060526261,0.0177229701294621,0.0255328669020915,2.42876767293196e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0509733916992444,0.00470943849844548,0.0417428922422912,0.0602038911561975,3.32260528852663e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0238322534339165,0.0022045741304987,0.0195112881381391,0.028153218729694,3.82179617758997e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,0.0885124402347459,0.00819046297042543,0.0724591328127121,0.10456574765678,3.99408784246144e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39961,0.0622983452207163,0.00577239002194621,0.0509844607777017,0.0736122296637308,4.66169440954611e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0835437167648666,0.00775699941114993,0.0683399979190127,0.0987474356107204,6.17025625044084e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,0.0573127766451551,0.00532643216362073,0.0468729696044585,0.0677525836858518,6.61196423182179e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0617699334922546,0.0057447513692841,0.0505102208084578,0.0730296461760515,7.41050721912424e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,0.0550670247914514,0.00512370836535507,0.0450245563953555,0.0651094931875473,7.53129239984992e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,0.0458803048731773,0.00427827614865172,0.0374948836218199,0.0542657261245347,1.00689922041138e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.0794379682355814,0.00741956340031601,0.064895623970962,0.0939803125002007,1.21209094063535e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40516,-0.04023765503443,0.00375956825350693,-0.0476064088113036,-0.0328689012575564,1.21519609720828e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0332830943135329,0.00311146405109569,0.0271846247733853,0.0393815638536804,1.29677983759427e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0635407222854291,0.00594397835868998,0.0518905247023968,0.0751909198684615,1.44885724245271e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0321854502419196,0.00301501977676428,0.0262760114794616,0.0380948890043776,1.63414633946824e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37959,0.0553948507730975,0.00518794032375452,0.0452264877385387,0.0655632138076564,1.65258449538986e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,0.0425052817403939,0.00398278157548196,0.0346990298524492,0.0503115336283385,1.683820948189e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELP,P-selectin,40403,0.0592538256884308,0.00555213399818638,0.0483716430519855,0.0701360083248761,1.6862293994508e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNST,Consortin,40359,0.110616946512146,0.0103745337234948,0.0902828604140967,0.130951032610196,1.87556192679021e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37998,0.0254912678693088,0.00239521274810349,0.020796650883026,0.0301858848555917,2.39923851926131e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,0.0498597617325587,0.00468735810947746,0.0406725398379828,0.0590469836271345,2.45546169470723e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37882,0.0368336062098324,0.00346162129754929,0.0300488284666358,0.043618383953029,2.45657314235956e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.0987876792093633,0.00929279921203971,0.0805737927537655,0.117001565664961,2.64324733902325e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,-0.0349954146076723,0.00329354437690638,-0.0414507615864088,-0.0285400676289358,2.77485667920736e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.033877230030483,0.00318931188738357,0.0276261787312112,0.0401282813297547,2.87936964801847e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.0773215870618224,0.00728493691234963,0.0630431107136171,0.0916000634100277,3.14614582471691e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,-0.0393803691215035,0.00371597881985129,-0.046663687608412,-0.032097050634595,3.75322809776062e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,40305,0.0559729329056883,0.00528680756691831,0.0456107900745284,0.0663350757368482,4.17228029904044e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.0736321656389712,0.00695690511817841,0.0599966316073415,0.0872676996706009,4.47501561339889e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,0.086632392048298,0.00818925254567555,0.070581457058774,0.102683327037822,4.56329123515198e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,40411,0.0586259785951995,0.0055504533011104,0.0477470901250231,0.0695048670653758,5.4248571269046e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.0701660474198356,0.00664383949023156,0.0571441220189818,0.0831879728206895,5.52593936656074e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0425902896331685,0.00403958991610907,0.0346726933975947,0.0505078858687422,6.64173267022558e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40471,0.0239649405873605,0.00227486710580494,0.0195062010599829,0.0284236801147382,7.26612487809612e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,40288,0.0302714470654666,0.00288108263617485,0.0246245250985639,0.0359183690323693,9.75018858321075e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,0.0526539062519444,0.00501725007003965,0.0428200961146666,0.0624877163892221,1.11023370692723e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,40403,0.101259581311063,0.00964894012387753,0.0823476586682631,0.120171503953863,1.11163320174652e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.100932935110245,0.00961795192430433,0.0820817493386085,0.119784120881881,1.11188917890078e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37900,0.0988911134742229,0.00946042907442257,0.0803486724883546,0.117433554460091,1.77498083147471e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39980,0.0622902432649315,0.00596651233619626,0.0505958790859868,0.0739846074438762,1.97689259407789e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.112268350015944,0.0107597933618499,0.0911791550267183,0.13335754500517,2.17328453265162e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0364415592855875,0.00349398366803612,0.0295933512962367,0.0432897672749383,2.18941224708204e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,40358,0.0578136706968586,0.00554549250165379,0.0469445053936172,0.0686828360001001,2.29311400034872e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37671,0.050804417684553,0.00488699779508983,0.041225902006177,0.0603829333629291,3.23959751695049e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,40341,0.082469625472571,0.00793919556815442,0.0669088021589883,0.0980304487861536,3.39806310792479e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,40411,0.0399927510917337,0.00385074320898589,0.0324452944021213,0.047540207781346,3.46430785079242e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40516,0.0937474918063174,0.00902920581247691,0.0760502484138626,0.111444735198772,3.5709198186252e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,0.0641356962514769,0.00617656427304694,0.0520296302763049,0.0762417622266489,3.65832763227612e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0287861727227644,0.00277698724703498,0.0233432777185759,0.034229067726953,4.4182177755173e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.0759057061894734,0.00732687088179929,0.0615450392611468,0.0902663731178,4.53642532298025e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37671,0.0623637931713756,0.00602007417228269,0.0505644477937015,0.0741631385490497,4.73452623254316e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40471,-0.0231956157608376,0.00224072886123788,-0.0275874443288639,-0.0188037871928114,4.9245222861641e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.0609746873085789,0.0058925229232124,0.0494253423790826,0.0725240322380752,5.16435317628026e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0258741436811394,0.00250128052911383,-0.0307766535182025,-0.0209716338440763,5.49963695973334e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.0941196415369846,0.00910619439416575,0.0762715005244197,0.111967782549549,5.83149245827706e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,40305,0.101865097467527,0.00985893748270534,0.0825415800014248,0.12118861493363,6.04288420642635e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,40359,-0.0355364347146046,0.00344076954292874,-0.0422803430187449,-0.0287925264104642,6.30832568691995e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0538341824062623,0.00522129960862388,0.0436004351733595,0.0640679296391651,7.57577479081659e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,0.0880039756289052,0.0085350908126684,0.0712751976360752,0.104732753621735,7.78334410480925e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,40341,0.0386686428649126,0.00375309513350764,0.0313125764032376,0.0460247093265876,8.16393633935888e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,40341,0.066355394260854,0.0064425685528841,0.0537279598972012,0.0789828286245068,8.47400942115278e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,40309,0.0663547859793416,0.00644291206106336,0.0537266783396574,0.0789828936190258,8.53358361448587e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0274144263954163,0.00266669861210708,0.0221876971156865,0.0326411556751462,1.0338523746991e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,38013,-0.02738353334801,0.00266337443520877,-0.0326037472410191,-0.0221633194550008,1.05195686483495e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37714,0.127608388835474,0.0124143139035478,0.103276333584521,0.151940444086428,1.08316351064705e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,40341,0.0817199836881625,0.00795377785124552,0.0661305790997213,0.0973093882766037,1.09850656328278e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37671,0.0305982727927832,0.00297773472755404,0.0247619127267773,0.0364346328587891,1.12303245720533e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.020330635316776,0.00197876840478167,-0.024209021390148,-0.0164522492434039,1.13893674352065e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,40305,0.0929480982147888,0.0090587332108131,0.0751929811215952,0.110703215307983,1.26610870594053e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39934,0.0681356532772585,0.00664558557484253,0.0551103055505671,0.0811610010039498,1.37818835772515e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0396454240429652,0.00387116502375264,0.03205794059641,0.0472329074895204,1.59354509207233e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.0238716510110593,0.00233317901396145,-0.0284446818784238,-0.0192986201436949,1.70752609175472e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,-0.0519753170300885,0.00508282308816349,-0.0619376502828889,-0.042012983777288,1.81175510557278e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.0208742014454631,0.00204087253300383,-0.0248743116101506,-0.0168740912807756,1.821695835707e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.112414959875562,0.0109924288481622,0.0908697993331643,0.13396012041796,1.85258306984493e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.0679148557398088,0.00664156635307638,0.0548973856877791,0.0809323257918386,1.86762643204461e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,40341,0.0892913149432949,0.00875647579388556,0.0721286223872792,0.106454007499311,2.42586371955951e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37671,-0.0529695784559345,0.0051956056767355,-0.0631529655823361,-0.042786191329533,2.56598147240057e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0748595934293451,0.0073524860493421,0.0604487207726346,0.0892704660860556,2.93401112771021e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0575105935970913,0.00565386323378301,0.0464290216588766,0.068592165535306,3.24978431682932e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37998,0.0273094226121179,0.00268964065683653,0.0220377269247183,0.0325811182995175,3.89822424740296e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37598,0.0453868368167533,0.00447840887743961,0.0366091554169717,0.054164518216535,4.75542062369424e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0438978905751358,0.00433343207073311,0.0354043637164989,0.0523914174337727,4.81451237678382e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40471,-0.0292895249408217,0.0028939055421053,-0.034961579803348,-0.0236174700782953,5.25899772439482e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0376052016627901,0.00371625749076739,0.0303213369808861,0.0448890663446942,5.53918983846548e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.100850523812495,0.00997134336976863,0.0813066908077481,0.120394356817241,5.65789636042608e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,40403,-0.0296428145415061,0.00293270248504257,-0.0353909114121895,-0.0238947176708226,6.03082813246134e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40516,-0.00841789486508469,0.000833095475883412,-0.0100507619978162,-0.0067850277323532,6.23008296863454e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.0409406313970816,0.00405580308037314,0.0329912573595502,0.0488900054346129,6.90406042279223e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37959,0.10030426765674,0.00993528516602173,0.0808311087313372,0.119777426582142,7.01055429882055e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37998,0.0723275620255044,0.00716731795749791,0.0582796188288085,0.0863755052222003,7.32998713174516e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40489,0.0353586222777538,0.0035090252969546,0.0284809326957228,0.0422363118597848,8.26382261564364e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,40228,0.0596621646666068,0.00592830181426847,0.0480426931106406,0.071281636222573,9.40372292966782e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,40341,0.0818202449288502,0.00813876195239394,0.065868271502158,0.0977722183555423,1.04742521683137e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,0.0653322075905211,0.00650048728070493,0.0525912525203394,0.0780731626607027,1.07654600688255e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0289769939622319,0.00288324433310736,0.0233258350693415,0.0346281528551223,1.11208010186035e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,0.0470717923529343,0.00468444011964675,0.0378902897184266,0.0562532949874419,1.13505929508332e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0461377142414383,0.00459197842714144,0.037137436524241,0.0551379919586355,1.14247236316536e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,0.0530798283766858,0.00529356112412817,0.0427044485733946,0.063455208179977,1.36494550354214e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,-0.0251027490358715,0.0025046885166535,-0.0300119385285123,-0.0201935595432306,1.42635414784238e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39956,-0.117231673014703,0.0117030065553862,-0.14016956586326,-0.0942937801661457,1.50996852421274e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0280067654888349,0.00279603450204732,0.0225265378648222,0.0334869931128477,1.51421241719593e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,0.0593369998466322,0.00593737305210034,0.0476997486645155,0.0709742510287489,1.96569833595605e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,40359,0.0338652208838952,0.00339387504327155,0.027213225799083,0.0405172159687075,2.22138253109593e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0254200135772329,0.00254817065582378,0.0204255990918183,0.0304144280626475,2.27933350388059e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,0.0394052218472647,0.00395155919022496,0.0316601658344238,0.0471502778601057,2.36108609703642e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,0.0491677146482278,0.00493417009608814,0.039496741259895,0.0588386880365606,2.54560551110472e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,-0.0362132558567451,0.00364257510622938,-0.0433527030649547,-0.0290738086485355,3.21130373165095e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,0.0231968683834589,0.00233420515306412,0.0186218262834532,0.0277719104834646,3.42254896233368e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.106657864637489,0.0107406958116669,0.0856061008466221,0.127709628428356,3.59699378060759e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0596265014737919,0.00600590476256706,0.0478549281391605,0.0713980748084234,3.77653985150505e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,0.0409488762535127,0.00413098916584199,0.0328521374884624,0.049045615018563,4.28185784189703e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.051926715802975,0.00524974614239785,0.0416372133638752,0.0622162182420748,5.29473332564747e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,38013,0.0302612628886855,0.00306504880189796,0.0242537672369655,0.0362687585404055,6.51147493381176e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40471,0.0572827840365492,0.0058098403343408,0.0458954969812412,0.0686700710918572,7.23614619490306e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.0910087466669626,0.00923036118792752,0.0729172387386246,0.109100254595301,7.43218848631695e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37598,0.042119057110277,0.0042731708933145,0.0337436421593806,0.0504944720611734,7.6998661193538e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.056897702959808,0.00577862939888473,0.0455715893379939,0.068223816581622,8.27356204571629e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37990,0.0707373709620273,0.00719056824808769,0.0566438571957755,0.0848308847282792,9.25019457931907e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,-0.0245911833537867,0.00250589245202404,-0.0295027325597538,-0.0196796341478196,1.14418650889786e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,0.0809019708985102,0.00825151346029921,0.0647290045163238,0.0970749372806967,1.24737310105096e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,40422,0.0446779709072539,0.00455773703597881,0.0357448063167354,0.0536111354977723,1.27011731167539e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,0.0775016472439425,0.00790429010187184,0.0620092386442737,0.0929940558436113,1.2742059968844e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RETN,Resistin,40283,0.0390947173047935,0.00399307525406772,0.0312682898068208,0.0469211448027663,1.43160932908666e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37942,0.0707068588046281,0.00722457391468187,0.0565466939318516,0.0848670236774046,1.52192135329235e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,0.0327153989180167,0.00334613189119637,0.0261569804112718,0.0392738174247616,1.63627206341499e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,-0.0225772255319894,0.00231053966635444,-0.0271058832780441,-0.0180485677859347,1.72755085020058e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.0251570300860932,0.0025740597157714,-0.0302021871290051,-0.0201118730431812,1.74056387763272e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,40228,0.0350539834581499,0.00359114274555703,0.0280153436768581,0.0420926232394417,1.91147309800985e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,0.0685503687865917,0.00702929333261154,0.054772953854673,0.0823277837185103,2.09405274487635e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.034207813100032,0.00350763542912155,-0.0410827785411103,-0.0273328476589538,2.14511972281309e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.100762026796699,0.0103378108973425,0.0804999174379079,0.121024136155491,2.25334401915721e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,0.0694093184828821,0.00713316613821989,0.0554283128519711,0.083390324113793,2.65496541287353e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,-0.0386250949377003,0.00397137261497911,-0.0464089852630594,-0.0308412046123412,2.69707383003956e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37966,0.0417627425681511,0.00429546996074133,0.0333436214450981,0.0501818636912041,2.85976651738768e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0193024403434842,0.00198602232927952,-0.0231950441088721,-0.0154098365780964,2.88013467860958e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0342666916974466,0.00352635803536779,0.0273550299481258,0.0411783534467675,3.01989743904361e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0522963398880553,0.00538390114671116,0.0417438936405015,0.0628487861356092,3.04178019811829e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,0.0733394150913103,0.00755311444837629,0.0585353107724927,0.0881435194101278,3.23646147230973e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,40332,-0.0428311705623204,0.00441564499453156,-0.0514858347516023,-0.0341765063730386,3.47867525669239e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37900,0.0191745174377012,0.00197827723117169,0.0152970940646047,0.0230519408107977,3.8325322736324e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39991,0.0464058351299894,0.00478900233446962,0.0370193905544289,0.0557922797055499,3.83822806310327e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37934,0.0784943623629223,0.00810008720860051,0.0626181914340653,0.0943705332917794,3.90523211647313e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0352634099635462,0.00364480928429828,0.0281195837663216,0.0424072361607708,4.45127635001703e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,40263,0.0791557314988095,0.00818315284012342,0.0631167519321676,0.0951947110654514,4.52026394469373e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37990,0.0434237626643544,0.00449497239808401,0.0346136167641098,0.0522339085645991,5.22421870942233e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,40370,-0.0263548166913055,0.0027290923749398,-0.0317038377461875,-0.0210057956364235,5.27611471455669e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,40042,0.0551619437806104,0.00571200889763258,0.0439664063412505,0.0663574812199702,5.28132807946915e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,0.0735889153122829,0.00762050261910657,0.058652730178834,0.0885251004457318,5.44244146484491e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37598,-0.0282334364969515,0.00292565255822643,-0.0339677155110753,-0.0224991574828277,5.79569513090517e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0484061842101133,0.00501691261111533,0.0385730354923273,0.0582393329278994,5.86588723743867e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASN,Vasorin,40116,-0.0255271402956038,0.0026478743828077,-0.0307169740859069,-0.0203373065053007,6.19745342819968e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.0714763767012149,0.00741320500403803,0.0569464948933004,0.0860062585091294,6.26716599166887e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,40305,0.0279330621144833,0.00290001930690042,0.0222490242729585,0.0336170999560081,6.72366033147941e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,0.0586426927778777,0.00609130258094769,0.0467037397192202,0.0705816458365351,7.20919863489116e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.0882348638812564,0.00916866642064951,0.0702642776967833,0.106205450065729,7.29349105172041e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,0.0783678727633786,0.00815425516857307,0.0623855326329754,0.0943502128937818,8.46904651749181e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.0807421010995125,0.00840725444230331,0.064263882392598,0.097220319806427,8.82007464661716e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,0.112492203416706,0.0117167047848442,0.089527462038411,0.135456944795,9.3302215830616e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,40290,0.0404314412171129,0.00421484168787979,0.0321703515088685,0.0486925309253572,9.83739599468177e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37901,0.0959567292442865,0.0100007283891373,0.0763553016015773,0.115558156886996,9.85251905260633e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0394914359477899,0.00412251714382505,0.0314113023458928,0.047571569549687,1.11547989781163e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40516,0.0502794396645269,0.00525309512661401,0.0399833732163634,0.0605755061126903,1.20471946340461e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,0.0613803680599841,0.00641348592645096,0.0488099356441403,0.073950800475828,1.21538343857639e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,0.1266320778908,0.0132604702802454,0.100641556141519,0.152622599640081,1.48805247619014e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,0.051294476779137,0.00537225320457213,0.0407648604981757,0.0618240930600984,1.50907570898684e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.0543538939659093,0.00570101318818456,0.0431799081170676,0.0655278798147511,1.72788475406288e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,40359,0.11072024025269,0.0116180388615312,0.0879488840840892,0.133491596421291,1.79424119343581e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,0.0659577420534978,0.00692514363019285,0.0523844605383198,0.0795310235686758,1.89111192408104e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,-0.016232394381186,0.00170559493873356,-0.0195753604611038,-0.0128894283012682,2.03012410724539e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,0.0497780856364586,0.00523262067397826,0.0395221491154612,0.060034022157456,2.16980556955871e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,0.0955917401717287,0.0100608098562096,0.075872552853558,0.115310927489899,2.35823255411195e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.0612020131976039,0.00644499116229202,0.0485698305195115,0.0738341958756962,2.49066769607587e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,0.076173739860646,0.00802297453769666,0.0604487097667606,0.0918987699545315,2.58154996463022e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.0709180325749602,0.00748142221509915,0.0562544450333658,0.0855816201165545,2.99413295688911e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37977,-0.0306749376805375,0.00323856744616729,-0.0370225298750253,-0.0243273454860496,3.20145656754978e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,-0.033116208158315,0.00350044302573529,-0.0399770764887562,-0.0262553398278738,3.48157875846019e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,0.0546000425179679,0.00577119125833652,0.0432885076516283,0.0659115773843075,3.55561975183965e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0521257620267657,0.00553411069838172,0.0412789050579375,0.0629726189955939,5.17905531434343e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0248848715592043,0.00264214452329069,0.0197062682935546,0.0300634748248541,5.19066324919141e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.0936107304301432,0.00994223444732701,0.0741239509133823,0.113097509946904,5.46530288259416e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,0.0753843112848947,0.00800862252666407,0.0596874111326332,0.0910812114371563,5.47455534714642e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0671859321631579,0.00713900329811501,0.0531934856988525,0.0811783786274633,5.68944654927184e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37810,-0.0970188555765831,0.0103134051953435,-0.117233129759456,-0.0768045813937098,5.92284636098548e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37987,0.0220004320432007,0.00234134908701515,0.017411387832651,0.0265894762537504,6.53293587882601e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,40411,0.0472118158181873,0.00502876871784691,0.0373554291312073,0.0570682025051672,6.89963317676888e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,-0.0356028411906883,0.00380020984202363,-0.0430512524810546,-0.028154429900322,8.3128740887983e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,40266,0.0348493096245037,0.00372006001710842,0.0275579919909712,0.0421406272580362,8.3728472824097e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,0.0346629148344506,0.0037012850845311,0.0274083960687697,0.0419174336001316,8.61601782649439e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0343559446854747,0.00366983386238074,0.0271630703152085,0.041548819055741,8.9316430232698e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBN,Nibrin,40044,0.0458537918451958,0.00491120561801258,0.0362278288338912,0.0554797548565005,1.12664749369305e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,37057,0.022190890325586,0.00237780007692597,0.0175304021748111,0.0268513784763609,1.20486082734583e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,40295,-0.0573084117280003,0.00614300326373449,-0.0693486981249199,-0.0452681253310807,1.20657230841547e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,0.0608561055167116,0.00653821645636363,0.0480412012622389,0.0736710097711843,1.47073624880228e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37671,0.0631054531727434,0.00677977913849111,0.0498170860613008,0.0763938202841859,1.50678476224513e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37628,0.0445553471287186,0.00478729087541184,0.0351722570129114,0.0539384372445258,1.52003016640549e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_E,,40341,0.0258130558056258,0.00277665903841175,0.0203708040903388,0.0312553075209129,1.63702492500261e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,0.0683848215537134,0.0073586167216694,0.0539619327792414,0.0828077103281854,1.72490574807194e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.0921576194837222,0.00991975236509426,0.0727149048481375,0.111600334119307,1.77655311943341e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,0.111573464605634,0.0120371788286641,0.0879805941014525,0.135166335109816,2.11251431611931e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,40309,0.0307976136152368,0.00332291658219499,0.0242846971141346,0.0373105301163389,2.13057537424903e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.0924065906908606,0.00997299961805669,0.0728595114394694,0.111953669942252,2.18043008841707e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,0.0606331528564417,0.00654603409611673,0.0478029260280529,0.0734633796848305,2.30232142463181e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0407772156606138,0.00440475539459783,0.032143895087202,0.0494105362340255,2.35363457523548e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,40332,0.0675602738955236,0.00730454532875195,0.0532433650511698,0.0818771827398774,2.54673396483756e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39961,0.0315662097110946,0.0034179342158571,0.0248670586480147,0.0382653607741745,2.89831639776473e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0329987526390135,0.00357272852720581,0.0259962047256901,0.0400013005523369,2.93957274675248e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,0.0241288748200174,0.00261345357101747,0.0190065058208231,0.0292512438192116,3.02958262733908e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0641161382179497,0.00694764494341546,0.0504987541288554,0.077733522307044,3.16038258791622e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,40332,0.0472548332796195,0.00512426298017018,0.037211277838486,0.0572983887207531,3.2817908917132e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37848,0.082455615413369,0.00895073614422585,0.0649121725706863,0.0999990582560516,3.66549068140555e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0420727639648959,0.00456717549896036,0.0331210999869336,0.0510244279428582,3.66724174995348e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0405172713039881,0.00439973303326989,-0.0491407480491971,-0.0318937945587792,3.69197747241682e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0512632042877488,0.00557118167414528,0.040343688206424,0.0621827203690735,3.97217020704779e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0509411703326663,0.00553536971614681,0.0400918456890186,0.0617904949763141,3.99328944107202e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,0.021050474824134,0.00228841117612526,0.0165651889189285,0.0255357607293395,4.0633653421592e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37901,0.0621893709170742,0.00676714081570458,0.0489257749182932,0.0754529669158551,4.50090444009256e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,0.0648466341335648,0.00705963497537539,0.0510097495818291,0.0786835186853006,4.68140935382719e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0566467538698492,0.00616871240128025,0.04455607756334,0.0687374301763585,4.70243277672037e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,0.0475593855619996,0.00517875988632783,0.0374090161847971,0.0577097549392022,4.7863155521212e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,40228,0.0463482144296294,0.0050590606665648,0.0364324555231624,0.0562639733360964,5.73929518644862e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.0303719453447011,0.00331538315848966,0.0238737943540614,0.0368700963353408,5.76212731438731e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37878,0.0368331602850066,0.0040211314905091,0.0289517425636088,0.0447145780064045,5.93729558729797e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0475981160260614,0.00519840229816123,0.0374092475216654,0.0577869845304574,6.00608030823091e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0349204585613258,0.0038171825604749,-0.0424021363798566,-0.027438780742795,6.47532316334099e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,0.0517331675195467,0.00565942342625565,0.0406406976040856,0.0628256374350078,6.91196484261021e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0349144607954648,0.00381857535230724,0.0274300531049426,0.042398868485987,6.91411567601653e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0455247160224248,0.00498622498952337,0.035751715042959,0.0552977170018906,7.6696451919062e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDK,Midkine,40352,0.044482493274112,0.00487787242004501,0.0349218633308238,0.0540431232174002,8.45296741282531e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,40341,0.0287783855466042,0.0031601581839043,0.0225844755061518,0.0349722955870566,9.49039327769171e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.030825425060147,0.00338482145226961,0.0241911750136985,0.0374596751065954,9.70202671390264e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37901,0.0249395148745719,0.00273980176383023,0.0195695034174647,0.0303095263316792,1.00388231455994e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37778,0.0960342826810252,0.0105501659167952,0.0753559574841067,0.116712607877944,1.00544147868393e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.057689554485275,0.00634661054543145,0.0452501978162294,0.0701289111543207,1.1059734274719e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,0.0534949764375125,0.00588889576586403,0.041952740736419,0.065037212138606,1.16727593690218e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,-0.0296632632955061,0.00326573440691238,-0.0360641027330543,-0.0232624238579578,1.17740989203282e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.0681931700475416,0.00750885026624539,0.0534758235257006,0.0829105165693826,1.19316775523934e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0550512102011722,0.006071029227116,-0.0669504274863196,-0.0431519929160249,1.35338802866054e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37990,0.0561196959636627,0.00619238312931631,0.0439826250302027,0.0682567668971226,1.44508106640408e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,-0.0781765847888462,0.00863133212992082,-0.0950939957634911,-0.0612591738142014,1.48988167233338e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37998,0.0356555825377024,0.00394225393196934,0.0279287648310425,0.0433824002443623,1.70593395230225e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0344634926727389,0.00381178412049436,0.02699239579657,0.0419345895489079,1.75665541660043e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,0.0478863390872926,0.00531603991591029,0.0374669008521084,0.0583057773224768,2.34054088058066e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39961,0.0273342706945915,0.00303864506623116,0.0213785263647785,0.0332900150244046,2.61810376911461e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,0.056651230287054,0.00630276212413355,0.0442978165237522,0.0690046440503557,2.78862561049924e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,40228,-0.0367240988446699,0.00409143134178775,-0.0447433042745739,-0.0287048934147659,3.12297466446825e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.032729821000652,0.00364840996880739,0.0255789374617895,0.0398807045395144,3.2676557873574e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0381737876323706,0.00425614403540039,0.0298317453229858,0.0465158299417553,3.31329730993262e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.0886059603224082,0.00989051587510463,0.0692205492072031,0.107991371437613,3.71307815394055e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,0.086693791554214,0.00968056023991183,0.0677198934839868,0.105667689624441,3.81961187736622e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0327298948708465,0.00365769061291574,0.0255608212695316,0.0398989684721613,3.99983486309178e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0381154163890738,0.00426102148190551,0.029763814284539,0.0464670184936086,4.11849818423576e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40489,0.0352283245348059,0.0039397009067948,0.0275065107574881,0.0429501383121237,4.23615759964738e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARC,SPARC,40411,0.0609304147216193,0.00681411430930429,0.0475747506753829,0.0742860787678556,4.24141680136883e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,0.0361503011457564,0.00404334836127803,0.0282253383576515,0.0440752639338614,4.37545560517331e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37671,0.0445103534630822,0.00498288906000581,0.0347438909054708,0.0542768160206935,4.70366823654783e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40536,0.0481322935231601,0.00539171691032318,0.0375645283789266,0.0587000586673935,4.83808489124363e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0362003159308613,0.00405548036829631,0.0282515744090005,0.0441490574527221,4.87975327662628e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,0.0472730133361108,0.00531317789134683,0.036859184669071,0.0576868420031506,6.44086095004993e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,0.0718345651931668,0.00808514932323853,0.0559876725196193,0.0876814578667143,7.08288332385449e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.072539115043457,0.00817629777074737,-0.0885646586741219,-0.0565135714127922,7.94289003851771e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0238056198617005,0.00268554652089303,0.0185419486807502,0.0290692910426508,8.49753256955211e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,-0.0220127769299737,0.00248549430721718,-0.0268843457721194,-0.017141208087828,9.11431619086251e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,0.0677566351852276,0.00765138941125859,0.0527599119391608,0.0827533584312945,9.19217151684415e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37900,0.0332182936508139,0.00375072710027885,0.0258668685342673,0.0405697187673604,9.28021151295868e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,0.0361116821230929,0.00408233310452723,0.0281103092382195,0.0441130550079662,1.00119510994926e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,0.0382921006838336,0.00433243916427499,0.0298005199218546,0.0467836814458125,1.07056036844651e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,0.0646047168346083,0.00730923794951421,0.0502786104535605,0.0789308232156562,1.08610382374423e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,40288,0.0747430567908986,0.00846431973444811,0.0581529901113803,0.0913331234704169,1.15087480524759e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,0.0975535216473627,0.0110525255182116,0.0758905716316679,0.119216471663057,1.19253520556084e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0527405064955577,0.00598242451546324,0.0410149544452497,0.0644660585458656,1.33543573122423e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,40192,0.0548597582939846,0.00622518590001218,0.0426583939299607,0.0670611226580085,1.34917221771661e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,40214,0.0194954612802049,0.0022172088261909,0.0151497319808708,0.0238411905795391,1.60733915923218e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,40472,0.0197240242940326,0.0022471007312112,0.0153197068608586,0.0241283417272065,1.83684411752986e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0224099914678898,0.00255424924855059,0.0174036629407306,0.0274163199950489,1.90252342427202e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40536,-0.0256887139729011,0.00293013930637163,-0.0314317870133895,-0.0199456409324127,2.01443492888796e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0490158690623602,0.00559511523977287,0.0380494431924054,0.059982294932315,2.14141268920089e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0375396406839526,0.00428574935712244,0.0291395719439926,0.0459397094239126,2.16694082905471e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,0.0454005516860372,0.00518358635618036,0.0352407224279237,0.0555603809441507,2.22147309034503e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.0777180552598183,0.00888462944207562,0.0603041815533501,0.0951319289662866,2.40172191653323e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0395114601886268,0.00451779808111777,0.030656575949636,0.0483663444276176,2.47621350983738e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37942,0.0311557542684099,0.00356473762431892,0.0241688685247449,0.038142640012075,2.60389597368471e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0574753712608012,0.00658815047345507,0.0445625963328292,0.0703881461887731,3.00477753423136e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0566425930595879,0.00649843776683135,0.0439056550365984,0.0693795310825773,3.21263017834137e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0587034374299402,0.006738922279923,0.0454951497612912,0.0719117250985893,3.3037876721368e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0545364151477219,0.00626856460677844,0.0422500285184362,0.0668228017770077,3.70112635460655e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37970,0.0384819167560414,0.00442450144233917,0.0298098939290566,0.0471539395830261,3.78186710830932e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.0874576926872078,0.0100601068186396,0.0677398833226741,0.107175502051741,3.8505669987377e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40516,0.0315015380152071,0.00362581660543499,0.0243949374685545,0.0386081385618597,4.03473062720181e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0403848533307398,0.00465574493885214,0.0312595932505896,0.04951011341089,4.55881682805329e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,40291,0.0343159735083725,0.00395798979202737,0.0265583135159989,0.0420736335007462,4.73198187111163e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0559256417733042,0.00645077414347184,0.0432821244520994,0.068569159094509,4.74575529642164e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0502791072649106,0.00580149347962511,0.0389081800448454,0.0616500344849759,4.8847474314203e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,40359,0.044713560013231,0.00516085400815186,0.0345982861572533,0.0548288338692086,4.98764855486485e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40536,-0.0245990301329752,0.00284107536170254,-0.0301675378419122,-0.0190305224240383,5.23392625419306e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39961,0.059769126672975,0.00692172715335875,0.0462025414523918,0.0733357118935581,6.43670412864832e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,40376,0.0762773243576129,0.00887110910186267,0.0588899505179621,0.0936646981972638,8.82596076378207e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,40192,-0.0420991322420913,0.00489769031107691,-0.0516986052518021,-0.0324996592323806,9.04318350627417e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0350288035754704,0.00407593109347918,0.0270399786322512,0.0430176285186896,9.32599683293848e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39980,0.080734253691994,0.00940550207915237,0.0622994696168554,0.0991690377671327,1.00446053757122e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0370240945389463,0.00432127037067006,-0.0454937844654596,-0.028554404612433,1.14931502565403e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,0.0284080344773663,0.00331593895672417,0.0219087941221869,0.0349072748325456,1.15921395232115e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37936,0.0623807515550856,0.00729024886913756,0.0480918637715759,0.0766696393385952,1.28538229776962e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0270475014997802,0.00316549372930596,-0.0332518692092199,-0.0208431337903405,1.40721990536913e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPTC,Opticin,40305,-0.0371155620953546,0.00434919643325371,-0.0456399871045319,-0.0285911370861774,1.54164213249184e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.0652146999047121,0.00764352334635491,0.0502333941458565,0.0801960056635677,1.5900206309052e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.0590736834174714,0.00694213084717078,0.0454671069570167,0.0726802598779262,1.90178600068949e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39961,0.0509862202114005,0.00599462689081115,0.0392367515054107,0.0627356889173904,1.9743926370223e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0583728068808336,0.00687041162094099,0.0449068001037892,0.0718388136578779,2.12886404627798e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0253801801878883,0.00298839221154887,0.0195229314532525,0.0312374289225241,2.19113751436585e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0255131078216891,0.00300411277196369,0.0196250467886403,0.0314011688547379,2.1933166905618e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,0.0242690834723639,0.00286086662599535,0.018661784885413,0.0298763820593147,2.3877778986617e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40489,0.0898672244334758,0.0106042272942358,0.0690829389367737,0.110651509930178,2.56013894175885e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0544047282595189,0.0064194578766417,0.0418225908213011,0.0669868656977366,2.59756284751047e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,0.0666228129541471,0.00786669425258653,0.0512040922190775,0.0820415336892167,2.72958346480738e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37934,0.079439992506798,0.00939444281250142,0.0610268845942952,0.0978531004193008,3.04760569597004e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0365838055439682,0.00432758418558581,0.0281017405402201,0.0450658705477164,3.11908757607308e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39980,0.0339423984014652,0.00401841578059906,0.026066303471491,0.0418184933314394,3.25873089564588e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0571183087800387,0.00676360618058867,0.0438616406660849,0.0703749768939924,3.35854527361158e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0523382657953015,0.00621071237093727,0.0401652695482644,0.0645112620423385,3.90672929720709e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37681,-0.017187565416825,0.00204004740266682,-0.0211860583260519,-0.013189072507598,3.97432873388364e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39961,0.0545444332149234,0.00648053324357631,0.0418425880575138,0.067246278372333,4.20863144742102e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,40228,0.0782842430573257,0.0093063915726744,0.0600437155748838,0.0965247705397675,4.37680791588342e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,0.0622611014946008,0.00740524990817059,0.0477468116745864,0.0767753913146151,4.60892385726475e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.0413518373644979,0.00492173861499844,0.031705229679101,0.0509984450498948,4.76024614678275e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0427415613188258,0.00509062445148671,0.0327639373939118,0.0527191852437398,5.07905952555747e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,0.0555625442925856,0.00662041188781844,0.0425865369924614,0.0685385515927097,5.14895136592174e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,0.0182284002596155,0.00217257276786016,0.0139701576346095,0.0224866428846214,5.34063277989023e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.0546239805839138,0.00651636157367133,0.041851911899518,0.0673960492683096,5.61780158057674e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,0.0325792571111456,0.00389008760445289,0.0249546854064179,0.0402038288158733,5.99251309544691e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,0.0620123674078163,0.00740679961824254,0.0474950401560609,0.0765296946595716,6.11309567223767e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C3,Complement C3,37360,0.0381891607573705,0.00456034033281814,0.029250893705047,0.0471274278096941,6.13049238362419e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0655626770083503,0.00783255008449181,0.0502108788427464,0.0809144751739543,6.31246936198e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0530036655485438,0.00633419250211735,0.0405886482443939,0.0654186828526938,6.43902900563718e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,40228,-0.0275588656343674,0.00329584780224113,-0.03401872732676,-0.0210990039419748,6.69363159480701e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,0.0320965248632837,0.00384308565818974,0.0245640769732318,0.0396289727533356,7.27334655903511e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,0.0156480999293441,0.00187374103141325,0.0119755675077741,0.0193206323509141,7.40500874259929e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40516,0.0393049385286127,0.00471040880187119,0.0300725372769452,0.0485373397802803,7.7417614073128e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37900,0.066035145998998,0.00791265501136846,0.0505263421767158,0.0815439498212801,7.77734493604776e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37959,0.0441535189879755,0.00529209234314912,0.0337810179954033,0.0545260199805478,7.92016839786168e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,-0.023436000382716,0.00282342588598206,-0.0289699151192408,-0.0179020856461912,1.13440086733689e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,0.0222166491768226,0.00267896669005336,0.0169658744643181,0.0274674238893272,1.19133388175495e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37901,0.0470769662893665,0.00568597442478802,0.035932456416782,0.058221476161951,1.35297231023121e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,0.0474565697987046,0.00573661060561953,0.0362128130116903,0.0587003265857189,1.41635604248899e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,38013,0.0333954404725076,0.00403719894200719,0.0254825305461735,0.0413083503988417,1.44003822583702e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,-0.0204837300208577,0.00247747516363889,-0.0253395813415899,-0.0156278787001255,1.46856875208165e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,0.0361420857707968,0.00438072581429713,0.0275558631747744,0.0447283083668192,1.70637142391193e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.0513506153558617,0.00622720131841881,0.0391453007717609,0.0635559299399626,1.78510777472237e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,40374,0.0845860730871116,0.0102660435803729,0.0644646276695807,0.104707518504643,1.86415581392536e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37942,0.0451650015773326,0.00548800476213065,0.0344085122435566,0.0559214909111087,2.04671946824254e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0252706929547654,0.00307245295583748,0.019248685161324,0.0312927007482069,2.1307052984063e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0488173601455943,0.00593680392981541,0.0371812244431561,0.0604534958480325,2.1434522014866e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,0.060758037681305,0.00738807042574898,0.046277419646837,0.075238655715773,2.15507211093152e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,40261,0.0615926290312995,0.00749213544322892,0.0469080435625708,0.0762772145000282,2.17397862726102e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0519614335330255,0.00632097062742551,0.0395723311032715,0.0643505359627795,2.18572377040088e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37628,0.0583660193875023,0.00710715214967991,0.0444360011741297,0.072296037600875,2.37093490409356e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37959,0.0524080644305724,0.0063853476325624,0.0398927830707501,0.0649233457903947,2.46064906694114e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37900,0.0280714150127755,0.00343184144930985,0.0213450057721282,0.0347978242534228,3.0993701310039e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.0857232419506026,0.0104981695290692,0.065146829673627,0.106299654227578,3.4832350651981e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0149108771977918,0.0018267460917614,0.0113304548579394,0.0184912995376441,3.52512526945998e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,-0.0233623601453889,0.00286431056764571,-0.0289764088579745,-0.0177483114328033,3.70641978699138e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,0.0704484458263452,0.00863574582035154,0.0535223840184562,0.0873745076342342,3.72001854443432e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.0615095434535573,0.00754809443703794,0.046715278356963,0.0763038085501517,3.94648891811183e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.0715056779158951,0.0087788706733677,0.0542990913960944,0.0887122644356958,4.1172206393729e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,40411,-0.0215279035529118,0.00264648138518793,-0.0267150070678802,-0.0163408000379435,4.43697643932255e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,40376,0.0530140753383829,0.00651910252089665,0.0402366343974255,0.0657915162793404,4.52701209658058e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,40204,0.040290823337389,0.00496012441356872,0.0305689794867943,0.0500126671879837,4.88471365515273e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40489,0.0302384091964605,0.0037315013891531,0.0229246664737205,0.0375521519192006,5.7195245780459e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40536,0.0413914207837318,0.00511168475872158,0.0313725186566375,0.0514103229108261,6.01305821414558e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0911611777659511,0.0112645139770916,-0.113239625161051,-0.0690827303708516,6.25393543208774e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,-0.0228668835676602,0.00282637108019182,-0.0284065708848362,-0.0173271962504842,6.36053251867794e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37671,0.0529929642329584,0.00655442390905768,0.0401462933712053,0.0658396350947114,6.75059633670563e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,0.0616993916480772,0.00764005913561472,0.0467248757422723,0.076673907553882,7.1817986329117e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,0.0237702845473442,0.00294447072562854,0.0179991219251123,0.0295414471695762,7.35357222848211e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,37441,0.0558621835337824,0.00691952189576329,0.0422999206180863,0.0694244464494784,7.45220864243755e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37598,0.0326132552188003,0.00404117024726603,0.0246925615341589,0.0405339489034418,7.62144742092997e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0254714482253447,0.00315773202378172,-0.0316606029919568,-0.0192822934587325,7.84724463851242e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,0.0363655143255077,0.00451702287766189,0.0275121494852903,0.045218879165725,8.81973391895468e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0453241459318065,0.0056322492818483,0.0342849373393839,0.0563633545242292,9.06171793034302e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,40359,0.0329339164545497,0.00409266440287879,0.0249122942249073,0.0409555386841921,9.07504962290487e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,0.0580148018147769,0.007210369634314,0.0438824773315215,0.0721471262980324,9.16448446591336e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.015434754671138,0.00191952522224408,-0.0191970241067364,-0.0116724852355395,9.54161120507378e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,0.0329029029134909,0.00409620874322264,0.0248743337767745,0.0409314720502073,1.03531346282163e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0316027743974894,0.00393531568940708,0.0238895556462515,0.0393159931487273,1.03917353496217e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0247971279582533,0.00308872489510572,0.0187432271638461,0.0308510287526606,1.05659124988815e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,40305,0.0700331712763281,0.0087349601754111,0.0529126493325224,0.0871536932201339,1.15329478031811e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,0.0480635475484555,0.00599802781271391,0.0363074130355363,0.0598196820613748,1.20855156076142e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0256407192440671,0.00320316602701748,0.0193625138311129,0.0319189246570214,1.278374059676e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37628,-0.0327813505561277,0.00409908393676745,-0.0408155550721919,-0.0247471460400635,1.37805934897107e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,0.0361824149777232,0.0045260041440399,0.027311446855405,0.0450533831000414,1.40773700763759e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0318818019302769,0.00399207382414414,0.0240573372349544,0.0397062666255994,1.48501265097209e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0495155270895754,0.00620060592007005,0.0373623394862381,0.0616687146929127,1.51146037235452e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.0549655311917224,0.00688432584171686,0.0414722525419574,0.0684588098414875,1.53117099014514e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37942,0.0479701847786827,0.00601403163267906,0.0361826827786318,0.0597576867787337,1.62771541894679e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.0160908578241049,0.00201891702528978,-0.0200479351936729,-0.0121337804545369,1.69532620726107e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0443634601924976,0.00557497147287108,0.0334365161056702,0.0552904042793249,1.87433416111983e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,40357,0.0195938841130067,0.00246580343150528,0.0147609093872563,0.024426858838757,2.05048875373276e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,0.0709920153008804,0.00893707936614367,0.0534753397432388,0.088508690858522,2.09891478437277e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0330463128789543,0.00416040921825751,0.0248919108111696,0.041200714946739,2.13247865377812e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,40309,0.0298878838283145,0.00376369640798111,0.0225110388686715,0.0372647287879575,2.13750355660524e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0586548845280304,0.00738839690660784,0.044173626591079,0.0731361424649817,2.176845094197e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,0.0638518890563075,0.00804409792741391,0.0480854571185762,0.0796183209940388,2.19579817532035e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39925,0.03417957498775,0.00430659524916072,0.025738648299395,0.042620501676105,2.22026820858842e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.034199093329579,0.00430907807010543,0.0257533003121723,0.0426448863469856,2.24664139282594e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.0686528579991106,0.00866295805803874,0.0516734602053546,0.0856322557928665,2.466899610184e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,40147,0.0354233218466901,0.00447129832028459,0.0266595771389323,0.0441870665544479,2.48547888194897e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,0.0235766012025492,0.00297737423029179,0.0177409477111773,0.0294122546939211,2.56629644859196e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.0654429316632897,0.00826321201535203,0.0492470361131997,0.0816388272133797,2.56867761435093e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,40203,0.0403544625844185,0.00509951069680243,0.0303594216186857,0.0503495035501512,2.67020994855707e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40471,0.0170810971855791,0.00216064277337776,0.0128462373497587,0.0213159570213996,2.83994412040808e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,40303,0.020777860990187,0.0026312892340407,0.0156205340914672,0.0259351878889067,3.05637071105852e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.0764413693471692,0.00968233912882351,0.0574639846546751,0.0954187540396633,3.09344982812799e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,40341,0.0371431601279062,0.00470758274440592,0.0279162979488706,0.0463700223069418,3.21577470719949e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,0.0346866285734082,0.00439682393234211,0.0260688536660177,0.0433044034807987,3.24066241694928e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37628,-0.0532023544480779,0.00675535783020749,-0.0664428557952846,-0.0399618531008712,3.65619714691959e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,40324,0.0779279148264569,0.00991311172877797,0.0584982158380521,0.0973576138148618,4.05114686287387e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,0.0864238000677068,0.0110012840174101,0.0648612833935831,0.107986316741831,4.27141708836957e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0580767418909368,0.00743026631670761,0.0435134199101899,0.0726400638716838,5.8454001356155e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,0.0736519512623281,0.00942556694674874,0.0551778400467006,0.0921260624779556,5.95669520591028e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.0643575315316543,0.00825139568051224,0.0481847959978503,0.0805302670654583,6.60376513409038e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,0.0452645761194962,0.00580409261361414,0.0338885545968125,0.0566405976421799,6.649194153382e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37598,0.0328465176352024,0.00421335014499661,0.024588351351009,0.0411046839193958,6.87907554563756e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40516,0.0255558619526605,0.0032789418351173,0.0191291359558306,0.0319825879494904,6.89118902218881e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELL,L-selectin,38013,-0.0174759940135142,0.00224193330504888,-0.02187018329141,-0.0130818047356184,6.90540296458545e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,40270,0.0592047995397102,0.00760028927301704,0.0443082325645968,0.0741013665148236,7.12569403454393e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,0.0424774980108682,0.00545483677165397,0.0317860179384264,0.05316897808331,7.36684946023658e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0728178614541084,0.00935440848753342,0.0544832208185429,0.0911525020896739,7.43798912227147e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,0.0501046052570582,0.0064392037745314,0.0374837658589767,0.0627254446551398,7.72134985115692e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.0512620366215999,0.00659289123377415,0.0383399698034026,0.0641841034397972,8.06674778082188e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,0.0515889877151464,0.00663831201449052,0.038577896166745,0.0646000792635478,8.23609803852643e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,40305,0.0447640758553807,0.00576013162684428,0.0334742178667659,0.0560539338439955,8.23862873277495e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,0.0363370064206305,0.00467996162811012,0.0271642816295346,0.0455097312117263,8.70606189332072e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,0.0450081365855663,0.0057970502328613,0.0336459181291582,0.0563703550419745,8.72743924047914e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37671,0.040659090939879,0.00523976580353922,0.0303891499649421,0.0509290319148158,9.13484654052881e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.022890263630892,0.00295298840023964,-0.0286781208953617,-0.0171024063664223,9.62281276476743e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0397032699104132,0.00512389885935346,0.0296604281460805,0.049746111674746,9.96740291091196e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,0.0535794112079497,0.00692704839541348,0.0400023963529392,0.0671564260629601,1.10870950659533e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,0.0604525422651052,0.00782830530644671,0.0451090638644697,0.0757960206657408,1.21079399668196e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.0830916867668148,0.0107647564253582,0.0619927641731126,0.104190609360517,1.2432709086585e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,40341,0.0250231636408581,0.00324192932864605,0.0186689821567118,0.0313773451250043,1.24581112196058e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,0.0478638209399429,0.00620243247808062,0.0357070532829049,0.0600205885969809,1.26147829281739e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.0776162544163709,0.0100749118079406,0.0578694272728073,0.0973630815599346,1.39719844864541e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.049423065589597,0.00641802916853021,0.0368437284192778,0.0620024027599163,1.43510065105843e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0349202391128363,0.00454452160375544,0.0260129767694757,0.043827501456197,1.63056517920435e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37572,0.0968000155728729,0.0126095350793287,0.0720853268173886,0.121514704328357,1.74718182299916e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.0770068578181159,0.010038916326671,0.0573305818178407,0.0966831338183911,1.82813021513603e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0425091841080285,0.00554459330695523,0.0316417812263963,0.0533765869896607,1.86523974948527e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,38013,0.048350105886909,0.00630638972040493,0.0359895820349154,0.0607106297389027,1.88242884559064e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0223142788719146,0.0029108774104122,0.0166089591475067,0.0280195985963225,1.89801367713955e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,0.0974734847281426,0.0127194627201463,0.0725433377966559,0.122403631659629,1.91541389531619e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0467866721151792,0.00610809737834246,0.0348148012536279,0.0587585429767304,1.97209737236575e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,0.039152922250101,0.00511984462137966,0.0291180267921969,0.0491878177080051,2.16857817444409e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,0.0143925903761095,0.0018828591309544,0.0107021864794389,0.0180829942727801,2.22567104063711e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0262296098002145,0.00343268219864401,0.0195015526908723,0.0329576669095568,2.27581079090551e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37901,0.0496516535613774,0.00649820290873149,0.0369151758602636,0.0623881312624911,2.30398473390087e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0346435151675321,0.00453638421917716,0.0257522020979448,0.0435348282371193,2.37563549719426e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,0.0138107622482252,0.00180936867262953,0.0102643996498713,0.0173571248465791,2.44795985154807e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0417399244615395,0.00546915846113815,0.0310203738777087,0.0524594750453703,2.47268318674628e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0374265307466134,0.00490525328627498,0.0278122343055144,0.0470408271877123,2.48108741226285e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37900,0.0466988533215374,0.00612253931785465,0.0346986762585423,0.0586990303845325,2.55657525401657e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.025813832537235,0.00338826548863429,0.0191728321795118,0.0324548328949583,2.73555612722562e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37990,0.0214471424676992,0.00281685318973361,0.0159261102158214,0.0269681747195771,2.83599292540782e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37671,0.054301314622421,0.00713322624969648,0.040320191173016,0.0682824380718261,2.8715688241673e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,40044,0.0581895837795285,0.00764800925943022,0.0431994856310452,0.0731796819280117,2.93189216952438e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,40330,0.0266004522449083,0.00350084997124449,0.0197387863012691,0.0334621181885476,3.16782537552264e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.027894498191382,0.0036743625375821,0.020692747617721,0.0350962487650429,3.33685195629306e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,40396,0.0420688778902924,0.00554244976596683,0.0312056763489974,0.0529320794315874,3.36766619514908e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0265775142085881,0.00350375819190383,0.0197101481524566,0.0334448802647196,3.49702906437612e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40483,0.0509498834345962,0.00671735104758149,0.0377838753813365,0.0641158914878559,3.51171241223812e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.0619446035820461,0.00816660142913717,0.0459380647809372,0.0779511423831549,3.54552764928507e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,0.0255416910174971,0.00336967205259855,0.018937133794404,0.0321462482405903,3.6832669300804e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,-0.0297958226091514,0.0039329616330348,-0.0375044274098996,-0.0220872178084032,3.79757810219929e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37572,0.0299577580423797,0.00396315006231045,0.0221899839202512,0.0377255321645082,4.32849620981153e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNC,Tenascin,40403,-0.0345016283550108,0.00456566858995631,-0.0434503387913252,-0.0255529179186965,4.3564546813272e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0495273293640933,0.00656103028641001,0.0366677100027297,0.0623869487254569,4.68585854135284e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37562,0.0342345581801584,0.00453680562022451,0.0253424191645184,0.0431266971957985,4.78542509567876e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,0.0356133615932648,0.00473119667078969,0.026340216118517,0.0448865070680126,5.51561784425327e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.01875046931724,0.00249391011146668,0.0138624054987653,0.0236385331357147,5.83445978851326e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.048667797849916,0.00647753078663309,0.0359718375081152,0.0613637581917169,6.13754133149534e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0154202428005905,0.0020538920910711,0.0113946143020911,0.0194458712990899,6.39696354335369e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37562,0.048654819966401,0.00648154585755272,0.0359509900855977,0.0613586498472044,6.45628448263359e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0209974756427445,0.00280170587394,0.0155061321298221,0.0264888191556669,7.06601685742122e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0415795091246289,0.00555013689397479,0.0307012408124383,0.0524577774368195,7.23695518602859e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37628,0.0492535013758151,0.00658062116929658,0.0363554838839938,0.0621515188676363,7.62997290648458e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0212313292539097,0.00284018133450492,0.0156645738382801,0.0267980846695394,8.1041709981359e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39980,0.0698476593497041,0.00934774003006329,0.05152608889078,0.0881692298086281,8.30973495871813e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0252671576237041,0.00338304710421219,0.0186363852994482,0.03189792994796,8.52560649230109e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,40422,0.066455133709434,0.00889924239768795,0.0490126186099656,0.0838976488089024,8.59455565554885e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.0668949407851447,0.0089612138242487,0.0493309616896172,0.0844589198806721,8.84330523661145e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,40333,0.0651233411385624,0.00872689529137241,0.0480186263674725,0.0822280559096524,8.93746069575103e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.0775554854867552,0.010398267772294,0.057174880653059,0.0979360903204515,9.28461396469637e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,40332,0.0530092961094756,0.00710997089603757,0.0390737531532419,0.0669448390657092,9.40515106986379e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,40203,0.0326864272983995,0.0043945776782256,0.0240730550490773,0.0412997995477217,1.07565614574527e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,0.0505944767164475,0.00680386827273251,0.0372588949018918,0.0639300585310032,1.10056527643196e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0443928197537828,0.00597169806513198,0.0326882915461241,0.0560973479614415,1.12017012762441e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELN,Elastin,37990,0.0252127986354515,0.0033925366094736,0.0185634268808832,0.0318621703900198,1.13513062136605e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,40332,0.0256447941024196,0.00345204531884893,0.0188787852774757,0.0324108029273635,1.15094724322763e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,0.0485390368276231,0.00653594360873321,0.035728587354506,0.0613494863007402,1.17154572431812e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37562,0.0426676998464262,0.00575369346852371,0.0313904606481197,0.0539449390447327,1.28406117100043e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,0.0512228702320994,0.00690939457996454,0.0376804568553689,0.0647652836088299,1.29165294127243e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,-0.0335017960088941,0.00452275217170781,-0.0423663902654414,-0.0246372017523468,1.35435582314534e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,0.040131677521141,0.00541768995567277,0.0295130052080223,0.0507503498342596,1.36502243345518e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.105222874508772,0.014225080730039,0.0773417162778957,0.133104032739649,1.475456119168e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0216370539798701,0.00292646747999211,0.0159011777190855,0.0273729302406546,1.50004423979186e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,-0.0423159135762902,0.00572482586481877,-0.053536572271335,-0.0310952548812455,1.53521204501634e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37705,0.0160349187738324,0.00216997935611745,0.0117817592358422,0.0202880783118226,1.56280768121458e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0827997831342305,0.0112073040290317,0.0608334672373283,0.104766099031133,1.5652430357768e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,0.0631856897368586,0.00855403899275869,0.0464197733110516,0.0799516061626657,1.59648155475579e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,0.0351026652163291,0.00475347755596669,0.0257858492066344,0.0444194812260238,1.60607081959419e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.0637122797651883,0.00862832189675156,0.0468007688475552,0.0806237906828214,1.61128001782091e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0389310426979384,0.0052759654235009,0.0285901504678767,0.0492719349280002,1.67590893223527e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,40332,0.0644735560143881,0.00873914544349641,0.0473448309451351,0.0816022810836411,1.69184577734746e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,0.0338631118549775,0.00459251536178876,0.0248617817458716,0.0428644419640835,1.7579682349186e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0257676662806259,0.00349714295355551,0.0189132660916571,0.0326220664695947,1.83257299018093e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,0.0164162109929196,0.00223156437736765,0.012042344813279,0.0207900771725602,1.99841476010784e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,0.0563041380813864,0.00765688487575458,0.0412966437249075,0.0713116324378654,2.02713339763242e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37628,0.0293883882163624,0.00399799949953034,0.021552309197283,0.0372244672354419,2.08679823257083e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37572,0.0567609090669181,0.00772376884138258,0.0416223221378082,0.0718994959960279,2.11724906830343e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,0.0278464364064181,0.00379260500968669,0.0204129305874322,0.035279942225404,2.22020722093653e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0189100469428843,0.00257620492834919,0.0138606852833199,0.0239594086024487,2.23524287273258e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,0.026455109827839,0.00360688355274476,0.0193856180644593,0.0335246015912187,2.33082041429264e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.0594909290136917,0.00812350435018741,0.0435688604873244,0.075412997540059,2.55931237542318e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,-0.0432176526484498,0.00590685391503806,-0.0547950863219244,-0.0316402189749752,2.66511212014269e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0288033781061996,0.00393692957290683,0.0210869961433022,0.036519760069097,2.69501342210098e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.0549459401211013,0.00751608117454924,0.0402144210189848,0.0696774592232179,2.79226307123205e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40471,0.0240114677840157,0.00328667492868467,0.0175695849237938,0.0304533506442377,2.88809644832158e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0282301679285359,0.00386856593913999,0.0206477786878215,0.0358125571692503,3.09895449966339e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0289586372013361,0.00397120566161113,-0.0367422002980939,-0.0211750741045783,3.19450045918774e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.0562930814274558,0.00772141759265881,0.0411591029458445,0.071427059909067,3.23319291635563e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0398016070470819,0.00546037377396385,0.0290992744501128,0.0505039396440511,3.26537683925527e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,0.0433969521554831,0.00596128756952883,0.0317128285192066,0.0550810757917596,3.50367365265384e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0347215426255845,0.0047777032631326,0.0253572442298446,0.0440858410213244,3.87544444127145e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0262923127421426,0.00362245041598367,0.0191923099268147,0.0333923155574706,4.13827085832744e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.0541307563099476,0.0074601601746289,0.039508842367675,0.0687526702522202,4.17201904871668e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0268065990395959,0.00369556989210367,0.0195632820510727,0.0340499160281191,4.24113715099895e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,0.0428912201962458,0.00591261647444223,0.0313024919063391,0.0544799484861526,4.26099872228993e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37901,0.0536877338692411,0.00740837663163783,0.039167315671231,0.0682081520672513,4.49673091572332e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,40332,0.0372313596509772,0.00515654389291432,0.0271245336208651,0.0473381856810893,5.42571295633981e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,-0.0237047142642946,0.00328530367692824,-0.030143909471074,-0.0172655190575153,5.62127561299263e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0138337661165231,0.00191832403682949,0.0100738510043373,0.0175936812287089,5.83357139529328e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,40305,0.0507755067505663,0.00704474221893169,0.0369678120014602,0.0645832014996724,5.95244292285151e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,0.0616841236116666,0.00856860573894062,0.0448896563633429,0.0784785908599902,6.34485383578029e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.0201065668954007,0.00279668072079345,-0.0255880611081558,-0.0146250726826455,6.79182776344538e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.0677685969930944,0.00943132434067005,0.0492832012853811,0.0862539927008077,7.05732150516984e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40516,0.0353258268248421,0.00492040579624349,0.0256818314642049,0.0449698221854794,7.30545064447941e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.0741770738813446,0.0103314537342569,0.053927424562201,0.0944267232004881,7.34901365133021e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI3,Elafin,40074,0.0370932058248013,0.00516734925085542,0.0269652012931247,0.047221210356478,7.37167914073042e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37901,0.047160516967922,0.0065692865566773,0.0342847153168345,0.0600363186190095,7.39402423805151e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.0666067699520962,0.00928681450219357,0.0484046135277968,0.0848089263763956,7.70633872913932e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,0.046615739247941,0.00649874014408612,0.0338782085655322,0.0593532699303498,7.71684445797726e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,40442,0.0505580153106394,0.00705813132804561,0.03672407790767,0.0643919527136088,8.23177114682941e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39809,0.0537686401818267,0.00750840801584756,0.0390521604707655,0.0684851198928879,8.3648551296898e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37998,0.0572099790931869,0.00798977555044118,0.0415500190143222,0.0728699391720516,8.45895998357112e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40514,-0.0289818935586214,0.00404912027979364,-0.0369181693070169,-0.0210456178102258,8.56666554990415e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39980,0.0420028745638293,0.00589050960689234,0.0304574757343203,0.0535482733933383,1.04338207592822e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39934,0.0615121327756746,0.00862736027439447,0.0446025066378615,0.0784217589134878,1.04890075411256e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0416029570883051,0.00583758412235946,0.0301612922084805,0.0530446219681296,1.0797526431309e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.0623633111470813,0.00877391709664689,0.0451664336376534,0.0795601886565092,1.23845093289404e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0303210138960912,0.00426585681095047,0.0219599345466283,0.0386820932455541,1.23904361328299e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2,Brorin,40167,0.0265936911976307,0.00374866468436105,0.019246308416283,0.0339410739789784,1.35676825733819e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.0206624472041619,0.00291273391882444,0.014953488723266,0.0263714056850578,1.36972547073822e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,0.0629023492211998,0.00888536669756943,0.0454870304939638,0.0803176679484359,1.51044252347795e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,0.0329597522728798,0.00466085430376877,0.023824477837493,0.0420950267082666,1.60675269391234e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39980,0.0259113563517487,0.0036660149029822,0.0187259671419035,0.0330967455615938,1.638852595479e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,0.0610477272496333,0.00864422997337198,0.0441050365018242,0.0779904179974424,1.7063180742397e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37942,0.0150113861928,0.00212748135034963,0.0108415227461147,0.0191812496394852,1.79801025598572e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.04208581297595,0.00596580284311009,0.0303928394034542,0.0537787865484458,1.81626164609897e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.0747610723521983,0.0106088691519762,0.053967688814325,0.0955544558900717,1.90253751294382e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.021304963790495,0.00302351536477645,0.0153788736755332,0.0272310539054569,1.92705134946572e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0646007780922204,0.00918380797740555,0.0466005144565056,0.0826010417279353,2.08655622290198e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.066995998563992,0.00952621156390258,0.0483246238987429,0.0856673732292411,2.1086673571032e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.0633811488580288,0.00901248083496632,0.0457166864214948,0.0810456112945628,2.12724152837938e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37642,0.0696007203380588,0.00991163881004384,0.0501739082703729,0.0890275324057447,2.29230211631547e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37735,-0.119585344282193,0.0170474136451755,-0.152998275026737,-0.0861724135376488,2.41314602710676e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,40332,-0.0214224770430505,0.00305506817876397,-0.0274104106734279,-0.0154345434126731,2.44210788359795e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40471,0.0239616928969338,0.00341735594064983,0.0172636752532601,0.0306597105406074,2.44731915884328e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,40332,-0.0159975922061736,0.00228464255747978,-0.020475491618834,-0.0115196927935133,2.620173436515e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0340742874250191,0.00487029639560396,0.0245285064896353,0.0436200683604029,2.75414998867364e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPART,Spartin,37671,0.0522098624519441,0.00746330624522504,0.037581782211303,0.0668379426925851,2.76956994553483e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.0212765568901966,0.00304253476282155,-0.0272399250253268,-0.0153131887550663,2.7970581147268e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37562,0.0266459767446732,0.00381374547340903,0.0191710356167915,0.0341209178725549,2.9475541262885e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,0.0458131335097762,0.0065604575589257,0.0329546366942818,0.0586716303252705,3.0198194450633e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37942,0.0720258967256076,0.0103150813112395,0.0518083373555783,0.092243456095637,3.03367104917041e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.0638625264385456,0.0091485582010526,0.0459313523644825,0.0817937005126087,3.056117804185e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37942,0.0918531724188233,0.0131570862784402,0.0660652833130806,0.117641061524566,3.06202847814461e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,40436,0.026870267880131,0.00385017854447364,0.0193239179329627,0.0344166178272993,3.09041759617579e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39980,0.0289882185106071,0.00415371377975273,0.0208469395022918,0.0371294975189225,3.0960858999269e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0367850639943485,0.00527241983210712,0.0264511211234185,0.0471190068652785,3.16170012076855e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0456170469787752,0.00654902979873024,0.0327809485732639,0.0584531453842865,3.40141191244536e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0200939247787606,0.0028850583183057,0.0144392104748814,0.0257486390826398,3.41713237029059e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.0553879556264504,0.0079527793015365,0.0398005081954389,0.0709754030574619,3.44632096386292e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,0.0169462306404759,0.00243372219602254,0.0121761351362717,0.02171632614468,3.4586600891202e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0430167395333563,0.00617856011847087,0.0309067617011534,0.0551267173655592,3.48294636078491e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37901,0.0553564174970117,0.00795228657913506,0.0397699358019069,0.0709428991921164,3.53358044909179e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.0598857843124202,0.00862755751647063,0.0429757715801378,0.0767957970447026,4.06544275845847e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0345270886017825,0.00497698393161995,0.0247722000958074,0.0442819771077576,4.15302006055074e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,-0.0116968925407054,0.00168676682713362,-0.0150029555218873,-0.00839082955952356,4.23335971868207e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,37541,0.0262262316154709,0.00378826183393609,0.0188012384209562,0.0336512248099856,4.62716410133262e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,0.0242419898894259,0.00350229095054878,0.0173774996263502,0.0311064801525015,4.63154044565402e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.061711882494319,0.00891561923705363,0.0442372687896938,0.0791864961989441,4.66722216010608e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,0.0500180964339245,0.00723034116501378,0.0358466277504975,0.0641895651173515,4.79345421783132e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0238347507808329,0.00344607770492153,0.0170804384791868,0.0305890630824791,4.84433984037443e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37900,0.0322072569478494,0.00466139295463522,0.0230709267567644,0.0413435871389344,5.08744999645921e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0354141514386716,0.00513022222206326,0.0253589158834276,0.0454693869939156,5.31749584908229e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37987,0.0604432550724138,0.0087607872320892,0.043272112097519,0.0776143980473087,5.45843723649575e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",38013,0.0109117186296126,0.00158164108764702,0.00781170209782445,0.0140117351614008,5.4698494533131e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37901,0.0683483441147258,0.00991013156580247,0.048924486245753,0.0877722019836987,5.55573621189852e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0194177480189801,0.00281673713694051,0.0138969432305767,0.0249385528073835,5.67753245646382e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0248786673057836,0.0036111869820661,0.017800740820934,0.0319565937906331,5.81591218363255e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,0.0597917833117266,0.00868998559280133,0.0427594115498359,0.0768241550736172,6.22477937431437e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0325238109653407,0.00473586062824289,0.0232415241339846,0.0418060977966967,6.77873730165403e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40489,-0.0296278958888719,0.00432328444441243,-0.0381015333999203,-0.0211542583778236,7.48986045759399e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.0555808684008681,0.00811827612808089,0.0396690471898296,0.0714926896119067,7.90093765788951e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,-0.0734972126763283,0.010739111258866,-0.0945458707437057,-0.0524485546089509,8.0615759585531e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0249809791956568,0.00365262746437122,0.0178218293654892,0.0321401290258244,8.25531373176349e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,40341,0.044447300356707,0.00651609745729079,0.0316757493404171,0.057218851372997,9.35709332613887e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,40433,0.0391961798604952,0.00575242520212712,0.027921426464326,0.0504709332566643,9.84125287719886e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40516,0.0415076149943052,0.0060972832163785,0.0295569398902033,0.053458290098407,1.02782602253775e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,38013,0.0242527126938703,0.00356330034409747,0.0172686440194393,0.0312367813683014,1.04385063635864e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,40341,0.0434500121768785,0.00638498527300087,0.0309354410417969,0.0559645833119602,1.04639568043913e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0348946272960067,0.00512859880224648,0.0248425736436036,0.0449466809484098,1.06111247585677e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,0.0236084075929785,0.00346991284443756,0.0168073784178808,0.0304094367680761,1.06232707041362e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,0.0221593676577659,0.00326165462686192,0.0157665245891165,0.0285522107264152,1.13838593243044e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,0.0459244941754672,0.00676012864974459,0.0326746420219678,0.0591743463289666,1.14100225368253e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,40396,0.0372824274970611,0.00550485869212862,0.026492904460489,0.0480719505336332,1.30872165900918e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,0.0464072956102265,0.00686299435049689,0.0329558266832526,0.0598587645372004,1.40881244077934e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,40185,0.0378369578491471,0.00559949880850052,0.0268619401844861,0.0488119755138081,1.45617776081353e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,40260,0.0369068131646583,0.00546189454036092,0.0262014998655509,0.0476121264637657,1.45653511335353e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0372907644100502,0.00551952943401275,0.0264724867193852,0.0481090421007152,1.46745214054727e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAX,Protein max,39961,0.0681216912081485,0.0100830376058098,0.0483589375007614,0.0878844449155356,1.46833121802948e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37671,0.0743731990631112,0.0110109756679556,0.0527916867539182,0.0959547113723042,1.49365184774495e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,0.0658161761056341,0.00974804977281751,0.0467099985509118,0.0849223536603565,1.51192540735239e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39961,-0.0479317263046226,0.00710702193826044,-0.0618614893036131,-0.0340019633056322,1.59226521162639e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37987,0.0443362636116034,0.00658528790763322,0.0314290993126423,0.0572434279105645,1.73348409647553e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.038016002799711,0.00564718167320941,0.0269475267202206,0.0490844788792014,1.74278899089575e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37770,0.0213916370252389,0.00317793100331229,0.0151628922587468,0.027620381791731,1.75028409942003e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40516,0.0296464076782512,0.00440934829204297,0.021004085025847,0.0382887303306554,1.83343539164852e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.0782889433590546,0.0116490404702608,0.0554568240373435,0.101121062680766,1.87293494064744e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,0.0536050114182513,0.0079782230138718,0.0379676943110626,0.06924232852544,1.90396049200684e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39877,0.0551969947222773,0.00821921180099974,0.0390873395923179,0.0713066498522368,1.93829635310147e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37900,0.0207267253745725,0.00308871486787557,0.0146728442335363,0.0267806065156086,2.01769313378397e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.0589592236817519,0.00880026016178235,0.0417107137646585,0.0762077335988453,2.17332528971524e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40497,-0.0307410451005495,0.00459901823024007,-0.03975512083182,-0.0217269693692789,2.39738950684514e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,40442,0.0449916190991951,0.00674187967511451,0.0317775349359707,0.0582057032624196,2.58062725014222e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0358830239411952,0.00537696963558261,0.0253441634554533,0.0464218844269371,2.58112432643048e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,40359,0.0155866829487935,0.00233862611172489,0.0110029757698127,0.0201703901277742,2.73570236687976e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0228744111850673,0.0034343673176352,0.0161430512425023,0.0296057711276323,2.83861572032288e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,0.0813603767704263,0.012232147272856,0.0573853681156285,0.105335385425224,2.99870033142681e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0393154968528764,0.0059163534747512,0.027719444042364,0.0509115496633887,3.12556235297431e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,0.0255795996903119,0.00385035956298172,0.0180328949468677,0.033126304433756,3.18462745910941e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40471,0.083857851098713,0.0126273191309799,0.0591083056019924,0.108607396595434,3.2161457709534e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37671,0.0190222892926785,0.00286395763067629,0.013408932336553,0.0246356462488041,3.21650427959012e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,0.0214240306964817,0.00323156191518429,0.0150901693427205,0.0277578920502429,3.47397967489215e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,0.075610826107408,0.0114297366870031,0.0532085422008819,0.0980131100139341,3.84835433672128e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.0739388793786786,0.0111825270659541,0.0520211263294085,0.0958566324279487,3.91273495978556e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0315984644539722,0.00478101774165236,0.0222276696803336,0.0409692592276108,4.01036999416445e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0363749279538032,0.00551121196324916,0.0255729525058348,0.0471769034017715,4.26410003780769e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0260246376245976,0.00394615474540868,0.0182901743235966,0.0337591009255986,4.38959891448354e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,0.0490249080806623,0.0074427818605476,0.034437055633989,0.0636127605273356,4.63173696576966e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,40209,0.0429844194842648,0.00653540883363412,0.030175018170342,0.0557938207981877,4.9461868252611e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,40305,-0.0182120301168209,0.00277060164518977,-0.0236424093413929,-0.012781650892249,5.07440155231806e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,0.0463092259318308,0.00704722224303856,0.0324966703354752,0.0601217815281863,5.14394066589473e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,40139,0.0485730086048789,0.00739544302941445,0.0340779402672266,0.0630680769425312,5.26116442234313e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,0.0346542764019052,0.00528183070801962,0.0243018882141867,0.0450066645896236,5.54554108284423e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0227890113793677,0.00347566044274058,0.0159767169115961,0.0296013058471392,5.66951495292426e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37987,0.0433199605630424,0.00660733829767171,0.0303695774996058,0.056270343626479,5.71442355822088e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,40360,-0.039739107194545,0.00606255315607885,-0.0516217113804595,-0.0278565030086304,5.74122513361145e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37671,0.0358215585773604,0.00546486949749738,0.0251104143622656,0.0465327027924553,5.77539521591576e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,40310,0.0294827403257573,0.00450055582424488,0.0206616509102373,0.0383038297412773,5.8947581267418e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,40396,-0.0193011103238312,0.00294689107289431,-0.0250770168267041,-0.0135252038209584,5.94356794782779e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,0.0372111904025741,0.00568382257564466,0.0260708981543106,0.0483514826508376,6.08921139833819e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,40411,0.0402111869382064,0.00614962909695613,0.0281579139081724,0.0522644599682404,6.38978268493285e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCN,Decorin,40042,-0.0144017594686183,0.00220427252893878,-0.0187221336253383,-0.0100813853118983,6.62123550474963e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37598,0.0316829076549258,0.00486093081528955,0.0221554832569583,0.0412103320528934,7.39160931503489e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37671,0.0680071943070953,0.0104389863906171,0.0475467809814857,0.0884676076327049,7.54573741003098e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37567,0.0270054157326541,0.00414724418455819,0.01887681713092,0.0351340143343881,7.70370287698476e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0351625376237978,0.00541565532651328,0.0245478531838318,0.0457772220637639,8.67842449877835e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,40359,-0.0437255094740187,0.00673854967032087,-0.0569330668278476,-0.0305179521201898,8.90437038819477e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37882,0.0288487275086802,0.0044569868688733,0.0201130332456886,0.0375844217716719,9.96127699059466e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,-0.0203168021939391,0.00314148392329585,-0.026474110683599,-0.0141594937042792,1.03305071019972e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0458599974082849,0.00709804688056852,0.0319478255223706,0.0597721692941992,1.0771919036267e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,40374,0.018418959595243,0.0028530484861266,0.0128269845624349,0.0240109346280511,1.10699343291442e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0201741621447667,0.00312602227300913,0.0140471584896688,0.0263011657998646,1.12378089024493e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37942,0.0436783557282872,0.00676862454285102,0.0304118516242992,0.0569448598322752,1.13357323095255e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,0.0546269867153974,0.00846582967239569,0.0380339605575019,0.071220012873293,1.13681250883733e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,0.0430854109549575,0.00668527613875092,0.0299822697230057,0.0561885521869093,1.19752734047547e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,0.0381092462291078,0.00591757362386856,0.0265108019263255,0.0497076905318902,1.22901796111578e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.0609107483036652,0.0094573926183436,0.0423742587717117,0.0794472378356186,1.23068051512034e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0339080251468425,0.00526852656835599,0.0235817130728648,0.0442343372208203,1.26935781567768e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,40332,0.0154204067598872,0.00239932996986606,0.0107177200189498,0.0201230935008247,1.33887670553696e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,0.026397480505264,0.00411083396696518,0.0183402459300122,0.0344547150805157,1.38819478782513e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37959,0.0473069423448314,0.0073708613241666,0.0328600541494648,0.0617538305401979,1.42591369600866e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0158550364829419,0.00247529324011978,-0.0207066112335766,-0.0110034617323071,1.55009338065097e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,0.015047821008101,0.00235260531109439,0.010436714598356,0.019658927417846,1.64491960085144e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0388189857794792,0.00607696379937482,0.0269081367327046,0.0507298348262539,1.72820890530952e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40489,-0.0280208289445286,0.00438987278467432,-0.0366249796024903,-0.019416678286567,1.7834851565541e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0266456008314271,0.00417493896955521,0.0184627204510989,0.0348284812117553,1.80347534515012e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,40305,-0.0174528018278735,0.00273626706995026,-0.0228158852849761,-0.012089718370771,1.83994278774729e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37572,0.0421446492385448,0.00662363735509356,0.0291623200225614,0.0551269784545282,2.04738536417376e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0363934037147119,0.00572569566293038,0.0251710402153683,0.0476157672140554,2.1263938397138e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,40250,0.0175858048226752,0.0027675828783433,0.0121613423811224,0.0230102672642281,2.15236694978068e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37905,0.0590742037615695,0.0093006495951347,0.0408449305551055,0.0773034769680335,2.19912151719395e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.0445251138208289,0.00701211064928343,0.0307813769482334,0.0582688506934245,2.21502011441533e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,37177,0.0757626338144972,0.0119436670335656,0.0523530464287087,0.0991722212002857,2.32464130493664e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,-0.01746926357428,0.00275528483486356,-0.0228696218506126,-0.0120689052979475,2.35604458433326e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.0660157160227208,0.0104174784505966,0.0455974582595514,0.0864339737858901,2.41730628858415e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,40359,0.0205583276395264,0.00324587076231112,0.0141964209453966,0.0269202343336562,2.45798785762971e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,0.0629920885078707,0.0099519063548904,0.0434863520522856,0.0824978249634559,2.5232069421375e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40516,0.0466936593878687,0.00738284979696116,0.0322232737858248,0.0611640449899125,2.60580665602092e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,40291,0.0430769594629597,0.00681118949174146,0.0297270280591464,0.0564268908667729,2.60966588537344e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0412040831035652,0.00653615502910616,0.0283932192465171,0.0540149469606132,2.99311038061126e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37942,0.0563458280050612,0.00894131423338117,0.0388208521076341,0.0738708039024883,3.03477187344661e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,0.0320136664734407,0.00508903326089782,0.022039161282081,0.0419881716648004,3.24466769781511e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37671,0.0346801891171645,0.00551317490277086,0.0238743663077337,0.0454860119265954,3.2658564453367e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,0.0402699057168053,0.0064029118240736,0.027720198541621,0.0528196128919895,3.27374616104068e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.0586551263380885,0.00933312516694049,0.0403622010108851,0.0769480516652918,3.38771593844064e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,-0.0377096783678145,0.00600260016513064,-0.0494747746914706,-0.0259445820441585,3.44386916291255e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37622,0.0401802499319764,0.00639944993111046,0.0276373280669999,0.0527231717969529,3.52129009983174e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0356012871457459,0.00567142158208258,0.0244853008448641,0.0467172734466278,3.55108681064236e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39924,0.0411671664901401,0.00656491361988051,0.0282999357951743,0.0540343971851059,3.68766449452722e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,0.0398659758517439,0.00636855221612549,0.0273836135081379,0.0523483381953499,3.95307407742476e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37598,0.0348055420183191,0.00556199134655529,0.0239040389790708,0.0457070450575675,4.02702024275461e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,-0.0145568990469449,0.00232688308995402,-0.0191175899032548,-0.00999620819063502,4.05184915688336e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0262870397749111,0.00420195814435942,0.0180512018119666,0.0345228777378556,4.07201763288925e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37942,0.0505735518469515,0.00808537063354242,0.0347262254052083,0.0664208782886946,4.09661134746588e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.0506089602184467,0.00809737003991342,0.0347381149402164,0.066479805496677,4.20776794532965e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,0.0466841880715174,0.00747359825054636,0.0320359355004465,0.0613324406425882,4.32530391158654e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,0.0496950017435631,0.00795859914102433,0.0340961474271554,0.0652938560599708,4.39043111854699e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39725,-0.0190421548293642,0.00305154247240364,-0.0250231780752753,-0.0130611315834531,4.48615570357328e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,0.0157319467834429,0.00252192998212529,0.0107889640184773,0.0206749295484084,4.54166760446232e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,0.0281140889595696,0.00451492703666584,0.0192648319677045,0.0369633459514346,4.89847046954973e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,-0.0188649077049389,0.00303213386061455,-0.0248078900717434,-0.0129219253381344,5.06877660188749e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0293270272910985,0.00471736863032909,0.0200809847756535,0.0385730698065436,5.22681873331943e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,40228,0.0432679312470427,0.00696210692090988,0.0296222016820593,0.056913660812026,5.26892764012854e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,40044,0.029454829652516,0.00474410317991401,0.0201563874198845,0.0387532718851474,5.47690511157178e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,0.0500555709210086,0.00806659507562584,0.034245044572782,0.0658660972692353,5.59432030815316e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37942,0.0274237925869247,0.00442766182486969,0.0187455754101801,0.0361020097636693,6.0458753101683e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37572,0.0270127260111319,0.00436482293864926,0.0184576730513794,0.0355677789708845,6.24552993819815e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,40311,0.0523744625273702,0.00847504296373416,0.0357633783184513,0.0689855467362892,6.57321304175237e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,0.0553908393918414,0.00898644066004396,0.0377774156981552,0.0730042630855276,7.27564411686318e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.0508351397813201,0.00825503889920599,0.0346552635388764,0.0670150160237638,7.5722412975224e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37884,0.0526289991802886,0.00854649500985282,0.0358778689609771,0.0693801293996002,7.5787160576936e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0298961593002765,0.00485705449972682,0.0203763324808119,0.0394159861197411,7.6779602041209e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37990,0.031908010158711,0.0051848500253536,0.021745704109018,0.0420703162084041,7.76421729924553e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.0222392646210112,0.00361483260840282,-0.0293243365334807,-0.0151541927085417,7.83109899750221e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40536,-0.0138749980422345,0.00225609077949531,-0.0182969359700454,-0.00945306011442373,7.93056454125881e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0362813548987248,0.00589938622221713,0.0247185579031792,0.0478441518942704,7.93261782897053e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37572,0.0264309916163356,0.00430514799552217,0.0179929015451121,0.0348690816875591,8.52274376718285e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,-0.0167286772912633,0.00272853463551509,-0.0220766051768728,-0.0113807494056537,8.9375822885808e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,0.0514073456161369,0.0083838032126657,0.0349750913193121,0.0678395999129617,8.94044820186569e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.0512657176102386,0.00836481742191202,0.0348706754632911,0.0676607597571862,9.10577848943392e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,40014,0.0235556879702731,0.00384437376648404,0.0160207153879644,0.0310906605525818,9.15271497088252e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0159032440672755,0.00259644560882921,0.0108142106739702,0.0209922774605807,9.28114852238403e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.0652158970235068,0.0106759461919323,0.0442910424873194,0.0861407515596942,1.02847342999851e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,0.0470391715611122,0.00771137865020596,0.0319248694067085,0.0621534737155159,1.09074627423551e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,38013,-0.0180200497554018,0.0029577793619443,-0.0238172973048126,-0.0122228022059909,1.14222574721831e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.0624551003007991,0.0102715774982444,0.0423228084042401,0.082587392197358,1.23190672963823e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,-0.0198742277837762,0.00327859772920218,-0.0263002793330125,-0.01344817623454,1.37639670176746e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,40044,0.0257212433788624,0.00424398128435826,0.0174030400615202,0.0340394466962046,1.38702365045194e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0466001117468783,0.00769410657505588,0.0315196628597687,0.0616805606339878,1.42823788507797e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40536,0.0514518519871003,0.00849652212330408,0.0347986686254243,0.0681050353487763,1.42973789781448e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,40372,0.0147495218470308,0.0024370646513601,0.00997287513036505,0.0195261685636966,1.46114462479902e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAYN,Layilin,40192,0.0200532991465997,0.00331583584842289,0.0135542608836908,0.0265523374095085,1.5021748134297e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,40332,0.0154720380689102,0.00255873591911039,0.0104569156674539,0.0204871604703666,1.51106617705497e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0383463242296359,0.00634658066699974,-0.0507856223369553,-0.0259070261223164,1.56180052241102e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40470,0.0351240033433916,0.00581617147049389,0.0237243072612236,0.0465236994255596,1.58473815931766e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,0.0692062131635775,0.0114625420275652,0.0467396307895498,0.0916727955376053,1.60617775628718e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,0.0240539832434628,0.00398531104633874,0.0162427735926389,0.0318651928942867,1.61857940538158e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,0.050825662463098,0.00843195215316172,0.034299036242901,0.067352288683295,1.70689438623125e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,0.0337096757725532,0.00560046904942399,0.0227327564356821,0.0446865951094242,1.79288835063365e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,37541,0.0319119905467676,0.00531334878751405,0.0214978269232401,0.0423261541702951,1.95193804110186e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,0.0265721593932208,0.0044253660284904,0.0178984419773796,0.035245876809062,1.96839667302319e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0392108964737025,0.00653227476523154,0.0264076379338487,0.0520141550135563,1.99261672154455e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,40305,0.0476793796589468,0.00794828318800914,0.0321007446104489,0.0632580147074447,2.03226102930281e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.033917959835499,0.0056550718277317,0.0228340190531449,0.0450019006178532,2.04382921994212e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,40396,0.0499029230341095,0.00832664142563198,0.0335827058398708,0.0662231402283481,2.10230569697309e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0173020047028824,0.0028874920899801,0.0116425202065214,0.0229614891992434,2.12469873750599e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.023939777672164,0.00400766530214839,-0.0317948016643748,-0.0160847536799531,2.37150197173953e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37990,0.0413668407563299,0.00692848288179064,0.0277870143080202,0.0549466672046395,2.42377018394018e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37628,0.0300272670092118,0.0050315117421327,0.0201655039946318,0.0398890300237919,2.46586382301132e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,40299,0.0163255751954369,0.00273740153298738,0.0109602681907816,0.0216908822000922,2.51531078755742e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0323212421469961,0.00542185726401493,0.0216944019095268,0.0429480823844654,2.56581350995003e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,-0.0155545399856004,0.00261219559007581,-0.020674443342149,-0.0104346366290518,2.6616006506099e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,40359,-0.021666193341972,0.00366169130621031,-0.0288431083021442,-0.0144892783817998,3.34616935687725e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39980,0.0263625373696476,0.00445635267083406,0.0176280861348129,0.0350969886044824,3.3737070393471e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0453651872066924,0.00766817821284642,0.0303355579095134,0.0603948165038714,3.3781739160267e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37942,0.0382548759822701,0.00646746817963481,0.0255786383501859,0.0509311136143544,3.39975066238232e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.0665075079166415,0.0112463096687728,0.0444647409658468,0.0885502748674363,3.42586768043872e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0158688608424002,0.00268755635939141,0.010601250377993,0.0211364713068074,3.60732372866225e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,0.0140420657590567,0.0023792898152864,0.00937865772109534,0.018705473797018,3.66808543486075e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,0.027560975097452,0.00467116711208551,0.0184054875577644,0.0367164626371396,3.71668472609043e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37942,0.015581706349732,0.00264379406698695,0.0103998699784376,0.0207635427210264,3.86678224005945e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,40177,0.0191685669544505,0.00325586753618733,0.0127870665835233,0.0255500673253776,4.00328439298383e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.0535849548733991,0.00910830786510301,0.0357326714577972,0.071437238289001,4.12263187255038e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,37482,0.0321687993225548,0.00546992342608846,0.0214477494074214,0.0428898492376881,4.17709967987681e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0235574179874883,0.00400603929717801,0.0157055809650194,0.0314092550099572,4.18969156324399e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0287655155486211,0.00489435341694487,0.0191725828514091,0.038358448245833,4.26925665295433e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,40330,0.021899520359939,0.00372870041963327,0.0145912675374578,0.0292077731824202,4.35919104475598e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,-0.0164798151552174,0.00280677874301588,-0.0219811014915285,-0.0109785288189062,4.42275585713491e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0321298760415518,0.00547271312020984,0.0214033583259405,0.0428563937571631,4.43835219441162e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,0.046596210390792,0.00796115150952292,0.0309923534321271,0.0622000673494569,4.94422301787999e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,0.0196849128239571,0.00336434850511423,0.0130907897539332,0.026279035893981,5.00061398608338e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,0.034065587693593,0.00583404832491695,0.0226308529767558,0.0455003224104303,5.3686645087757e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0388926100224753,0.00668479840474437,-0.0519948148957743,-0.0257904051491763,6.08867549887503e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGMN,Legumain,40422,0.0199324158992866,0.00342691381107218,0.0132156648295851,0.0266491669689881,6.12657600940445e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.029654488068114,0.00510459376751657,0.0196494842837815,0.0396594918524465,6.41559028893049e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,40305,0.0762911339108959,0.0131628390493233,0.0504919693742223,0.10209029844757,6.92266548771512e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0159727470593547,0.00275862802260483,0.0105658361350492,0.0213796579836601,7.19540333115492e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0352229611233538,0.00608600629190258,0.0232943887912247,0.0471515334554828,7.27763584823704e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39980,0.0329953617036691,0.00570260402183372,0.021818257820875,0.0441724655864632,7.34636536042204e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0272374484134729,0.0047081808064175,-0.0364654827940512,-0.0180094140328947,7.41009180797122e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,40341,0.0171842341154305,0.00297156676433714,0.0113599632573297,0.0230085049735313,7.4808829599573e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0193432531594852,0.00334716669805851,0.0127828064312905,0.0259036998876799,7.65601557418418e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.0117230133565325,0.00203022328051616,-0.0157022509863442,-0.00774377572672083,7.87333171461894e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39665,0.01259320973954,0.00218171720628645,0.00831704401521852,0.0168693754638614,7.9788967689531e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.0419733839220843,0.00727767771952689,0.0277091355918116,0.056237632252357,8.20301497104695e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,0.0182812160315908,0.00317643867941914,0.0120553962199293,0.0245070358432524,8.81056952371422e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0227790380031334,0.00396844354510538,0.0150008886547268,0.0305571873515399,9.66939855427181e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0385071618970686,0.00672170894514025,0.0253326123645937,0.0516817114295435,1.02993749048049e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0178985573454112,0.0031286747993915,0.0117663547386039,0.0240307599522186,1.08260166494008e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,0.0498668372583907,0.00872429151727766,0.0327672258845265,0.0669664486322549,1.11457176154479e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,0.0195256992862237,0.00341750492660219,0.0128273896300834,0.026224008942364,1.1311802565413e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,40274,0.0269349473512232,0.00471535727700506,0.0176928470882933,0.0361770476141532,1.1354619271713e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0287179851216622,0.00503185411243149,0.0188555510612964,0.0385804191820279,1.16865452147235e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0407767000385849,0.00714831806078888,0.0267659966394387,0.0547874034377311,1.18868310939755e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.027209997638025,0.00477073366592529,0.0178593596528114,0.0365606356232386,1.19860530903732e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0445467504189188,0.00781213083635222,0.0292349739796685,0.0598585268581692,1.20335818840609e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.0420837300917756,0.00738266375082552,0.0276137091401576,0.0565537510433937,1.21737849817072e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37628,0.0280078589667978,0.00491339574091379,0.0183776033146068,0.0376381146189888,1.22157055968834e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,0.0430525879926012,0.00755827138259233,0.0282383760827202,0.0578667999024821,1.24756933021551e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0305393937967134,0.00536194385322037,0.0200299838444015,0.0410488037490253,1.25169302214725e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,40359,0.0313056309965528,0.00549831569658825,0.0205289322312398,0.0420823297618657,1.2652746719397e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,40444,-0.023243668693777,0.00409272547237399,-0.03126541061963,-0.015221926767924,1.3762735940418e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0402359558836116,0.0070847829777208,0.0263497812472789,0.0541221305199444,1.38160955891916e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0246803447271766,0.00435859110199281,0.0161375061672707,0.0332231832870825,1.51799855663553e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0182691121875229,0.00322749416033836,0.0119432236332597,0.0245950007417861,1.53566303005616e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,-0.0146540213332607,0.00258859093852855,-0.0197276595727766,-0.00958038309374473,1.53620998857998e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,0.0417868990027547,0.00738290295726795,0.0273164092065095,0.0562573887989999,1.54052060778561e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,0.0129784586088021,0.00229313785808602,0.00848390840695351,0.0174730088106507,1.54232243094275e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.082152162789536,0.0145245667351074,0.0536840119887254,0.110620313590347,1.57533087018566e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,0.0265303016759331,0.00469197036244481,0.0173340397655413,0.0357265635863249,1.59139907863529e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.0219868893255734,0.00389177629555991,0.014359007786276,0.0296147708648709,1.63624150920462e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.0487706440570995,0.008675877799109,0.0317659235708459,0.0657753645433531,1.93149756223777e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,40379,-0.0181200120931263,0.00322388206554089,-0.0244388209415864,-0.0118012032446661,1.93533441641494e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,37402,0.0429035684814453,0.00763678559024718,0.0279354687245608,0.0578716682383298,1.97146172316298e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,40044,0.0616767200245415,0.0109881534706221,0.0401399392221222,0.0832135008269608,2.02213003145077e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37901,0.0563066362897729,0.0100493379847958,0.0366099338395731,0.0760033387399726,2.14785319365105e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0350736861391069,0.00627302997918577,0.0227785473799028,0.047368824898311,2.30005000771435e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37698,-0.0166867582037767,0.00298588198832875,-0.022539086900901,-0.0108344295066523,2.33489093743871e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,0.0536932077647335,0.00963757730307849,0.0348035562506997,0.0725828592787674,2.57781659718052e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,-0.0184666912358234,0.00331728196739607,-0.0249685638919197,-0.0119648185797271,2.64518293706528e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,40332,0.0250989787430391,0.00451095650544044,0.0162575039923758,0.0339404534937023,2.67914768057923e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0398167279250941,0.00717993970754855,0.025744046098299,0.0538894097518893,2.98517378190869e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,40228,0.0179358536737788,0.00323782661956781,0.0115897134994259,0.0242819938481318,3.08233368754051e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGN,Mimecan,40332,0.0217528993747323,0.00392979268822501,0.0140505057058113,0.0294552930436534,3.15470824006073e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37721,0.0135050902833654,0.00243959938735059,0.00872347548415823,0.0182867050825725,3.1572454812792e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.0171736329557595,0.00310263923996095,-0.0232548058660829,-0.011092460045436,3.15943685227837e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,-0.011696611638873,0.00211343930111369,-0.0158389526690558,-0.00755427060869016,3.18246463196738e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,0.0191869400728758,0.00346939765622758,0.0123869206666698,0.0259869594790819,3.24753279694584e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37921,0.0170341016760753,0.00308101591579544,0.0109953104811163,0.0230728928710344,3.2856086369434e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,0.0496383686694468,0.00897926181955054,0.0320390155031277,0.0672377218357658,3.28788805692345e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,0.0281277904558087,0.00508823842741039,0.0181548431380843,0.0381007377735331,3.29118247123898e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0409558539110097,0.00743524552006049,0.0263827726916911,0.0555289351303283,3.6888794380746e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0151355483586673,0.00274998617401817,-0.0205255212597429,-0.00974557545759169,3.77301966536619e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0133716479751454,0.00243087720074921,0.00860712866167692,0.0181361672886138,3.85041550113339e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0325241984317384,0.00591393193856695,0.0209328918321472,0.0441155050313296,3.87746381129299e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37598,0.0203403927792666,0.00370352125536399,0.0130814911187532,0.0275992944397801,4.04385799624003e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,40332,-0.0177079225976281,0.00322498723042573,-0.0240288975692625,-0.0113869476259937,4.06140868385881e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,40044,0.0372681093424548,0.00678858466275432,0.0239624834034563,0.0505737352814532,4.08627064226118e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.0525202652375518,0.00956910999020921,0.0337648096567418,0.0712757208183619,4.12620232146629e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0241508717892028,0.00440047970333231,0.0155259315706714,0.0327758120077341,4.13317341967699e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37990,0.0342910895420555,0.00626287383215047,0.0220158568310406,0.0465663222530704,4.44563887209731e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37714,0.0289416884542343,0.00528844718742861,0.0185763319668742,0.0393070449415943,4.51469887679469e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,40228,0.0183166602456934,0.00335101389330646,0.0117486730148127,0.024884647476574,4.67275237044142e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.0629731934064349,0.0115374052630098,0.0403598790909356,0.0855865077219341,4.88236952540254e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0277758587513578,0.0050926365074285,0.017794291196798,0.0377574263059177,4.99688929499278e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,40332,0.0636060022848995,0.0116636224391555,0.0407453023041546,0.0864667022656443,5.01635882733763e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37628,0.0158102627914759,0.00290149414993499,0.0101233342576033,0.0214971913253485,5.15620675716889e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0229891556950994,0.00422195885619279,0.0147141163369616,0.0312641950532373,5.25478477506931e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,40341,-0.0218486112496731,0.00401467180447187,-0.0297173679864379,-0.0139798545129082,5.34087178537004e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.0525083359047111,0.00965547006996834,0.0335836145675731,0.071433057241849,5.47891077135257e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,-0.0318921562859028,0.00587028340405165,-0.043397911757844,-0.0203864008139616,5.6434643463807e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0173294456046733,0.00319275078468651,-0.0235872371426589,-0.0110716540666878,5.78960485925084e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,-0.0246953192033555,0.00455348757361376,-0.0336201548476385,-0.0157704835590725,5.93352340893354e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0299491572073442,0.00552287168711398,0.0191243287006008,0.0407739857140876,5.95390207011886e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.0144072398918677,0.00266050515692259,-0.0196218299994359,-0.00919264978429939,6.20967197183988e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40516,0.0463190874394751,0.00856043595367422,0.0295406329702737,0.0630975419086766,6.36308634866124e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,0.0175940536497433,0.00325438945935081,0.0112154503094158,0.0239726569900709,6.54710426430969e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0341270852570194,0.00634820551316495,0.0216846024512161,0.0465695680628227,7.74894902941133e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37990,0.015709436580262,0.0029229928850748,0.00998037052551542,0.0214385026350086,7.80961191505178e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,-0.0146235554465482,0.00272481235680172,-0.0199641876658796,-0.00928292322721687,8.12927624477206e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0342807264918654,0.00639746055355299,0.0217417038069016,0.0468197491768293,8.51130734461095e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39961,0.0366376464188612,0.00683787440728223,0.023235412580588,0.0500398802571343,8.53283022583179e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,0.0317949740853452,0.00594038930121291,0.0201518110549679,0.0434381371157225,8.82872791719592e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,40042,0.0436802718234396,0.00816797786680674,0.0276710352044984,0.0596895084423808,9.03121097673956e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37900,0.0205841876571251,0.00385245779942254,0.013033370370257,0.0281350049439933,9.28443614541628e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0298362442728215,0.00558824933355988,0.0188832755790442,0.0407892129665989,9.4721234562333e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,40422,0.0223333112782748,0.00418378155667271,0.0141330994271963,0.0305335231293533,9.52260676366314e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,40379,-0.0169573812187814,0.00317934398415166,-0.0231888954277187,-0.0107258670098442,9.75943031526725e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.0483077523142325,0.00906937498526874,0.0305317773431057,0.0660837272853592,1.01504217550015e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.0434489342651376,0.0081578497009709,0.0274595488512346,0.0594383196790406,1.01782676155894e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0397524199617311,0.00746456252109337,-0.0543829625030741,-0.0251218774203881,1.02052631960978e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37942,0.0192750458923118,0.00361985870755683,0.0121801228255004,0.0263699689591232,1.0268181045457e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSG,Basigin,40502,0.0103539846239841,0.00194913487953979,0.00653368026008615,0.0141742889878821,1.0981963498523e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,40341,0.027208689784976,0.00512867111203577,0.0171564944053858,0.0372608851645661,1.14051154007024e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0448546954334148,0.00846143038106976,0.028270291886518,0.0614390989803115,1.16983926488616e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,0.0206220181168564,0.00389265088056138,0.0129924223909561,0.0282516138427567,1.19176126504636e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.018698911754488,0.00353946492758477,0.0117615604964219,0.0256362630125542,1.29125817248504e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,-0.0136437822275139,0.0025852200811721,-0.0187108135866112,-0.00857675086841657,1.32907710844754e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0142844876813718,0.00270776151609516,0.0089772751098253,0.0195917002529183,1.34585728763127e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,-0.0121752461451054,0.00230951058759951,-0.0167018868968004,-0.00764860539341033,1.36862404253589e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37572,0.0247987935163161,0.00471205080513944,0.0155631739382428,0.0340344130943894,1.4407853247945e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40536,-0.00866170855307434,0.00164729917821806,-0.0118904149423817,-0.00543300216376695,1.47392046315364e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,0.0270240111547383,0.005141176454307,0.0169473053042966,0.03710071700518,1.49207731735006e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37562,0.0203874314708159,0.00388374878124893,0.012775283859568,0.0279995790820637,1.54960880599511e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,-0.017640425753174,0.00336327962732622,-0.0242324538227334,-0.0110483976836146,1.58288274304112e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,40359,0.0347395794763133,0.00662869705426218,0.0217473332499594,0.0477318257026672,1.6193692636722e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.0477777457620646,0.00912023507852718,0.0299020850081513,0.0656534065159779,1.6382292762311e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.0405359239528467,0.0077393951627702,0.0253667094338171,0.0557051384718763,1.65114046500595e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0200917299465719,0.00383891567862026,0.0125674552164762,0.0276160046766676,1.68639401431222e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,0.0478411232420237,0.00914340967656994,0.0299200402759466,0.0657622062081007,1.69967516954464e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39961,0.0366298484664316,0.00700391173608336,0.0229021814637083,0.050357515469155,1.71794204359637e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,40359,0.0341959848494491,0.00654105540391187,0.0213755162577818,0.0470164534411164,1.73615136797228e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,37541,0.0324044156272532,0.00619832799713998,0.0202556927528589,0.0445531385016476,1.74058486211032e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0355683942008334,0.00680576929469795,0.0222290863832254,0.0489077020184413,1.75610377492045e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,0.0489821675248782,0.00937883107776285,0.030599658612463,0.0673646764372934,1.78626617771053e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,0.0369454354990023,0.00707658429948929,0.0230753302720033,0.0508155407260013,1.80371348478308e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0167018858401047,0.00321112093776767,0.0104080888020801,0.0229956828781293,2.00844992016572e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,40042,0.0191375794837783,0.00368823359705624,0.0119086416335481,0.0263665173340085,2.14284795871236e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,-0.0163738856317138,0.00315635324944566,-0.0225603380006273,-0.0101874332628003,2.16099894236319e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,0.0330957823247018,0.00638516956700895,0.0205808499733642,0.0456107146760393,2.20823363846273e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.035437223240908,0.00684727189641599,0.0220165703239326,0.0488578761578833,2.30703417141347e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0437212645590964,0.0084571806001518,0.0271451905827989,0.0602973385353939,2.37292228081268e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0185550764584983,0.00359386697619889,0.0115110971851484,0.0255990557318481,2.45983613186378e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.0550220457154074,0.0106669739935237,0.0341147766881009,0.0759293147427138,2.52360391820502e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,40422,-0.0310207670566862,0.00603193722115187,-0.0428433640101439,-0.0191981701032286,2.73941462593948e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,40221,-0.0142379588065297,0.00277283461396617,-0.0196727146499034,-0.00880320296315601,2.85801818168449e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,0.0208102023224623,0.00405975471452168,0.0128530830819998,0.0287673215629248,3.00193803693792e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.0507335043953195,0.00990818406604212,0.0313134636258769,0.070153545164762,3.09247940434967e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0319118344976057,0.00623348087141172,0.0196942119896387,0.0441294570055727,3.10135722241214e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.0432414665715082,0.00845226642093979,0.0266750243864663,0.0598079087565502,3.16520542202959e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,0.0264111376713386,0.00516441723708696,0.0162888798866482,0.0365333954560291,3.18944251040064e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37990,0.0258327318570397,0.00505717193942763,0.0159206748557616,0.0357447888583179,3.29772904029823e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37598,0.0215224058355921,0.00421390338247872,0.0132631552059338,0.0297816564652504,3.31062582699025e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.0134871950412198,0.00264077487918019,0.00831127627802663,0.018663113804413,3.3128771608023e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,38013,-0.0111515100700515,0.00218955575616306,-0.0154430393521311,-0.00685998078797188,3.57082738331067e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,-0.0104482232294984,0.00205211625249668,-0.0144703710843919,-0.00642607537460495,3.59428427406755e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0355493766903623,0.00699157431033732,0.0218458910421012,0.0492528623386235,3.72580626679987e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0359648650353262,0.00707701235953581,0.0220939208106361,0.0498358092600164,3.77967533785383e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37959,-0.021861298853624,0.00430640030440207,-0.0303018434502521,-0.013420754256996,3.89632952301931e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0340147457337612,0.00672587888974042,0.02083202310987,0.0471974683576524,4.30992200189057e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,40228,0.0641087148825449,0.0126992430979251,0.0392181984106117,0.0889992313544781,4.50885817450717e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,0.0339117228749669,0.0067201356970581,0.020740256908733,0.0470831888412008,4.55587607214149e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.0428336758992735,0.00848868430132188,0.0261958546686826,0.0594714971298644,4.56294860586586e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39980,0.0335316423829008,0.00664846255248092,0.0205006557800381,0.0465626289857634,4.62202468321541e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0174211075837504,0.00345582732288945,0.010647686030887,0.0241945291366137,4.69083665191531e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-0.0151265583590844,0.00300180185892673,-0.0210100900025808,-0.00924302671558807,4.736331248523e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,0.0338702086598125,0.00673099916905552,0.0206774502884637,0.0470629670311613,4.9169789634229e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.048818809758134,0.00970454320801746,0.0297979050704198,0.0678397144458483,4.94510786442738e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0228386949580543,0.00454287505067149,0.0139346598587382,0.0317427300573704,5.02674221560764e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0331568077836894,0.00660708585468263,0.0202069195085114,0.0461066960588673,5.27744457012993e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0148153937008435,0.0029531580403697,0.00902720394171884,0.0206035834599681,5.32061657723197e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,0.0140574778511462,0.00280209469003547,0.00856537225867667,0.0195495834436157,5.32167332447185e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.0121544668745948,0.00242892638218417,0.00739377116551388,0.0169151625836758,5.68419488989764e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0347294924813573,0.00695836720805948,0.0210910927535608,0.0483678922091539,6.07024636408549e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,40332,0.0319039724673906,0.0064025175429887,0.0193550380831328,0.0444529068516485,6.32529895025609e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,40305,0.0359518377812849,0.00721711867970412,0.0218062851690648,0.050097390393505,6.37683093131999e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0177998075596977,0.0035786489641674,0.0107856555899296,0.0248139595294658,6.64439402909078e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0130652439193,0.00262791055638394,0.0079145392287875,0.0182159486098125,6.704935291036e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.017191102162713,0.00345942953402579,0.0104106202760224,0.0239715840494035,6.80269003303368e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37987,-0.0118579311108184,0.00238751557630613,-0.0165374616403784,-0.00717840058125841,6.89535799239196e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,40032,0.0208202428579747,0.00419312380565315,0.0126017201988946,0.0290387655170549,6.9309840814977e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.0538635323943134,0.0108485232893376,0.0326004267472117,0.0751266380414151,6.94106805876876e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37987,-0.0228610074349137,0.00460677666336724,-0.0318902896951135,-0.0138317251747139,7.04471237935465e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,0.0248650919017674,0.0050105978301564,0.0150443201546609,0.0346858636488739,7.04704934210745e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0160515615497322,0.00324339295375861,0.00969451136036535,0.0224086117390991,7.53583952472582e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37900,0.0180978491294241,0.00365701360852526,0.0109301024567146,0.0252655958021336,7.55742080368764e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,40203,-0.0149267377936444,0.00301967879332931,-0.0208453082285698,-0.00900816735871894,7.76590435208017e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0227507007979753,0.00460380618012761,0.0137272406849251,0.0317741609110254,7.83662415173117e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,-0.00741005178285751,0.0014998117791958,-0.0103496828700813,-0.00447042069563375,7.8643196382304e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,0.0266723024765302,0.00541117924149454,0.0160663911632009,0.0372782137898595,8.36097299691006e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37812,0.0476680808631567,0.00967483758625915,0.0287053991940887,0.0666307625322246,8.44950338022545e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0257837062560661,0.00523481050684865,0.0155234776626428,0.0360439348494895,8.51676744093255e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0314884113333113,0.00641487651860813,0.0189152533568394,0.0440615693097833,9.261213986895e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,40435,0.0209097404174916,0.00427289692744547,0.0125348624396985,0.0292846183952847,9.99856490707215e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.00979343087567388,0.00200179792661752,0.00586990693950355,0.0137169548118442,1.00646008524987e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,40116,0.0319504432018944,0.00653543451691255,0.0191409915487458,0.0447598948550429,1.0245670057312e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37628,0.0440220665836187,0.00900570040203647,0.0263708937956272,0.0616732393716101,1.02937655257362e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37942,-0.0173533660964207,0.00355322415430233,-0.0243176854388532,-0.0103890467539881,1.05234198596728e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39980,0.025247227772127,0.00517021086953451,0.0151136144678394,0.0353808410764147,1.05410852493111e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.0135309656540203,0.00277280845771529,-0.0189656702311423,-0.00809626107689837,1.07402356943338e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0203339880056631,0.00416898632402427,0.0121627748105755,0.0285052012007507,1.08514017617072e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37900,0.0307649201118976,0.00631118026742192,0.0183950067877506,0.0431348334360446,1.10235053833978e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0231171709925934,0.00474578254652376,0.0138154372014068,0.0324189047837799,1.12243475893567e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,40346,0.0242963190593237,0.00499346435038295,0.0145091289325731,0.0340835091860743,1.15189990556112e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39990,0.0420400855000213,0.008679737338265,0.0250278003170219,0.0590523706830207,1.28817394121212e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37628,0.0548018216260919,0.0113305130232914,0.0325940161004406,0.0770096271517431,1.33533050440157e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,38013,-0.0351201400189834,0.00726278995123063,-0.0493552083233954,-0.0208850717145713,1.34183693701663e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0157644328956251,0.00326141838528129,0.00937205286047375,0.0221568129307764,1.35318991142165e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0288687178588909,0.0059826516294622,0.017142720665145,0.0405947150526368,1.41291371756049e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0313478219689048,0.00650535842306965,0.0185973194596882,0.0440983244781213,1.4604600304908e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,0.0327622607568986,0.00681270329522555,0.0194093622982565,0.0461151592155406,1.53376582958725e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0289648781976411,0.00602649579869221,0.0171529464322044,0.0407768099630778,1.5544075259477e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,40332,0.0181680791641161,0.00378675387486418,0.0107460415693823,0.0255901167588499,1.61877441568142e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37990,0.0259569333610276,0.00543122685005152,0.0153117287349267,0.0366021379871286,1.77840997733888e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39980,0.0347246190458339,0.00727400123533584,0.0204675766245757,0.0489816614670922,1.82430927202538e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39934,0.0287308797195435,0.00601858217235689,0.016934458661724,0.040527300777363,1.82529271946375e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,0.0439249565651404,0.00920530236368335,0.025882563932321,0.0619673491979598,1.84596453248885e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0282407578551459,0.00592413257774273,0.0166294580027702,0.0398520577075217,1.88930989173178e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40489,0.0209035616646842,0.00438568873569074,0.0123076117427304,0.0294995115866381,1.89274411572477e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,-0.0133740866228663,0.00280796415638259,-0.0188776963693761,-0.00787047687635639,1.92485437003221e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39947,0.0399184833469487,0.0083941588820404,0.0234659319381495,0.0563710347557479,1.99730533558975e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,0.0264635415271232,0.00556918010657216,0.0155479485182418,0.0373791345360047,2.03706413288211e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,-0.00677327034566372,0.00142784010387241,-0.00957183694925365,-0.0039747037420738,2.1197856651734e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,-0.0183707432917836,0.00387704408325598,-0.0259697496949653,-0.0107717368886018,2.1734384395678e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39961,0.0281546687972192,0.00594372717780578,0.0165049635287199,0.0398043740657185,2.18965779387936e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0383182219490096,0.00809784429522239,0.0224464471303738,0.0541899967676455,2.24385830830419e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,40341,0.0294117149317659,0.00621652989462709,0.0172273163382968,0.041596113525235,2.25104954463323e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0233126973082763,0.00493483656501285,0.0136404176408511,0.0329849769757015,2.33466082823983e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,40411,0.0133321312903612,0.00282637245106706,0.00779244128626977,0.0188718212944526,2.41319216114285e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37990,-0.0117541900777212,0.00250320749268792,-0.0166604767633895,-0.00684790339205287,2.68366991426033e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40471,0.011820976073028,0.00251900023780437,0.00688373560693144,0.0167582165391246,2.71819193822841e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0252629538708374,0.00538459194213014,0.0147091536642623,0.0358167540774125,2.73628237734698e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37598,0.0234480675550248,0.00499930826476353,0.0136494233560883,0.0332467117539613,2.75601284225736e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,0.018186964837221,0.00387862914443689,0.0105848517141247,0.0257890779603173,2.76810719120102e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0215089090123698,0.00458958235429498,0.0125133275979516,0.0305044904267879,2.80680981092213e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37986,0.0165233324957908,0.00352852363888613,0.00960742616357393,0.0234392388280076,2.857469990441e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,-0.026165194646954,0.00559021386827284,-0.0371220138287687,-0.0152083754651392,2.88466840789926e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.012773450775946,0.00273561205610648,-0.0181352504059147,-0.00741165114597725,3.04686593343103e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39961,0.0303327307292237,0.00650565268991264,0.0175816514569949,0.0430838100014525,3.14965132867861e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37678,-0.014243922619599,0.00305626149986639,-0.0202341951593371,-0.00825365007986083,3.1841230468288e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37901,0.0152152880983976,0.00326879355304107,0.00880845273443705,0.021622123462358,3.27535511107872e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,-0.0120483079267076,0.0025894861964153,-0.0171237008716816,-0.00697291498173365,3.30686551393795e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,40312,0.0302240023518719,0.00649726068630534,0.0174893714067135,0.0429586332970304,3.31696763530587e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37608,0.0186943515579111,0.00402010109805472,0.0108149534057239,0.0265737497100984,3.34808873741698e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,0.0213043915352539,0.00458439283802607,0.0123189815727228,0.030289801497785,3.3923790957975e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,-0.0182412871104264,0.00392951193406542,-0.0259431305011946,-0.0105394437196581,3.47654235123834e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,0.0390164266286702,0.00840500704951859,0.0225426128116138,0.0554902404457266,3.47721475332534e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,0.0346780676018823,0.00747209129093769,0.0200327686716444,0.0493233665321202,3.50027690543367e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0181927990655801,0.00392561430660417,0.010498595024636,0.0258870031065243,3.61444959811249e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37643,0.06334685476044,0.0136735512615856,0.0365466942877322,0.0901470152331477,3.64200433946075e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,0.0251231450323125,0.00542669118218096,0.0144868303152379,0.0357594597493872,3.69414923486557e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,-0.0126167438877495,0.00272801885031228,-0.0179636608343615,-0.00726982694113739,3.77777757924382e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0114008587407845,0.00246939696074546,0.00656084069772344,0.0162408767838457,3.92664022362329e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0280235015893666,0.00607303527019947,0.0161203524597756,0.0399266507189575,3.97941696506844e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,40359,-0.0373565688171941,0.00810012672756696,-0.0532328172032253,-0.0214803204311628,4.02210237731828e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,0.0299484757308766,0.00652214364701606,0.0171650741827251,0.0427318772790281,4.42778345562744e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0166310430910717,0.00363680284979689,0.00950290950546976,0.0237591766766736,4.85103450256939e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37931,0.0284147541713808,0.00622216388562606,0.0162193129555537,0.0406101953872079,4.99851241448144e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.0204785311111833,0.0044913507883565,0.0116754835660046,0.0292815786563621,5.16558201999567e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0208797417861341,0.00458125666737652,0.0119004787180761,0.0298590048541921,5.21955485923257e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0156995998553826,0.00344643140920647,0.00894459429333788,0.0224546054174272,5.27022367899959e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40471,0.0130955890503395,0.00287704109887532,0.00745658849654391,0.0187345896041351,5.35913230849941e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0336883341918826,0.00741231024298845,0.0191602061156253,0.04821646226814,5.53715748048103e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,0.0276763582535752,0.00609356451985688,0.0157329717946557,0.0396197447124947,5.62467948404686e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00888495094133625,0.0019581220418682,-0.0127228701433979,-0.00504703173927457,5.7434691642264e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0235415624268669,0.00519726197275823,0.0133549289602608,0.033728195893473,5.95241256557501e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0240367305018722,0.00530758629034045,0.0136338613728049,0.0344395996309395,5.97662050251741e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0221702466390481,0.00489633643164194,-0.0317670660450663,-0.0125734272330299,6.00772765662369e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,0.0103331894260171,0.00229406064707221,0.00583683055775561,0.0148295482942787,6.70637783305927e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0217078600964911,0.00482298906740894,-0.0311609186686126,-0.0122548015243696,6.81419682669736e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0268951514527416,0.00597788032751777,0.0151785060108068,0.0386117968946764,6.88218919697979e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,0.0321433358316945,0.00714511988410861,0.0181389008588416,0.0461477708045473,6.88850462456966e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,-0.0112472670006428,0.00250190754768143,-0.0161510057940984,-0.0063435282071872,6.99906412853882e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,40332,-0.00842622343577511,0.00187479518424257,-0.0121008219968906,-0.00475162487465967,7.02341308931124e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,0.013936965126145,0.00310073019716422,0.00785953393970312,0.0200143963125869,7.02499690554935e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,0.0372610010740782,0.00829907406714792,0.0209948159024683,0.0535271862456882,7.17984517695511e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,40305,-0.00659579650012305,0.00146910096392762,-0.00947523438942119,-0.00371635861082491,7.18324445206923e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0139637294449495,0.00311401388214746,0.00786026223594045,0.0200671966539585,7.37169324596198e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,0.0209554920481311,0.00467841876867778,0.0117857912615227,0.0301251928347396,7.54559751213526e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,0.0542623993218751,0.0121213116701705,0.030504628448341,0.0780201701954093,7.64716628861461e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0117572983489115,0.00262783431537234,0.00660674309078168,0.0169078536070413,7.72462404147227e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37942,0.0308053847589208,0.00688520551246311,0.0173103819544931,0.0443003875633485,7.73464633852151e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.0543003087196838,0.0121397447111593,0.0305064090858116,0.078094208353556,7.77823412797995e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39961,0.0227508950676613,0.00509343498243633,0.0127677625020861,0.0327340276332365,7.99932013381366e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.028759988143011,0.00645598800147878,0.0161062516601126,0.0414137246259094,8.46551639344118e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39961,0.0196261193909343,0.00440731068560326,0.0109877904471519,0.0282644483347167,8.52373532933249e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,0.0301356584916402,0.00676900629826322,0.0168684061470443,0.0434029108362361,8.57662607473366e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,40359,0.0290871826858646,0.00654594371215526,0.0162571330100403,0.0419172323616889,8.90871066099394e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0123088715428238,0.00277259037768517,0.00687459440256086,0.0177431486830867,9.09081722056616e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,0.0525155857627186,0.0118311250475163,0.0293265806695866,0.0757045908558505,9.12152782874331e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0296073667773283,0.00667437247677164,0.0165255967228558,0.0426891368318007,9.24014474440431e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37819,0.0191187109079081,0.00431359037878584,0.0106640737654879,0.0275733480503284,9.40176158084629e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37671,0.0153918366747522,0.00347694106406107,0.0085770321891925,0.0222066411603119,9.63932653056237e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,0.0190682587744869,0.00431251453812531,0.0106157302797613,0.0275207872692125,9.86127316956091e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0445787622927261,0.0100927157975528,0.0247970393295226,0.0643604852559297,1.0078154332589e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,0.0329954223813812,0.00747585276328211,0.0183427509653482,0.0476480937974141,1.02479401177755e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.0505434413758948,0.0114670870557979,0.0280679507465309,0.0730189320052586,1.05157096360239e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0185757469805514,0.00423146172703386,0.010282081995565,0.0268694119655377,1.14257605866271e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,0.0118486786991963,0.00270329331644418,0.00655022379896571,0.0171471335994269,1.1777220012377e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0257802204584214,0.00589464262445199,0.0142267209144955,0.0373337200023473,1.23041831617384e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0202062608368258,0.00462760234239732,0.0111361602457271,0.0292763614279246,1.2721475682942e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0230300283335449,0.00528914503293384,0.0126633040689946,0.0333967525980952,1.34537471376283e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,0.0360558826517493,0.00828887993061761,0.0198096779877387,0.0523020873157598,1.37044076452222e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0174664590979669,0.00401897954235298,0.00958925919495501,0.0253436590009787,1.39685575251437e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F3,Tissue factor,40393,-0.0117750460875733,0.00270963818915475,-0.0170859369383167,-0.00646415523683004,1.39745074853367e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0169637916493099,0.00390599974056364,-0.0246195511408146,-0.00930803215780517,1.41600115804041e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,38013,0.0110186806504623,0.00253720956767202,0.00604574989782519,0.0159916114030995,1.41677373612195e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.0140809673267128,0.00324467525925923,-0.0204405308348609,-0.00772140381856474,1.43556278732695e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,0.0245567660713375,0.00565888898832283,0.0134653436542248,0.0356481884884503,1.43677540838816e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37942,0.0304179412681306,0.00701622397805313,0.0166661422711464,0.0441697402651147,1.46568807948337e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0161327485401704,0.00372191830725163,0.00883778865795721,0.0234277084223836,1.47164127665736e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37900,0.0172514255955228,0.00398029359032467,0.00945005015848641,0.0250528010325591,1.47347760575438e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,-0.015421722586132,0.00357315671550065,-0.0224251097485132,-0.00841833542375068,1.60045819027616e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40489,0.0118914834035563,0.00275748855136249,0.00648680584288584,0.0172961609642268,1.62432712778991e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,40171,0.0243285700068218,0.00564809958990354,0.0132582948106109,0.0353988452030328,1.66194224851374e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,40172,0.0292124699108003,0.00679102662862074,0.0159020577187036,0.042522882102897,1.70571275927117e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,0.0199985204678664,0.0046495214721743,0.0108854583824047,0.029111582553328,1.71078562895296e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,40359,0.0316715714313176,0.00737037814239779,0.017225630272218,0.0461175125904173,1.74041271290277e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0212226181481287,0.00494151417439917,0.0115372503663063,0.030907985929951,1.75944529962266e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,0.0154518649488516,0.00360169637455116,0.00839254005473131,0.0225111898429718,1.7962328464891e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0100273459032114,0.00233746347810203,0.00544591748613143,0.0146087743202914,1.79867287333368e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAT,Catalase,37786,0.0226357368773439,0.00527650108724087,0.0122937947463518,0.032977679008336,1.80001502311958e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,0.0282707738224638,0.00659519011648256,0.015344201194158,0.0411973464507696,1.82538973903626e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,0.0237232824604142,0.0055386441207318,0.0128675399837799,0.0345790249370486,1.85478280825925e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.0127843104402692,0.0029911157757513,-0.0186468973607417,-0.00692172351979666,1.93060342957326e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,0.0335046163425674,0.00784511147164945,0.0181281978581344,0.0488810348270003,1.95929837785783e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,0.0263575532766988,0.0061739194055019,0.0142566712419151,0.0384584353114825,1.97332730690383e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,40042,0.0307313963622395,0.00721763170250214,0.0165848382253353,0.0448779544991437,2.07635841016715e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0278830456629818,0.00655078102100541,0.0150435148618112,0.0407225764641524,2.08921309754528e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,0.0305717020445638,0.00718889964729724,0.0164814587358612,0.0446619453532664,2.12725788586046e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0206710536841853,0.00486130253525354,0.0111429007150884,0.0301992066532823,2.13174565595331e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,0.0432609280657531,0.010198220017773,0.023272416830918,0.0632494393005883,2.23006997855929e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.0111648617605791,0.00263821363212071,-0.0163357604795357,-0.00599396304162256,2.32934421746096e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0198783926460249,0.00470561894983263,0.0106553795043529,0.0291014057876969,2.40951607189105e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0136364910897578,0.00323040576326573,-0.0199680863857586,-0.00730489579375696,2.4454373227455e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0167972392029028,0.00398329641481894,0.00898997822985769,0.0246045001759479,2.49327812136572e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,0.0187507873156416,0.00444974007829395,0.0100292967621855,0.0274722778690977,2.52411140247081e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0178371525627753,0.00423396929313905,0.00953857274822278,0.0261357323773279,2.53576858392436e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39897,0.0191480660034091,0.00454553285580735,0.0102388216060267,0.0280573104007916,2.53990089997746e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,40314,0.0164142249788027,0.0039052488287838,0.00875993727438647,0.024068512683219,2.64703894645604e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37998,-0.0125337645928898,0.00298210373287838,-0.0183786879093314,-0.00668884127644813,2.65096805918654e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,0.0208277276655749,0.00496762272606273,0.011091187122492,0.0305642682086579,2.77469720430518e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,-0.0111174314786763,0.00265298149697709,-0.0163172752127514,-0.00591758774460124,2.7977416055165e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,0.0120123438205237,0.00286820572817647,0.00639066059329785,0.0176340270477496,2.82840515553114e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,0.0394430768502618,0.00945511008855578,0.0209110610766924,0.0579750926238311,3.04347487854256e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,0.0383427370273434,0.00920814425234994,0.0202947742927376,0.0563906997619493,3.14352773226712e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,40357,-0.0144557476120617,0.0034781671642351,-0.0212729552539625,-0.00763853997016088,3.25363904601225e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,0.0110282051275535,0.00265501970149239,0.00582436651262842,0.0162320437424786,3.29122211190758e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39961,0.0197784194286853,0.00476978233989178,0.0104296460424974,0.0291271928148732,3.39231458157974e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,0.0105243640880084,0.00254003593298224,0.0055458936593632,0.0155028345166536,3.43969030513885e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0140814693001123,0.00340292639051406,0.00741173357470477,0.0207512050255199,3.52456359112478e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,0.0136116172029113,0.00329278527418395,0.00715775806551078,0.0200654763403119,3.5901025905787e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39980,-0.033743998570429,0.00816909356566495,-0.0497554219591323,-0.0177325751817257,3.63568600531953e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0166069705582943,0.00402792113572133,0.00871224513228045,0.0245016959843081,3.76278817376194e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,-0.00743350838125622,0.00180315952399031,-0.0109677010482772,-0.00389931571423522,3.77033672739942e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,0.01533273901971,0.00373259679295924,0.00801684930550987,0.0226486287339101,4.01506183065552e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40471,-0.0122611079167835,0.00298601908721521,-0.0181137053277253,-0.00640851050584166,4.04265805655784e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,40042,0.0177696858778407,0.00433337789472888,0.00927626520417214,0.0262631065515094,4.14072753039117e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0203515355536596,0.00497177828546607,0.0106068501141461,0.0300962209931731,4.27222065096554e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40522,0.0133547127587754,0.00326252224425036,0.00696016916004468,0.0197492563575061,4.27225081683886e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,-0.0107695995357687,0.00263505361086467,-0.0159343046130634,-0.00560489445847391,4.39027809154094e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,40355,-0.0178209556771329,0.00436389424427587,-0.0263741883959136,-0.0092677229583522,4.45358857965437e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLU,Clusterin,38013,-0.013097132772656,0.00320714195558114,-0.0193831310055951,-0.00681113453971698,4.45711290077164e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,40209,-0.0502655947940375,0.012310438525885,-0.0743940543047721,-0.0261371352833029,4.46451329885516e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,-0.0169777669893278,0.00415803661705766,-0.0251275187587608,-0.00882801521989477,4.46979019557668e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,40355,0.0156000098433178,0.00382492671890002,0.00810315347427374,0.0230968662123618,4.55456150864578e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,40260,0.0116888643289286,0.00286736255110621,0.0060688337287604,0.0173088949290967,4.59380737337433e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,0.0392366252058756,0.00964711939978873,0.0203282711822897,0.0581449792294615,4.78136359200679e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0143521090907382,0.00352861511707246,0.00743602346127612,0.0212681947202002,4.78268539148285e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,0.0207409691053579,0.00510924726755703,0.0107268444609461,0.0307550937497696,4.94553179641647e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0237954957371639,0.00586843652984767,0.0122933601386625,0.0352976313356654,5.0461224020842e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.0287540065720922,0.00709262085151066,0.0148524697031313,0.0426555434410531,5.05718237352162e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,-0.00988632949955268,0.00243998603073217,-0.0146687021197877,-0.00510395687931763,5.10643648319081e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,0.0138395061796927,0.00342303103305369,0.00713036535490744,0.0205486470044779,5.3005527316288e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,0.0295994735086176,0.00732965039617255,0.0152333587321194,0.0439655882851158,5.40949947153769e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,0.045730940317915,0.0113287430257216,0.0235266039875007,0.0679352766483293,5.45122577174574e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,0.0270036646801864,0.00669375311804917,0.0138839085688101,0.0401234207915628,5.50550414886214e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2,Complement C2,40372,0.00934704403412543,0.00231765629641682,0.00480443769314847,0.0138896503751024,5.53325236316294e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.0344721832793586,0.00856172145136544,0.0176912092346823,0.0512531573240348,5.69666899443812e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0184980494652758,0.00460015892911298,0.00948173796421434,0.0275143609663372,5.81820384541879e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,0.0247722382508963,0.00616060814988305,0.0126974462771255,0.0368470302246671,5.82578988590745e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,-0.0183786808231923,0.00457730141272461,-0.0273501915921326,-0.00940717005425207,5.97219925054967e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.00526652595340145,0.00131467442099001,0.00268976408826103,0.00784328781854188,6.21036033994475e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0337355504792237,0.00843874343110105,0.0171956133542657,0.0502754876041818,6.43029353147857e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,40028,0.0165048452752996,0.00413092258679437,0.00840823700518268,0.0246014535454166,6.48717565042676e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40536,0.0189508724509519,0.00474933359859312,0.00964217859770942,0.0282595663041944,6.630539526207e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0155649182433668,0.00390257288209703,0.00791587539445666,0.023213961092277,6.6880002367959e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,-0.0107786652086908,0.00270337204170483,-0.0160772744104323,-0.00548005600694931,6.72438701118316e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0127887206810934,0.00321490411101291,-0.0190899327386787,-0.00648750862350807,6.98196803409013e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0243302178712812,0.00612091839341395,0.0123332178201899,0.0363272179223726,7.07744460210793e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37959,-0.0139401680389908,0.00350918675085965,-0.0208181740706757,-0.00706216200730589,7.14979441759283e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37990,0.0373479454462864,0.00940355976034097,0.0189169683160181,0.0557789225765547,7.1736378129716e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,0.0248600449444546,0.00626432638993123,0.0125819652201894,0.0371381246687198,7.26977412550434e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0185846719990427,0.00469073889430788,0.00939082376619926,0.0277785202318862,7.46516973435024e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,0.0196901936337756,0.00501087803978797,0.0098688726757912,0.02951151459176,8.55521822576166e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37942,0.0363712488521674,0.00927953863851719,0.0181833531206738,0.0545591445836611,8.91672980120611e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,0.017481339773548,0.00446109019927566,0.00873760298296767,0.0262250765641282,8.94950540917129e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37901,0.0133069431748719,0.00340091213837769,0.00664115538365167,0.0199727309660922,9.16974709808716e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39961,0.0312576350331021,0.00799059130058923,0.0155960760839472,0.046919193982257,9.19994662950145e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.021856773659002,0.00559148476731804,-0.0328160838029454,-0.0108974635150587,9.30882065951395e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,-0.0134910519951878,0.00345491336115094,-0.0202626821830436,-0.00671942180733191,9.47259927731655e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40516,0.0229020781628662,0.00588051579365858,0.0113762672072954,0.034427889118437,9.87714586933501e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,0.0275916439993192,0.00708732132735955,0.0137004941976945,0.0414827938009439,9.93771209435324e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0171771758222437,0.00442155243308011,0.00851093305340671,0.0258434185910808,0.000102886043180554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,-0.00846631020601381,0.0021801661598066,-0.0127394358792347,-0.00419318453279288,0.000103450665739491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0218519381736603,0.0056311239416939,0.0108149352479402,0.0328889410993803,0.000104638266984961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39980,0.0304847986993254,0.00785683088586677,0.0150854101630265,0.0458841872356242,0.000104871609357258
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,38013,0.00779362843100543,0.00200881444969586,0.00385635210960155,0.0117309047524093,0.000105073155550393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,0.0134248594392677,0.00347464030601047,0.00661456443948722,0.0202351544390483,0.000112237711861866
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0175731117908976,0.00455177497747356,0.00865163283504938,0.0264945907467458,0.000113514856164079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0341240471638041,0.00884171297821917,0.0167942897264945,0.0514538046011137,0.000114190042309832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,0.0194924344228945,0.00506347301991294,0.00956802730386512,0.0294168415419238,0.000118862665254254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0128968644351395,0.00335624523789919,0.00631862376885706,0.0194751051014219,0.000122191566187992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,0.0221742272595378,0.00579561058940048,0.0108148305043129,0.0335336240147628,0.000130808540359335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37987,-0.00827110183437776,0.00216489683069339,-0.0125142996225368,-0.00402790404621872,0.000133748249762024
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.0101249320490564,0.00265288019107254,0.00492528687455422,0.0153245772235586,0.00013582844215116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,-0.0533764519159235,0.0139882431912944,-0.0807934085708605,-0.0259594952609864,0.000136341826083265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,0.0412092426173076,0.0108083136252736,0.0200249479117714,0.0623935373228437,0.000138061255031937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37714,0.0141710264100304,0.00372337029283375,0.00687322063607623,0.0214688321839845,0.000141886049357138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37901,0.0167399531839164,0.00440099666703434,0.00811399971652909,0.0253659066513037,0.000143196900704571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,40434,0.0226260740202202,0.00596503138674166,0.0109346125022065,0.0343175355382338,0.000149314709556402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0203536279272591,0.00536595769577337,0.0098363508435433,0.0308709050109749,0.00014943714701996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,0.0225415061766074,0.00594816791469683,0.0108830970638016,0.0341999152894132,0.000151535787223265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,40359,-0.0133180781381096,0.00351564831934012,-0.0202087488440162,-0.00642740743220293,0.000152284168553371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,40379,-0.0108644886344362,0.00286801356101678,-0.0164857952140291,-0.00524318205484327,0.000152326432417565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0191236129010631,0.00504987801961165,-0.029021373819502,-0.0092258519826243,0.000153191264462855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0120457095067335,0.00318148361843351,0.00581000161460384,0.0182814173988632,0.000153529838759478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0114853191053718,0.00304566045708329,0.00551582460948854,0.017454813601255,0.000163155650438712
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0138858311250911,0.00368568522029025,0.00666188809332218,0.02110977415686,0.000165604265330454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,40184,-0.017041758987591,0.0045278504020223,-0.0259163457755547,-0.00816717219962732,0.00016798323046239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37901,0.0126313299794589,0.00337289944161908,0.00602044707388551,0.0192422128850323,0.000181184523696184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,-0.00806440985849554,0.00216013149879449,-0.0122982675961327,-0.00383055212085834,0.000189650524975286
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,40044,-0.0108849392793513,0.00291882943962937,-0.0166058449810249,-0.00516403357767774,0.000192758252439851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,0.0201421470864675,0.00540379676499139,0.00955070542708441,0.0307335887458507,0.000194131728159842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37714,-0.0106136055875734,0.00286137584905838,-0.0162219022517278,-0.00500530892341896,0.000208708840568563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,40044,0.0308766076864778,0.00832661434541264,0.014556443569469,0.0471967718034866,0.000209475659134254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,0.0148104045032108,0.00400331002353443,0.00696391685708334,0.0226568921493383,0.000216879194714166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,-0.0124269095397655,0.00336643034894852,-0.0190251130237046,-0.00582870605582645,0.000223741981988161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,40359,0.0124120395406008,0.00336767378912968,0.00581139891390663,0.019012680167295,0.000228884557045548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39951,0.0394083122174949,0.010706208594875,0.0184241433715399,0.0603924810634499,0.000233215099019204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,0.018678608782445,0.00508003218380599,0.00872174570218522,0.0286354718627047,0.00023691108928545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00914657195688677,0.00248849073807505,-0.0140240138035139,-0.00426913011025966,0.000238284388155653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,0.00777892618655103,0.00212312446802204,0.00361760222922784,0.0119402501438742,0.000249350564337993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,0.0149917412321466,0.00409198541945205,0.0069714498100206,0.0230120326542726,0.000249438242602147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,0.0186112817329295,0.00508971822580397,0.00863543401035375,0.0285871294555053,0.00025638064350017
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,40341,0.0222111350626098,0.00607901072943902,0.0102962740329093,0.0341259960923102,0.000259277930991744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,-0.0138208581622953,0.00378937765956832,-0.0212480383750492,-0.00639367794954142,0.00026607018962057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40471,0.0231296151365808,0.00634401179828638,0.0106953520119395,0.0355638782612221,0.000267304104535862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37998,0.0318109154662208,0.00872962936277058,0.0147008419151904,0.0489209890172511,0.000269419211642778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,0.0254080693036133,0.00698646182660947,0.0117146041234588,0.0391015344837679,0.000277116427540823
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0110428707754071,0.00303677853486788,0.00509078484706608,0.0169949567037482,0.000277556475436955
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0120821758293921,0.0033288752667294,-0.0186067713521817,-0.00555758030660249,0.000285045261808986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,40305,-0.0266787020716008,0.0073571640568457,-0.0410987436230184,-0.0122586605201832,0.000288501000207868
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,40042,0.0166217364003801,0.00458419421709666,0.00763671573487069,0.0256067570658896,0.00028889725457816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,0.00930835509145895,0.00257085860699559,0.00426947222174758,0.0143472379611703,0.000294689898771812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0217364915605382,0.00600436507134951,0.00996793602069312,0.0335050471003832,0.000295576199874689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,40271,0.0189575162261648,0.00523778866887469,0.0086914504351704,0.0292235820171592,0.000296237823919364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0287769313465512,0.00795097687606851,0.013193016669457,0.0443608460236455,0.000296324080009959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0217038155052367,0.00599725521172565,0.00994919529025438,0.0334584357202189,0.000296868811146441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,40044,0.0291562072991821,0.00806339502927226,0.0133519530418085,0.0449604615565558,0.000300281846852077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0109600493991785,0.0030310926536953,0.00501910779793568,0.0169009910004213,0.000300433393228698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0209971912489878,0.00580990215995265,0.00960978301548056,0.032384599482495,0.000302420869556378
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.010169632692719,0.00281877003678055,-0.0156944219648089,-0.00464484342062918,0.000309908606980417
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,-0.020547073099211,0.00570317813428988,-0.0317253022424191,-0.0093688439560028,0.000315831723917702
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,0.0169367419384976,0.0047247229099425,0.00767628503501027,0.0261971988419849,0.000338488559811461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0124837172209771,0.00348447085020448,-0.0193132800873778,-0.00565415435457628,0.000341121158507264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40471,-0.0264934959027321,0.00740398617605941,-0.0410053088078086,-0.0119816829976557,0.00034689080726992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,0.0171971056578994,0.00482804825871216,0.00773413107082359,0.0266600802449753,0.000369260578014857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRN,Progranulin,40262,0.00833314913208521,0.00234305450105599,0.00374076231001547,0.012925535954155,0.000376880735069311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.034887012647434,0.00981101218028613,0.0156574287740732,0.0541165965207948,0.00037800961933825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0260993535668607,0.00734768405491428,0.0116978928192287,0.0405008143144927,0.000383565804480957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,40044,0.0177620081791924,0.00501764911873047,0.00792741590648065,0.0275966004519041,0.000401434838817261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,40173,0.0354350352995266,0.0100161232497102,0.0158034337300946,0.0550666368689586,0.000404639348291182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0134299249897723,0.00380087859319428,0.00598020294711147,0.0208796470324331,0.000411662086436401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.019723344816211,0.0055856311130246,-0.0306711817977392,-0.00877550783468283,0.000415286210758479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.00950022884542785,0.00269361064835865,0.0042207519746449,0.0147797057162108,0.000421562701517021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,40341,0.0136962868170446,0.00388810981474271,0.00607559158014889,0.0213169820539403,0.000428522075984499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,38013,0.00886609410950696,0.00251868947234659,0.00392946274370765,0.0138027254753063,0.000432763214690273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.00896915935563699,0.00255244796924441,0.00396636133591795,0.013971957375356,0.000442727234524897
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0182187985311094,0.00519877291529908,0.00802920361712322,0.0284083934450956,0.000458853935609273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,-0.00763810352435472,0.00218278746081011,-0.0119163669475425,-0.00335984010116691,0.000467843073796374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0193159614660383,0.00553326024794018,0.00847077138007554,0.0301611515520011,0.000482771655317217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,0.0203389754384205,0.00584670932559737,0.00887942516024965,0.0317985257165913,0.000505477735257392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0225816981114623,0.00649828371516793,0.00984506202973314,0.0353183341931914,0.00051245747747382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,40207,0.0150463281642725,0.00434173753450929,0.00653652259663427,0.0235561337319107,0.00053063908929352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39946,0.0188847507976841,0.00545776252288458,0.00818753625283037,0.0295819653425379,0.000541300784230437
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.00953352856554037,0.00275697670193919,0.00412985422973957,0.0149372029013412,0.000545702278584579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37598,0.0208853517160514,0.00603955885612176,0.00904781635805274,0.03272288707405,0.000545737609620313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0198745031239785,0.00575421370742474,0.008596244257426,0.031152761990531,0.000554279292025811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,-0.0139814332426745,0.00404979739853859,-0.0219190361438102,-0.0060438303415389,0.000557391865428187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.0101744155162378,0.0029479199318194,0.00439649244987181,0.0159523385826039,0.000559464339421444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,-0.023186372211074,0.00673073815082599,-0.0363786189866929,-0.00999412543545505,0.000572865802255688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,37541,-0.0121447424205231,0.00352784328673803,-0.0190593152625297,-0.00523016957851661,0.000578080288267375
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,0.0117151420516563,0.00342580118534598,0.00500057172837821,0.0184297123749345,0.000628525704084829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37598,0.0390161626293516,0.011416025420602,0.0166407528049716,0.0613915724537316,0.000633519685133472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0134079631722643,0.00392554168416002,0.00571390147131064,0.0211020248732179,0.000638115335709371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,-0.0218516887865379,0.00640005391333446,-0.0343957944566735,-0.00930758311640239,0.000641080091629869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,-0.00806844055102187,0.00236567726777268,-0.0127051679958563,-0.00343171310618742,0.000649751639578008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,0.0186013111364396,0.00546184295490887,0.00789609894481824,0.029306523328061,0.000661959457324201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39961,0.0149313253928999,0.00438844414990633,0.00632997485908353,0.0235326759267163,0.000669608987513296
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,40278,0.0195746360669665,0.0057616699204217,0.00828176302293998,0.030867509110993,0.000681995839053702
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,40305,0.013921429457677,0.00410023063155487,0.00588497741982944,0.0219578814955245,0.000687266557078155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.0084314429430264,0.00248543872155658,0.0035599830487755,0.0133029028372773,0.000694978480467484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.0371601057870465,0.010955582915915,0.015687163271853,0.05863304830224,0.000696128223513233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,40257,0.0218024366968225,0.00643983639558397,0.00918035736147791,0.0344245160321671,0.000712066712196939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37562,0.0197989595412085,0.00585270357485913,0.00832766053448465,0.0312702585479324,0.000719413495140627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37562,-0.0121147243919651,0.00358229381791068,-0.0191360202750701,-0.00509342850886017,0.000722139476175002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,0.031275830749618,0.0092535413084588,0.0131388897850388,0.0494127717141973,0.000727286895626256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0296167193267961,0.00878478101641934,0.0123985485346142,0.046834890118978,0.000750058973503874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37942,-0.00860814260014191,0.00255959247549137,-0.013624943852105,-0.00359134134817883,0.000772893344889237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,0.00842249259122163,0.00250503674338091,0.00351262057419505,0.0133323646082482,0.000775317628618357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,0.0197520387952154,0.00588269902936696,0.00822194869765614,0.0312821288927746,0.000787941880883609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,0.0100600005456094,0.00300040413565041,0.00417920843973463,0.0159407926514842,0.000801945348998382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0139674281629056,0.00417123610725431,0.00579180539268713,0.022143050933124,0.000814734018329449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37628,0.0170503131075845,0.00509979788385868,0.00705470925522145,0.0270459169599475,0.000830097137269338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,-0.0104422979874723,0.00313161511259187,-0.0165802636081524,-0.00430433236679226,0.000856537277228943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,40341,0.0180352434817217,0.00542952628208524,0.00739337196883466,0.0286771149946088,0.000896734525350821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0212525495213011,0.00640041075315944,-0.0337973545974936,-0.00870774444510859,0.000901022232307749
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.0193187021672913,0.00582306833859744,-0.0307319161109423,-0.00790548822364031,0.000909940194948949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,0.0170714934439742,0.0051467374424994,0.00698388805667542,0.0271590988312731,0.000912463857405427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,40305,0.00937577089655209,0.00282702358667925,0.00383480466666077,0.0149167371264434,0.000913635512914368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,-0.0118080090767184,0.00356081233386751,-0.0187872012510987,-0.00482881690233807,0.000915283786058727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37900,-0.0376406484909377,0.0113669133227808,-0.0599197986035882,-0.0153614983782873,0.000930676221696519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,0.0120142089733341,0.00362959123813733,0.00490021014658491,0.0191282078000832,0.000935172849206626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,0.0763141353038175,0.0230988473866498,0.0310403944259839,0.121587876181651,0.00095629834563497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,0.0143310135221532,0.00434197686512052,0.00582073886651702,0.0228412881777895,0.00096700471720471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,0.0223849338417621,0.006809645330189,0.00903802899459169,0.0357318386889326,0.00101440725860578
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,0.0192682558120424,0.00586344434105471,0.00777590490357513,0.0307606067205096,0.00101820966323597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,-0.0114098928750693,0.00347709271192747,-0.0182249945904472,-0.0045947911596915,0.00103498971402431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.0102521784172176,0.00313781579657224,-0.0164022973784992,-0.00410205945593598,0.00108809920234371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0183944184578089,0.00563298239322659,0.00735377296708476,0.029435063948533,0.00109507970454208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37901,0.0176773229321187,0.00541324932891226,0.00706735424745072,0.0282872916167868,0.00109518866689411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,0.010774431145656,0.00330666579091849,0.00429336619545577,0.0172554960958562,0.00112282696671363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSPN,Persephin,40341,0.0312483772189064,0.00960268275257731,0.0124271190238548,0.0500696354139579,0.00113977986819769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.00760871288713788,0.0023390231839762,0.00302422744654454,0.0121931983277312,0.00114453116037642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0280005775678642,0.00861625232523889,0.011112723010396,0.0448884321253325,0.00115799463568644
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,0.0110269176797968,0.00339577709635822,0.00437119457093469,0.0176826407886589,0.00116775622064353
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,40359,0.0141593513260698,0.00436827431705581,0.00559753366464044,0.0227211689874992,0.00119186338828758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,-0.0117630700366727,0.00363075355116356,-0.0188793469969533,-0.00464679307639215,0.00119847360496978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,0.0132931802583434,0.00411477734071871,0.00522821667053471,0.0213581438461521,0.00123829731882732
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0141534915032753,0.00438116905224654,-0.0227405828456786,-0.00556640016087213,0.00123857362568798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,40042,0.0156552745654801,0.00485649238800504,0.00613654948499018,0.0251739996459699,0.00126860951126595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0148125517881519,0.00461128167895521,0.00577443969739971,0.0238506638789041,0.00131972952898134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,37231,-0.0216999113069744,0.00676051526257434,-0.0349505212216201,-0.00844930139232873,0.00133154906916819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0209569640098618,0.00653093827569081,0.00815632498950776,0.0337576030302157,0.00133573397157216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,40267,0.0107007429741482,0.00333577683843557,0.00416262037081452,0.017238865577482,0.00133987645367177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,0.018428782997609,0.00575248218149148,0.00715391792188569,0.0297036480733323,0.00136025539572492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37998,-0.0155146724071668,0.0048448448333806,-0.0250105682805928,-0.00601877653374083,0.00136647453360006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0153722055315531,0.00480080392508951,0.00596262983837765,0.0247817812247285,0.00136799404465883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,-0.0137303778370029,0.0042910885432885,-0.0221409113818484,-0.00531984429215748,0.0013787704631254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,-0.0326956253409987,0.0102358267571888,-0.0527578457850888,-0.0126334048969086,0.00140524165808352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,40411,0.0177842484903242,0.00558230140929269,0.00684293772811055,0.0287255592525379,0.00144618460199861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0118798485488714,0.00372936592744362,0.00457029133108186,0.0191894057666608,0.00144847835184191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,-0.0233275387730155,0.00732614133596529,-0.0376867757915074,-0.00896830175452348,0.0014551936297604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.0184103650808405,0.00578693441633568,0.00706797362482255,0.0297527565368584,0.00146921477715734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0189393066752103,0.00597204495446173,-0.0306445147859553,-0.00723409856446532,0.00152094419199385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.0374295982362438,0.0118287503092769,0.0142452476300612,0.0606139488424265,0.00155754776230043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,0.00828236828828758,0.0026215355854963,0.00314415854071484,0.0134205780358603,0.00158465219464869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0125185903049005,0.00396444756423809,0.00474827307899387,0.0202889075308072,0.00159316406091874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0116584827521345,0.00369401210672497,0.00441821902295359,0.0188987464813155,0.0016027437837207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,-0.00873880097990057,0.00277348373723568,-0.0141748291048825,-0.00330277285491863,0.00163168356296291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0115044292138447,0.00365433847391012,-0.0186669326227085,-0.00434192580498086,0.0016467187641828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,40341,-0.0118192746048053,0.00375864507968402,-0.0191862189609859,-0.00445233024862458,0.0016664479008992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.007618251365094,0.00242554722025995,-0.0123723239168035,-0.0028641788133845,0.00168836518882141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,0.0138671845195817,0.00441948636103988,0.0052049912519435,0.0225293777872198,0.00170567687083189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,0.0187223042348131,0.00596867151565631,0.0070237080641267,0.0304209004054994,0.0017119610487562
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37562,0.0131220781673648,0.00418385771284991,0.00492171705017896,0.0213224392845506,0.00171438207728687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37959,0.0250731416818601,0.00799670204675883,0.00939960567021284,0.0407466776935075,0.00171967235798241
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0209777999074882,0.00669493109094912,0.00785573496922796,0.0340998648457485,0.00173113100679171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.00867213859109437,0.00276803147419802,0.00324679690166625,0.0140974802805225,0.00173430881140026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0179758185960274,0.00573871368530784,0.00672793977282406,0.0292236974192308,0.00173773986015133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,0.0110968504206619,0.00355049618094712,0.00413787790600552,0.0180558229353182,0.00177931410686307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,-0.010324541527012,0.00331125863470972,-0.016814608451043,-0.00383447460298091,0.00182467990325954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,0.0191130820079529,0.00613077789164717,0.00709675734032447,0.0311294066755814,0.00182735400861044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0219252684391713,0.00703294809020118,0.008140690182377,0.0357098466959656,0.00182770225851014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0260952164682821,0.0083837166171326,-0.042527301037862,-0.00966313189870217,0.00185782797068929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,0.0161275106383094,0.0051862476339621,0.0059624652757437,0.0262925560008751,0.00187694265285735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,-0.00970277426978501,0.00313331592098894,-0.0158440734749233,-0.00356147506464669,0.00196135343629312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,40003,0.0187359905239581,0.0060516493588403,0.00687475778063113,0.0305972232672851,0.00196489842062623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,40279,0.0214615581107464,0.00693226364934974,0.00787432135802096,0.0350487948634719,0.00196562727549983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,-0.0126410210615436,0.00409753215697716,-0.0206721840892189,-0.0046098580338684,0.00203940910066501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40489,0.0219411102284367,0.00713328957683984,0.00795986265783061,0.0359223577990428,0.00210238742797198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,0.0111688450011326,0.00364213967123469,0.00403025124551261,0.0183074387567526,0.00216977230803856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40489,-0.00744564125386403,0.00242983816952606,-0.0122081240661351,-0.00268315844159296,0.00218575772798287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39961,0.015525630961738,0.00507330197864996,0.00558195908358409,0.0254693028398919,0.00221521531327507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37628,0.0086001808621554,0.00281962814282904,0.00307370970221049,0.0141266520221003,0.00229210671135068
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37628,0.00870776213014317,0.00285806649380368,0.00310595180228796,0.0143095724579984,0.00231801711281877
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,40042,0.00899693229642178,0.00295407416985138,0.00320694692351306,0.0147869176693305,0.00232603221701117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37562,0.0236549995918568,0.00777299100858545,0.0084199372150293,0.0388900619686843,0.00234516789947929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0257182565005683,0.00845128327694834,0.0091537412777495,0.042282771723387,0.00234598342199368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,-0.0100048445095004,0.0032890563161815,-0.0164513948892161,-0.00355829412978462,0.00235572336759518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,37541,0.0134127757846684,0.00441238388798992,0.00476450336420814,0.0220610482051286,0.00237200859665303
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37598,-0.00836420233514707,0.00275415942001069,-0.013762354798368,-0.00296604987192612,0.00239465584611062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0184068948916189,0.00606574903153423,0.00651802678981178,0.0302957629934259,0.00241281685499067
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39857,-0.0194229783261328,0.00641599769066954,-0.0319983337998451,-0.00684762285242053,0.00247178629631942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,37541,-0.0129100596818655,0.00427401700327136,-0.0212871330082774,-0.00453298635545362,0.00252768271267306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,40015,0.0140926389573512,0.00466686272674236,0.00494558801293618,0.0232396899017662,0.00253415011960804
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0119156946528882,0.00394853854941892,0.00417655909602711,0.0196548302097493,0.00255149469258652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39801,0.0103118755122571,0.0034197874600352,0.00360909209058813,0.0170146589339261,0.00257097766738896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00883159114711349,0.00293008369950101,-0.0145745551981355,-0.0030886270960915,0.00258231056029837
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.0115750260635011,0.00384151984794861,-0.0191044049654804,-0.00404564716152185,0.00258968957558709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40536,-0.0116829774340049,0.00388387333341726,-0.0192953691675027,-0.00407058570050704,0.00263315952541905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,40044,-0.00934099815893248,0.00312215844711373,-0.0154604287152754,-0.00322156760258958,0.00277735435083946
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.0344006913042395,0.0115159502259819,0.011829428861315,0.056971953747164,0.00281955605996928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37900,0.0224407855519794,0.00754109504520596,0.00766023926337573,0.0372213318405831,0.00292745748076941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.0108103604815779,0.0036337441337497,0.00368822197942847,0.0179324989837273,0.00293514956841105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,0.0128768770857507,0.00433799507271018,0.00437440674323875,0.0213793474282627,0.0029989567260564
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,37482,-0.0103272940312449,0.00348002211825825,-0.0171481373830311,-0.00350645067945877,0.00300685558195735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37981,0.00641531080183055,0.00216459703842605,0.00217270060651549,0.0106579209971456,0.00304450722882083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,-0.0140575886374074,0.00474608722370213,-0.0233599195958636,-0.00475525767895125,0.00306167472215323
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,40305,0.0117968108141761,0.00399120358814706,0.00397405178140785,0.0196195698469443,0.00312416879846791
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,0.00888674238245813,0.00301483650978039,0.00297766282328856,0.0147958219416277,0.00320648857278766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,0.0129777928097166,0.00440415073857027,0.00434565736211889,0.0216099282573143,0.00321730683409055
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,0.0094181360211345,0.00319934703221476,0.00314741583799356,0.0156888562042754,0.00324809878900954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00840589737065718,0.00285735593864911,-0.0140063150104094,-0.00280547973090493,0.00326816003531641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,0.0101733714637458,0.00346871577430273,0.00337468854611249,0.0169720543813792,0.00336300357843027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,0.0168551266876805,0.00576018635559727,0.00556516143070984,0.0281450919446512,0.00343688710476556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,40396,0.00827335158161593,0.00283641143540855,0.00271398516821517,0.0138327179950167,0.00354092932993091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.011838925830391,0.00406789965354759,0.00386584250943772,0.0198120091513443,0.00361559343114364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37714,-0.00973597421112492,0.00334998818109164,-0.0163019510460645,-0.0031699973761853,0.00366369528797061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,-0.0174388205079905,0.00600430785139223,-0.0292072638967193,-0.00567037711926173,0.00368591099692016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0133858569274898,0.00463171099010211,0.00430770338688965,0.0224640104680899,0.00385801622990231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0150258622114081,0.0052156752996965,0.00480313862400291,0.0252485857988132,0.00397178332509243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,40359,0.00772167390425445,0.00268124799246121,0.00246642783903048,0.0129769199694784,0.0039835682102166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37934,0.00717845166305261,0.00250146658330805,0.00227557715976884,0.0120813261663364,0.00411503789535191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0102416382336061,0.00357303814372035,0.0032384834719142,0.017244792995298,0.00415857155020182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.00880686685493112,0.00307475561766323,0.0027803458443112,0.014833387865551,0.00418543696325399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37562,-0.0141215618596848,0.00495280664473458,-0.0238290628833646,-0.00441406083600503,0.00436192765582446
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,0.0150961526100403,0.00531017404188832,0.00468821148793918,0.0255040937321414,0.00447761755377257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.00851278722380377,0.00299503395431272,0.00264252067335084,0.0143830537742567,0.00448464113919566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,0.00646122886618096,0.00227631326854912,0.00199965485982468,0.0109228028725372,0.00454008167098526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00808707442578331,0.00284951158054204,-0.0136721171236457,-0.00250203172792091,0.00454586895050703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00809400419893784,0.00285226502755658,-0.0136844436529487,-0.00250356474492695,0.00454901452963223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,0.0144519250810225,0.00509344280160534,0.00446877718987603,0.024435072972169,0.00455454785630993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0164645445946919,0.00581225512601028,-0.027856564641672,-0.00507252454771172,0.00462228749226875
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37714,-0.00975676616981759,0.00344454166940165,-0.0165080678418448,-0.00300546449779036,0.00462509149905955
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37959,-0.00994169086833626,0.00351199291002893,-0.016825196971993,-0.00305818476467955,0.00465027492337338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0123820278686186,0.00438195500282209,0.00379339606308733,0.0209706596741499,0.00472490543280204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,-0.0110546036894371,0.00391326045231052,-0.0187245941759657,-0.00338461320290847,0.00473525570630117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0160698089657926,0.00569686566159217,0.00490395226907192,0.0272356656625132,0.00479713410324712
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,0.00776914536762337,0.00276071642422572,0.00235814117614097,0.0131801495591058,0.00489749029345515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37901,0.0159084878996364,0.00565539825870567,0.00482390731257325,0.0269930684866995,0.00491567960796849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37562,-0.0115138381428977,0.00410002416250311,-0.0195498855014038,-0.00347779078439159,0.00498872456616058
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37598,-0.0121381124777739,0.00433338938978958,-0.0206315556817615,-0.00364466927378633,0.00510083995462279
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,0.0295828986403531,0.0105625243988468,0.00888035081861344,0.0502854464620929,0.00510470627333261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40489,-0.0164314202087667,0.00587229909788138,-0.0279411264406142,-0.00492171397691916,0.00514617079065827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37671,-0.0244429520898459,0.00873905461754831,-0.0415714991402406,-0.00731440503945122,0.00516574268683735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0162854476569479,0.00582952911889504,0.00485957058391366,0.0277113247299822,0.00521864086289455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,40456,-0.0116432367869904,0.0041722329047941,-0.0198208132803869,-0.00346566029359399,0.0052664782643119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,0.00945526738626036,0.00339064251888414,0.00280960804924744,0.0161009267232733,0.005299468450501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00886153274972672,0.00318217721469762,-0.0150986000905341,-0.00262446540891939,0.00536476669412923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,40411,0.00821525724864053,0.00295197996645204,0.00242937651439453,0.0140011379828865,0.0053927908847517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFP,Properdin,38013,0.00586684320859866,0.002116801907454,0.00171791146998883,0.0100157749472085,0.00558644494917798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,38013,0.00511079852241075,0.00184610331256876,0.00149243602977598,0.00872916101504553,0.00564044118935056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.022739211059406,0.00823274373743968,0.00660303333402421,0.0388753887847877,0.00575065022511583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0060335772607878,0.00218933352176127,0.00174248355813571,0.0103246709634399,0.00585986463114936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0112980037955376,0.00410000975791734,0.00326198467001965,0.0193340229210556,0.00586643441184414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.010912656189549,0.00396445613559718,0.00314232216377857,0.0186829902153195,0.00591990675870719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0104682515187139,0.00381445170207986,0.00299192618263739,0.0179445768547904,0.00607083180901031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0196784538632241,0.00718605249888865,0.00559379096540234,0.0337631167610459,0.00618169450927567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37942,-0.0103735649197726,0.00378882235131213,-0.0177996567283444,-0.00294747311120088,0.006190658870466
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,0.0127619935765768,0.00466295640361097,0.00362259902549928,0.0219013881276543,0.00620926814883595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00955361745871659,0.00349110922421154,0.00271104337926196,0.0163961915381712,0.00621686015438687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0138689206199279,0.00507067041217602,-0.0238074346277929,-0.0039304066120629,0.00624402323540227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,-0.0252362376920453,0.00925295632799994,-0.0433720320949252,-0.00710044328916539,0.00639264481232277
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37642,-0.00842492491320399,0.00309361653337917,-0.0144884133186272,-0.00236143650778081,0.00647133603008969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00836905327323057,0.00308564458646335,-0.0144169166626987,-0.0023211898837624,0.00669144376940487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,0.0114551165766641,0.00422501094910628,0.00317409511641577,0.0197361380369124,0.0067112149218182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37598,-0.00908205344913075,0.00335723385842259,-0.015662231811639,-0.00250187508662248,0.00683472994111269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,0.0141419005471719,0.00523230308671586,0.00388658649720878,0.0243972145971349,0.00688431827327244
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,-0.0071509036253462,0.00264748284432391,-0.0123399700002211,-0.00196183725047133,0.00692001904241621
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,0.0128936482251614,0.00477913245994737,0.00352654860366455,0.0222607478466582,0.00698507893808252
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37900,0.0132903487950967,0.00494512715350737,0.00359789957422223,0.0229827980159711,0.00720637412516848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0134364714041789,0.00500570884154755,0.0036252820747457,0.0232476607336121,0.00727862406548543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,-0.00902002785409966,0.00336184756313681,-0.0156092490778478,-0.00243080663035151,0.0073041448384422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0231912648452598,0.00865054906281315,0.00623618868214608,0.0401463410083736,0.00735168567037605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,40070,0.0142526170971857,0.00532653580283507,0.00381260692362895,0.0246926272707424,0.00746341989067034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,0.00952153853156363,0.00357030778292738,0.00252373527702597,0.0165193417861013,0.00766390205039767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39903,0.0294275750021469,0.0110575843748819,0.0077547096273783,0.0511004403769155,0.00779195157661765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,0.013935927815813,0.00524100965532972,0.00366354889136675,0.0242083067402593,0.00784620921106435
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,0.00921954923378189,0.0034768436161346,0.00240493574615808,0.0160341627214057,0.00801688005476088
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37562,-0.0137261453071303,0.00518217616697819,-0.0238832105944075,-0.00356908001985305,0.00808935151967058
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37562,-0.00823003735610569,0.00310887151702627,-0.0143234255294772,-0.0021366491827342,0.00812404111283569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,40288,0.0277415983197113,0.0104895825854876,0.00718201645215567,0.0483011801872669,0.00818486599610365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0145504264153864,0.00550416232580606,0.00376226825680651,0.0253385845739663,0.00821285507343381
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,-0.00664050416083758,0.00251250496236144,-0.011565013887066,-0.00171599443460916,0.00822767404886455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,-0.0103275087422004,0.00391888892996726,-0.0180085310449363,-0.00264648643946461,0.00841581568783349
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,40309,0.00689727019815364,0.00262232392127486,0.00175751531245492,0.0120370250838524,0.00854138493595653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,0.00974025157886578,0.00370474006274951,0.00247896105587674,0.0170015421018548,0.00856874954671592
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37714,-0.00894057369619266,0.00341126601715294,-0.0156266550898124,-0.0022544923025729,0.00877990266352701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.0154415923931424,0.00589351045505559,0.00389031190123341,0.0269928728850513,0.00879863208441458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.0146970397797232,0.0056152815786802,-0.0257029916739364,-0.00369108788550998,0.00887227828572287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37562,-0.0103109560195033,0.00398991238554796,-0.0181311842951773,-0.00249072774382927,0.00976963577566323
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,37482,-0.00796180360525837,0.00308263592863272,-0.0140037700253785,-0.00191983718513824,0.00981127383321744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.0177777260813431,0.0068994743462584,0.00425475636267664,0.0313006958000096,0.00998600192750213
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0234129495887054,0.00910161338271928,0.00557378735857555,0.0412521118188352,0.0101088118793313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.0106410058621159,0.00413801214906865,-0.0187515096742904,-0.0025305020499413,0.0101360770800287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,0.0121818845079166,0.00473735302009837,0.00289667258852381,0.0214670964273094,0.0101381171928798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0137485517571705,0.00535144849132601,0.00325971271417149,0.0242373908001695,0.010204765967962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37900,-0.0145498831927186,0.00567280329189694,-0.0256685776448366,-0.00343118874060058,0.010332826293685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,0.0194430681591645,0.00758422396852051,0.00457798918086427,0.0343081471374647,0.0103696467492495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37598,-0.00677313679706591,0.00264565880150213,-0.0119586280480101,-0.00158764554612173,0.0104754443840862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,40305,0.00694516575222156,0.00272059066617389,0.00161280804652074,0.0122775234579224,0.0106948963108593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,0.0151334686159995,0.00593351452347629,0.00350378014998597,0.026763157082013,0.0107676285647023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPS,Colipase,40311,-0.0168485974853086,0.00661878707664067,-0.0298214201555243,-0.00387577481509289,0.0109192749185905
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40453,0.0127332164871465,0.00500623738886036,0.00292099120498018,0.0225454417693128,0.0109850631692898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00782296247330152,0.00308435396759717,0.00177762869681107,0.013868296249792,0.0112115453541937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37598,-0.00823508977567734,0.00326267912160022,-0.0146299408540138,-0.0018402386973409,0.0116135846375259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39961,0.0137150369111495,0.00543544060586123,0.00306157332366149,0.0243685004986375,0.0116371068110386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,37541,-0.0240784086568661,0.00954656174334768,-0.0427896696738276,-0.00536714763990467,0.0116738530179624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00774088844322015,0.00307777769877455,-0.0137733327328183,-0.00170844415362203,0.011912075336181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0118615195377909,0.00471665053947861,0.00261688448041279,0.0211061545951689,0.0119191509768339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,0.00542151579806898,0.00215600044787077,0.00119575492024226,0.00964727667589569,0.0119259861968769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37959,0.00729444233007565,0.0029181080150853,0.00157495062050847,0.0130139340396428,0.0124410452326852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37562,0.00925885737685814,0.00370457354448113,0.00199789322967513,0.0165198215240412,0.0124558641464121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,0.00819827554891402,0.00328264571243623,0.001764289952539,0.014632261145289,0.0125189345590868
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37562,-0.00889299129523382,0.00357069155569006,-0.0158915467443863,-0.00189443584608131,0.0127667808737674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.00931715996088367,0.00374705183700737,-0.0166613815614181,-0.00197293836034922,0.012911490989993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,-0.011170003607187,0.00449976487278804,-0.0199895427578515,-0.00235046445652239,0.0130642223517915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37562,0.0150008447474746,0.00604613897985718,0.00315041234695452,0.0268512771479947,0.0131116081464267
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0185957600735966,0.00750066232077338,0.00389446192488075,0.0332970582223124,0.0131797160894518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,-0.0062029283222803,0.00250964286111609,-0.0111218283300678,-0.00128402831449277,0.0134622520528048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.0096027009312398,0.00388545922931099,0.00198720084179025,0.0172182010206893,0.0134694139735625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,0.0133701298336759,0.00542044810377593,0.00274605155027511,0.0239942081170768,0.0136505683414132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,40341,-0.00830036123076624,0.00337687465596323,-0.0149190355564542,-0.00168168690507832,0.0139818753874196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37714,-0.00998269186005387,0.0040656989838439,-0.0179514618683879,-0.00201392185171982,0.0140877023063159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37655,-0.00881112116084064,0.00359378957921438,-0.0158549487361008,-0.00176729358558044,0.0142286766624567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.00762738583504941,0.00311385826717044,0.00152422363139534,0.0137305480387035,0.0143164354873193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0115161561861466,0.00470320283817441,0.00229787862332478,0.0207344337489685,0.0143547855243466
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,0.0115111892432448,0.0047043620037427,0.00229063971590907,0.0207317387705804,0.014419039038596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,0.0104400758091403,0.00426881701076379,0.00207319446804326,0.0188069571502373,0.0144697444025945
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37824,0.00692769672124099,0.00283339553484586,0.0013742414729431,0.0124811519695389,0.0144973942481787
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37900,0.0124831938770215,0.00510566196811458,0.0024760964195169,0.022490291334526,0.014499132461343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0155844682778229,0.0063829061625428,0.00307397219923903,0.0280949643564068,0.0146333189426731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.016242151520254,0.00665339649504026,0.0032014943899751,0.0292828086505329,0.0146522616312352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.00633908581677734,0.00261196540318255,0.00121963362653954,0.0114585380070151,0.0152378248132504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00756936977646228,0.00312004206651921,-0.0136846522268399,-0.00145408732608463,0.0152776692385771
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37998,-0.0122032592414946,0.00504699952014197,-0.0220953783009729,-0.00231114018201635,0.0156224612155454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37562,-0.00940704785832647,0.00389604653935515,-0.0170432990754626,-0.00177079664119038,0.0157699435073878
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,40357,-0.00541202566361727,0.0022438884542817,-0.00981004703400941,-0.00101400429322513,0.015881056545788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,-0.0105337961423359,0.0043758721736546,-0.019110505602699,-0.00195708668197293,0.0160871062651272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.00793543596999289,0.00330446791964566,-0.0144121930924984,-0.00145867884748739,0.0163429340405741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00659518731822961,0.00275171753411267,0.00120182095136879,0.0119885536850904,0.0165546351933755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.019598082620698,0.00818990689916663,0.00354586509833139,0.0356503001430646,0.0167272520966406
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39896,0.00708243317110244,0.00296351635381627,0.00127394111762255,0.0128909252245823,0.0168660313483602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0104578147681585,0.00438168178724893,0.00186971846515059,0.0190459110711664,0.0170138018846494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0274130380814987,0.0115061965099254,0.00486089292204493,0.0499651832409525,0.0172091575584369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,0.0147493262450578,0.00619390451689604,0.00260927339194153,0.026889379098174,0.0172652397237267
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,-0.0123207353701539,0.00518870107020523,-0.0224905894677561,-0.00215088127255162,0.0175833421442224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,-0.00586723793880009,0.00247246711428711,-0.0107132734828028,-0.00102120239479737,0.0176547195946871
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0224676129972934,0.00947798144492619,-0.0410444566293487,-0.00389076936523805,0.0177756015822287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCT,Secretin,37572,0.0105211014062888,0.00445797363560184,0.00178347308050922,0.0192587297320684,0.0182863555933135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,37541,0.0199591632600697,0.00846813223672453,0.0033616240760896,0.0365567024440498,0.0184392055834401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37810,-0.00691604649534132,0.00293688756576987,-0.0126723461242503,-0.00115974686643238,0.0185425860252534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.0114624754055023,0.00487715732824213,-0.0210217037688569,-0.00190324704214773,0.0187737117941447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,-0.00525006652861566,0.0022388350297454,-0.00963818318691663,-0.000861949870314684,0.0190394081409968
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,0.0106894990503432,0.00457914542166024,0.00171437402388918,0.0196646240767973,0.019590470900601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,37541,-0.0208016365000437,0.00891104180370878,-0.0382672784353129,-0.00333599456477453,0.0195915907495206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.011947477980378,0.00512444344544567,0.00190356882730448,0.0219913871334515,0.0197433684188382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.00876603206111447,0.00378884698784668,0.00133989196493498,0.016192172157294,0.0207027652684451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0124501908675129,0.0053849651877364,0.00189565909954959,0.0230047226354763,0.0207915525107275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,40250,-0.0113672290819628,0.00492189848612933,-0.0210141501147762,-0.00172030804914926,0.0209275059275913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00922440342169398,0.00399491363563982,0.00139437269583994,0.017054434147548,0.0209569989035436
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,-0.0125426166504819,0.00544642150206926,-0.0232176027945376,-0.00186763050642612,0.0212995066690803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.016463439965054,0.00716103765494706,-0.0304990737687502,-0.00242780616135772,0.0215187083935956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00922849990969886,0.0040147056265939,-0.0170973229378229,-0.00135967688157482,0.0215391312763078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.0203869995675369,0.00887006017623199,0.00300168162212217,0.0377723175129516,0.0215516125219345
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,-0.00784037483686454,0.00341240789454462,-0.014528694310172,-0.00115205536355708,0.0215973729436772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40489,-0.00697771419428061,0.003039530205767,-0.0129351933975839,-0.00102023499097728,0.0217084284828259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0177802876805961,0.00775070028370038,0.00258891512454335,0.0329716602366488,0.021802442051962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00554048451622285,0.00241765453758247,-0.0102790874098845,-0.000801881622561205,0.0219395392690779
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.0239722295634966,0.0104879836147649,0.0034157816785573,0.0445286774484358,0.0222889820163962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0147351041520439,0.00645374590979175,0.00208576216885212,0.0273844461352358,0.0224354243316221
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0640796598229346,0.0282999090221353,0.00861183813954947,0.11954748150632,0.023568691871768
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.00737882634039992,0.00325878521866732,0.000991607311811981,0.0137660453689879,0.0235697832898318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37572,0.0114256685975912,0.00504889325229738,0.00152983782308838,0.0213214993720941,0.0236516790731933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0107471336969301,0.00476195158561892,-0.0200805588047431,-0.00141370858911698,0.024032211730203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERVV_1,,37562,-0.0105809453021268,0.00469031271284053,-0.0197739582192942,-0.00138793238495936,0.0240923848043765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,0.00684379410708102,0.00304168766731097,0.000882086279151525,0.0128055019350105,0.0244653884956325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0083988504584673,0.00373828145145847,0.0010718188136087,0.0157258821033259,0.0246744203094481
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,40305,0.0406511452143895,0.0181202168305405,0.00513552022653002,0.0761667702022489,0.0248838919601585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40489,0.00440669132877323,0.00196861199968796,0.00054821180938482,0.00826517084816163,0.0252036750517646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37901,0.0153637455495093,0.00688210853478382,0.00187481282133301,0.0288526782776856,0.0256037220217011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,40391,-0.00853346560454997,0.00382783591979194,-0.0160360240073422,-0.00103090720175776,0.0258065977638295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.0116942187461715,0.00524671099405711,-0.0219777722945235,-0.00141066519781959,0.0258396674361688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37959,0.0148130446325142,0.00664696603007889,0.00178499121355955,0.0278410980514688,0.025860769935557
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,-0.010140677122831,0.00456455519970075,-0.0190872053142444,-0.0011941489314175,0.0263240710966086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,37482,-0.00997716852004439,0.00449805064489844,-0.0187933477840453,-0.00116098925604344,0.0265645481007499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,37482,-0.00803476252943293,0.00363862317050404,-0.0151664639436209,-0.000903061115245014,0.0272485478221921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,0.0130971782617512,0.00594943298942709,0.00143628960247412,0.0247580669210283,0.0277211682325038
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,-0.0111385777177605,0.00506812634912346,-0.0210721053620425,-0.00120505007347853,0.0279828994589207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,0.00589405088728995,0.00268258744434016,0.000636179496383249,0.0111519222781967,0.0280265526701205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,40044,-0.0309260356286496,0.0141268376497698,-0.0586146374221984,-0.00323743383510084,0.0285993293098866
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,37482,-0.00970739963918963,0.00443559510051018,-0.0184011660361896,-0.00101363324218968,0.028649254333687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.0150919936489847,0.00690753883343707,-0.0286307697625213,-0.00155321753544803,0.0289169094794318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,-0.009018388167601,0.00413660514422798,-0.0171261342502878,-0.00091064208491416,0.0292645858903588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00932643119400243,0.00428210817968458,-0.0177193632261842,-0.00093349916182065,0.0294238056181427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37901,0.00648379720310288,0.00297896138078748,0.000645032896759412,0.0123225615094463,0.0295330315895338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39961,0.00926329688604746,0.00425669150184265,0.00092018154243587,0.0176064122296591,0.0295573713075525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37562,-0.0100416926952505,0.00461656135724119,-0.0190901529554432,-0.000993232435057738,0.029637024375328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00795900072094987,0.00367116980599957,-0.015154493540709,-0.00076350790119072,0.0301785962012589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,-0.00763493338933842,0.00352661025713243,-0.014547089493318,-0.000722777285358851,0.0304062230018979
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,40044,-0.00717444965420038,0.00331530151431803,-0.0136724406222637,-0.000676458686137044,0.030476307381315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.00575391608647884,0.00267193188224463,0.000516929597279374,0.0109909025756783,0.0312973908758932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,0.00824671134331583,0.0038313589038195,0.000737247891829614,0.0157561747948021,0.0313790677341614
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,0.00989586710625557,0.00459765122964872,0.000884470696144087,0.0189072635163671,0.0313860685684794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,0.0083905106123348,0.00391089940452434,0.000725147779467098,0.0160558734452025,0.031937821966133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,-0.00706710758141512,0.00329453685307463,-0.0135243998134414,-0.000609815349388843,0.0319632821993046
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,-0.00561773825554203,0.00262326156741807,-0.0107593309276815,-0.000476145583402609,0.0322509622246765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37562,-0.00752591639335427,0.00352885580360735,-0.0144424737684247,-0.000609359018283863,0.0329695982022838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.0145690345422561,0.00684759571480072,-0.0279903221432655,-0.00114774694124666,0.033387780722704
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.00536607729336771,0.00252701786107696,-0.0103190323010785,-0.000413122285656868,0.0337320530863243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,0.00525844729209418,0.00247700582980846,0.000403515865669608,0.0101133787185188,0.0337803708525097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00710662526199865,0.00335165106099863,-0.013675861341556,-0.000537389182441324,0.0339965912190331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37598,0.00676188709566606,0.00319271974990715,0.000504156385848039,0.0130196178054841,0.0342015656438875
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37942,-0.0062477930412704,0.00295820532806609,-0.0120458754842799,-0.000449710598260874,0.0347029438481196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,0.0107968392549137,0.0051902345133232,0.000623979608800233,0.0209696989010272,0.0375244044695135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,0.0106388405212277,0.00512689261626096,0.000590130993356251,0.0206875500490992,0.0379962456804159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,0.0154017428172018,0.00742380807824538,0.000851078983840903,0.0299524066505628,0.0380361744774604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.00975861206279846,0.00470373365492517,-0.0189779300264518,-0.000539294099145127,0.0380382304594864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LXN,Latexin,40183,-0.013299163621526,0.00641351412664082,-0.025869651309742,-0.000728675933310002,0.0381312495328436
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,37541,-0.0100966275638973,0.00487015014659371,-0.019642121851221,-0.000551133276573634,0.0381763924357175
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,40044,0.00946707346746968,0.00457564792040771,0.000498803543470571,0.0184353433914688,0.0385613385526593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,0.00410123604192559,0.00198237246827336,0.000215786004109799,0.00798668607974137,0.0385794405195413
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.00960594698389934,0.0046444212371529,0.00050288135907966,0.018709012608719,0.0386331072673369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.0159377782400515,0.00770934063446355,-0.0310480858836,-0.000827470596502929,0.0387223022675673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.00891299738017767,0.00432586137612564,0.000434309082971408,0.0173916856773839,0.0393801130580459
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37998,-0.00457620728565943,0.00222347950748198,-0.00893422712032411,-0.000218187450994749,0.039596854902424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,40182,-0.0137744644491872,0.00671420632152436,-0.026934308839375,-0.000614620058999501,0.0402308867378701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,-0.0115532349716129,0.005633484734462,-0.0225948650511584,-0.000511604892067398,0.0403048332714973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,-0.00689007714660426,0.00336006583118375,-0.0134758061757244,-0.000304348117484112,0.0403279287517481
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,0.00749156455649214,0.003657457086633,0.000322948666691455,0.0146601804462928,0.0405505603599981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,40359,-0.0052462525554663,0.00256699709538519,-0.0102775668624213,-0.000214938248511331,0.0409965263027963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0090374803518573,0.00443107981272512,0.000352563918916058,0.0177223967847985,0.0414104484512701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.0155311446277992,0.00761987770934289,-0.0304661049381113,-0.000596184317487125,0.0415458817708155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,0.0108200038784902,0.00532745724014184,0.000378187687812245,0.0212618200691682,0.0422727850949437
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,0.015098324239983,0.00748231880790583,0.000432979376487536,0.0297636691034784,0.0436248481927215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.0144726324650302,0.00717900080269137,0.000401790891755115,0.0285434740383053,0.0438201789807897
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.00579201079477166,0.00287978313299424,0.000147635854102941,0.0114363857354404,0.0443143609510999
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-0.00347572864053044,0.00173263261851495,-0.00687168857281974,-7.97687082411389e-05,0.0448719079191104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,40341,-0.0114562867061764,0.00571437138836271,-0.0226564546273673,-0.000256118784985524,0.044999214319352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.00976406004366177,0.00487406581088393,0.000210891054329259,0.0193172290329943,0.0451685595051814
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.00409133212843038,0.00204454750432675,8.40190199499517e-05,0.00809864523691081,0.0453992566357425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,40422,0.0147823627884336,0.00740210243283228,0.000274242020082317,0.0292904835567849,0.045836777120622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.00837261033914451,0.00419254787259944,0.000155216508849608,0.0165900041694394,0.0458429650510949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.00944252640964676,0.00473610763061717,0.000159755453637106,0.0187252973656564,0.0462021001529357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,0.00631405812209454,0.00316981808903925,0.000101214667577613,0.0125269015766115,0.0463956558509688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00906840678852976,0.0045611459314091,-0.0180082528140916,-0.000128560762967916,0.0468120039239693
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,37541,-0.00931272043902814,0.00469838687794332,-0.018521558719797,-0.000103882158259246,0.0474877911057674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.0119998232735161,0.00607554950159729,-0.0239079002966468,-9.17462503854313e-05,0.048277643552958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,40044,0.0113740231028843,0.00575931019592186,8.57751188774545e-05,0.0226622710868912,0.0482978710414333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.00504861668432088,0.00256087512551807,-0.0100679319303363,-2.93014383054603e-05,0.0486944693148997
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0095854657491921,0.00487842350570419,-0.0191471758203723,-2.37556780118778e-05,0.049450458199223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,0.0120884662389219,0.00616632117057987,2.47674458538766e-06,0.0241744557332585,0.0499661748084272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39802,-0.00498065035286898,0.00254246726232327,-0.00996388618702259,2.58548128463914e-06,0.0501328447398488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00485153460693201,0.0024795351878419,-0.00971142357510214,8.35436123812396e-06,0.0504122330695898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.00796920848884023,0.00407828342408293,-0.0159626440000428,2.42270223623168e-05,0.0507153538064173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.00572061850978485,0.00292867462342013,-0.0114608207716883,1.9583752118601e-05,0.0508038780478884
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,0.0125451266846396,0.00643314911427573,-6.38455793408356e-05,0.02515409894862,0.0511846425729945
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,0.0104085225007784,0.00533750627929562,-5.29898066410316e-05,0.0208700348081978,0.0511889321452906
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37934,0.00595594123769206,0.00305563751494608,-3.31082916022619e-05,0.0119449907669864,0.051296450402992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,-0.00867145005094551,0.00446557752140283,-0.0174239819928951,8.10818910040451e-05,0.0521775481633426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0110223122878187,0.00568459890766876,-0.00011950157121207,0.0221641261468495,0.0525220373263876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37572,0.00588193250614202,0.00303476583772446,-6.62085357979259e-05,0.011830073548082,0.0526222867600583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0267075255774814,0.0137810530306806,-0.000303338362652544,0.0537183895176154,0.0526427232002031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,-0.0038292784145611,0.00198030987796595,-0.00771068577537437,5.21289462521641e-05,0.0531705803623081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37598,-0.00778054544089833,0.00402469043601653,-0.0156689386954907,0.000107847813694073,0.0532325866799523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,-0.00556047880706688,0.002879581778229,-0.0112044590923957,8.35014782619636e-05,0.053504252990715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.00856118323848231,0.00443767851910546,-0.000136666658964385,0.017259033135929,0.0537266010912658
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,-0.00614420657245334,0.00318712250990768,-0.0123909666918724,0.000102553546965706,0.053895347359354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,40316,0.0237947502762103,0.0123463420282063,-0.000404080099074069,0.0479935806514946,0.0539636672699923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,39311,-0.00898201555009976,0.00466612892756459,-0.0181276282481264,0.000163597147926844,0.0542560041288738
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.00531794145729938,0.00276367916099237,-9.88696982456589e-05,0.0107347526128444,0.0543439676445377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSND,Barttin,37482,-0.00640500705277203,0.00332940934134569,-0.0129306493618096,0.00012063525626552,0.0544055836292285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,-0.00469568903907178,0.00244344290207855,-0.00948483712714574,9.3459049002171e-05,0.0546547863388484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00713072825600697,0.00371243619059794,-0.0144071031895789,0.000145646677565,0.0547826395757116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.012176206417683,0.00634257635944162,-0.0246076560821886,0.000255243246822603,0.0549102913562264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,-0.0057656450097821,0.00300876241658452,-0.0116628193462877,0.000131529326723554,0.0553503545390081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,0.00493974715174468,0.00257782938047904,-0.000112798433994238,0.00999229273748359,0.055355298882776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37598,0.00775633834222022,0.00405721381166904,-0.000195800728651101,0.0157084774130915,0.0559312551752067
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37598,-0.0103589430072876,0.00542966903368127,-0.0210010943133028,0.000283208298727716,0.0564335869288658
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00706014947413754,0.00370558382294263,-0.0143230937671051,0.000202794818830009,0.056766425954932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,40455,0.00804655144720566,0.0042257204768446,-0.000235860687409755,0.0163289635818211,0.056904074987715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37714,-0.00729992766195851,0.00383399387990821,-0.0148145556665786,0.000214700342661576,0.056931692447409
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37551,0.0127000081096549,0.00668156292067573,-0.000395855214869519,0.0257958714341793,0.0573561580891957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0187258475120312,0.00986243071998899,-0.000604516699147233,0.0380562117232096,0.057624643126379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.00983622297338237,0.00522783784263023,-0.000410339198172877,0.0200827851449376,0.0599248586191365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.00636349641430705,0.00338836098701607,-0.000277691120244445,0.0130046839488585,0.0603935781088842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0112458777179989,0.00599043586236886,-0.000495376572244065,0.0229871320082419,0.0604983710709113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37648,0.0104127310301688,0.0055483841597239,-0.000462101922890087,0.0212875639832276,0.0605793312647415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,0.0153930735481129,0.00821352732182378,-0.000705440002661673,0.0314915870988876,0.060936971334957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C5,Complement C5,38013,0.00277375106120969,0.00148245858739019,-0.000131867770075087,0.00567936989249447,0.0613599556367547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,40013,0.0131031328341429,0.00700659881241917,-0.000629800838198618,0.0268360665064845,0.0614868617908268
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,37482,-0.00866475946286074,0.0046374306151009,-0.0177541234684585,0.000424604542737021,0.061723230994216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.0089025726303507,0.00477400699600061,-0.0182596263425119,0.000454481081810496,0.06223164123737
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,40396,-0.0149140016148539,0.00801190932447593,-0.0306173438908267,0.000789340661118947,0.062694940158434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,-0.00994206196652532,0.00534121656857727,-0.0204108464409368,0.000526722507886126,0.0627080308796678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,0.00630432492752309,0.00339534377974648,-0.000350548880780003,0.0129591987358262,0.0633643500105877
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,-0.0102706094746626,0.00555125042898314,-0.0211510603154696,0.000609841366144347,0.0643148012640505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.00783075403866193,0.00423485998058233,-0.000469571523279432,0.0161310796006033,0.0644632714274572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37901,0.0190752055871051,0.0103417274290365,-0.00119458017380636,0.0393449913480166,0.0651338408419198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0128166589281833,0.00695102972629003,-0.0264406771917118,0.000807359335345141,0.0652274975959925
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,-0.00872084871000998,0.0047424486934909,-0.0180160481492521,0.000574350729232183,0.0659544171631869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00584620498921502,0.00318315287559366,-0.000392774646948557,0.0120851846253786,0.0662897031068859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,0.00551594485740711,0.00301382628106211,-0.000391154653474624,0.0114230443682888,0.0672365499217052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,-0.0110285876129241,0.0060705876272196,-0.0229269393622746,0.00086976413642627,0.0692822136443812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,0.00398419473298691,0.00219458823533093,-0.000317198208261725,0.00828558767423554,0.0694714408594622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,40044,0.00870289167246038,0.0047939608771374,-0.000693271646728914,0.0180990549916497,0.0694837419328643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37562,-0.00608595180749404,0.00335305098140977,-0.0126579317310572,0.000486028116069097,0.0695392210269697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,37482,-0.00808417214599926,0.0044589738753072,-0.0168237609416014,0.000655416649602853,0.0698530050926544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37598,-0.0103706382531881,0.0057314675366942,-0.0216043146251087,0.000863038118732543,0.0704084396368861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39980,-0.00985164498624581,0.00544743868049335,-0.0205286248000128,0.000825334827521153,0.0705494191893424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,0.0167612239560764,0.00927331330557237,-0.00141447012284549,0.0349369180349982,0.0707122005269114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,37457,-0.00711339956597889,0.00394166264936854,-0.0148390583587412,0.000612259226783455,0.0711494905471665
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.0141757563181377,0.0078705734546452,-0.0296020802892423,0.0012505676529669,0.0717087962779451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00525152886595856,0.00291686155192354,-0.0109685775077287,0.000465519775811569,0.0718199018696769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.0111259242710766,0.00619207300520053,-0.0232623873612696,0.00101053881911642,0.0723902305707807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37959,-0.0037111456505758,0.00206671458634195,-0.00776190623980603,0.000339614938654429,0.0725687220828062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37577,-0.0119817690459497,0.00668426840095196,-0.0250829351118155,0.00111939701991616,0.0730707124560325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.00716583841003016,0.00401481440701237,-0.000703197827714076,0.0150348746477744,0.0743052904405676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,-0.00480799130491322,0.00270435778777813,-0.0101085325689584,0.000492549959131916,0.0754446277897986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37628,0.0145251044380139,0.00817678164172551,-0.00150138757976808,0.0305515964557959,0.0756927091496662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40500,0.010462414120565,0.00590211260147144,-0.00110572657831902,0.022030554819449,0.0763047261508098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,0.00485357545405098,0.00274043093111977,-0.000517669170943767,0.0102248200790457,0.0765666813825746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,-0.0071013328491603,0.00401621318505403,-0.0149731106918662,0.00077044499354561,0.0770520580863747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00483258090620003,0.0027376415507433,-0.000533196533256834,0.0101983583456569,0.0775468858276966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0106845787823022,0.00605834588210843,-0.0225589367112348,0.00118977914663028,0.0778203490613057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,40276,0.00570254348757788,0.00323366366692069,-0.000635437299586677,0.0120405242747424,0.0778366598143288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.011270616136513,0.00640136952139867,-0.00127606812542835,0.0238173003984544,0.0783197853165869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37572,-0.0101921373219617,0.00579746556120949,-0.0215551698219323,0.00117089517800891,0.0787651641601534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.0137679371356441,0.00784938682146739,-0.00161686103443196,0.0291527353057202,0.0794477975785293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,37482,0.0121446666787917,0.00692604817313483,-0.00143038774055262,0.0257197210981359,0.0795436625940013
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00979725233968805,0.00560423566948721,-0.020781554251883,0.00118704957250687,0.0804550841381718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,-0.00808914782509539,0.00462849869997691,-0.0171610052770501,0.000982709626859356,0.080538330094936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,-0.00678106366531411,0.00388668465735814,-0.0143989655937361,0.00083683826310785,0.0810584819747084
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,-0.00981593921159757,0.00563335303165001,-0.0208573111536316,0.00122543273043645,0.081445801689724
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,0.00900728821610542,0.00517406109690601,-0.00113387153383036,0.0191484479660412,0.0817322542236609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00879909841063793,0.00506515925508723,-0.0187268105506089,0.00112861372933304,0.082378713585255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37763,0.0105332041246374,0.0060866501592516,-0.00139663018749577,0.0224630384367705,0.0835566486696594
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.00681646658287388,0.00396170837567201,-0.014581414999191,0.000948481833443254,0.0853492689844742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,-0.00382580717422411,0.00222409312628331,-0.0081850297017394,0.000533415353291182,0.0854217650305921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00355326571437767,0.00207943107177332,-0.000522419186298044,0.00762895061505338,0.0875169659635949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37572,0.0127497055641185,0.00747051937245971,-0.00189251240590257,0.0273919235341395,0.0879072127921935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.00895596258899837,0.00524852839479872,-0.00133115306480712,0.0192430782428039,0.0879611231505798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,40017,0.00919791812165464,0.00540691340967294,-0.00139963216130432,0.0197954684046136,0.0889366247094455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,-0.00884434284562253,0.00520980180852205,-0.0190555543903258,0.00136686869908069,0.08959967407086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37714,0.00728873524889892,0.00429402320001955,-0.00112755022313939,0.0157050207209372,0.0896418735157703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,-0.0172587259979779,0.0101702100279738,-0.0371923376528065,0.00267488565685075,0.0897218857085936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39961,-0.00863207345028421,0.00509087370041838,-0.0186101859031042,0.00134603900253581,0.0899821761269062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,0.0143344538627167,0.00846512982593112,-0.00225720059610826,0.0309261083215417,0.0904114700150383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,40299,0.0129550193444352,0.0076543042536746,-0.00204741699276698,0.0279574556816375,0.090567614928706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,-0.00742821205202969,0.00438970564596486,-0.0160320351181208,0.00117561101406142,0.0906297026436137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,-0.00776850289421499,0.00459397549142711,-0.0167726948574121,0.00123568906898215,0.0908560700134667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00750511224320455,0.0044484442645931,-0.016224063001807,0.00121383851539793,0.09160171614262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,0.004286107540431,0.0025442486671837,-0.000700619847249046,0.00927283492811105,0.0920804294170311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39961,-0.00535352218920274,0.00319260485737138,-0.0116110277096506,0.000903983331245159,0.0935918031230517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,-0.00482806892666059,0.00288147475633072,-0.0104757594490688,0.000819621595747619,0.0938492529030515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,37541,-0.0148310822996882,0.00886804057369998,-0.0322124418241401,0.00255027722476377,0.0944655669047077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.00882347484993979,0.00527799402670081,-0.0191683431422734,0.0015213934423938,0.0945979691393543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,0.00527863756778499,0.00316054466647367,-0.000916029978503401,0.0114733051140734,0.0949101234911618
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37959,0.00765657517869415,0.0046027397636686,-0.00136479475809631,0.0166779451154846,0.096239171239603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39961,0.00711047111049704,0.0042749046447518,-0.00126834199321648,0.0154892842142106,0.0962715639807996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,0.0084863007558924,0.00510474636794303,-0.00151900212527594,0.0184916036370607,0.0964497984966358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-0.00813052579986242,0.00489399808038265,-0.0177227620374124,0.00146171043768757,0.0966718547300231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.00553265426224691,0.00333552349627742,-0.00100497179045684,0.0120702803149507,0.0971947635121992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,37352,-0.00620305875942585,0.00375991208197033,-0.0135724864400877,0.001166368921236,0.0990106001468549
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,37541,-0.0126871751394491,0.00769532774655666,-0.0277700175227001,0.00239566724380199,0.0992360849319777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37714,0.00472329342495204,0.00286709085266976,-0.000896204646280694,0.0103427914961848,0.0994961104903266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00541571771591922,0.00329575884337701,-0.0118754050489382,0.00104396961709972,0.100357622341812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37998,-0.0143886542655654,0.008772830714671,-0.0315834024663206,0.00280609393518973,0.100999666363192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,-0.00647792091418541,0.00395636692731622,-0.0142324000917252,0.00127655826335437,0.101579287277839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,40341,0.0108710173186096,0.00665603968591302,-0.00217482046577988,0.0239168551029992,0.102434962273358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.011397475662272,0.00698145348908239,-0.0250811245008735,0.0022861731763295,0.102590591328738
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,37541,-0.00846648124258892,0.00519345345191968,-0.0186456500083515,0.00171268752317365,0.10307868099705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.00660027993713164,0.00405093337625331,-0.00133954948032486,0.0145401093545881,0.103264807666821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.00382717999838354,0.00235354532531249,-0.000785768839228942,0.00844012883599602,0.103941011784224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37981,0.0023113724634246,0.00142721704867283,-0.000485972951974148,0.00510871787882334,0.105363869999881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,38013,0.00311814434409181,0.00192975638905736,-0.000664178178460623,0.00690046686664425,0.106155895584809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37959,0.00571814808930349,0.0035505690576663,-0.00124096726372246,0.0126772634423294,0.10731477755157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,-0.00915500700712894,0.00572139971314008,-0.0203689504448835,0.0020589364306256,0.109588940683831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,0.00503718392322199,0.00315534237866166,-0.00114728713895487,0.0112216549853989,0.110420219143497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.00467827071895976,0.0029329431248609,-0.0010702978057676,0.0104268392436871,0.110715348476104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,37541,-0.00563432272563546,0.00354435679518106,-0.0125812620441903,0.00131261659291943,0.111935584228379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,40411,-0.00567290828037415,0.003578413226053,-0.012686598203438,0.00134078164268973,0.112914842168383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,0.00594764163232808,0.00375529996819821,-0.0014127463053404,0.0133080295699966,0.113262746288691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0109736415476654,0.00696066664463412,-0.00266926507581748,0.0246165481711483,0.114929488850517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.00586170359464561,0.00373445047520651,-0.0131812265260504,0.00145781933675916,0.116525505917556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,37541,0.00988527892708499,0.00629949527071883,-0.00246173180352391,0.0222322896576939,0.116621414230788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37628,0.0103866457310836,0.00662749550817295,-0.00260324546493533,0.0233765369271026,0.117090738584656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,40044,0.0136254160095114,0.00870132342056626,-0.00342917789479846,0.0306800099138213,0.117391955774961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,-0.0040148555903098,0.00257428831436394,-0.00906046068646313,0.00103074950584353,0.118874971781587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0157062604888826,0.0100775870351334,-0.00404581009997887,0.0354583310777441,0.119130870645233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,40044,-0.00431628443339316,0.00277627642362434,-0.00975778622369688,0.00112521735691055,0.120037188929156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00847705161300907,0.00546901925245478,-0.00224222612180229,0.0191963293478204,0.121161824489464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,0.00990279102202431,0.00639243424310072,-0.00262638009445309,0.0224319621385017,0.121371416833904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,0.00994429506014144,0.0064384550440795,-0.00267507682625438,0.0225636669465372,0.122483739409094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.011285677228505,0.0073512636461038,-0.0256941539748684,0.00312279951785848,0.124758301464212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,0.00690724071193007,0.0045013847629771,-0.00191547342350505,0.0157299548473652,0.124937877044718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,-0.0135748657220005,0.00885791639731306,-0.0309363818607341,0.00378665041673306,0.125420235883641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,40341,-0.00887646561726636,0.0057940056888801,-0.0202327167674714,0.00247978553293863,0.125540260884272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0115539191878804,0.0075487564359122,-0.00324164342650752,0.0263494818022683,0.125899083606863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0136066417172082,0.00889686782034574,-0.00383121921066948,0.0310445026450858,0.12619550975668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,-0.00967213140661935,0.00633035067177214,-0.0220796187232927,0.00273535591005403,0.126558208156076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,0.00558215038676849,0.00365768990675819,-0.00158692183047757,0.0127512226040145,0.126994483462008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37598,-0.0086005080015885,0.00564273546980791,-0.019660269522412,0.002459253519235,0.127489425026422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.00590458808111349,0.00389072664407084,-0.00172123614126537,0.0135304123034923,0.129137220410819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37901,0.0088319732644177,0.00583571662938216,-0.00260603132917132,0.0202699778580067,0.130192895605482
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0128601506319846,0.00850379444776952,-0.00380728648564365,0.0295275877496129,0.130485716895494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0057383514101951,0.00380975161169858,-0.0132054645691243,0.00172876174873412,0.132032940177398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.00739017129021963,0.00490974286218955,-0.0170132673001112,0.00223292471967189,0.132295101649113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,37410,0.00639977430425996,0.00425969087890293,-0.00194921981838979,0.0147487684269097,0.133017312005278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0119646369390835,0.00797121872376912,-0.00365895175950394,0.027588225637671,0.13338506038969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,-0.00605879111929491,0.00403771643192939,-0.0139727153258765,0.00185513308728669,0.133496495277548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00424741278027627,0.00283229611507198,-0.00130388760526482,0.00979871316581735,0.133732984510282
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,0.00548835547868027,0.00366504298799593,-0.00169512877779176,0.0126718397351523,0.134289864319731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0138691767578485,0.0092638471229628,-0.0320263171188555,0.00428796360315863,0.134383844643568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,-0.0101477415472872,0.00678565240782813,-0.0234476202666303,0.00315213717205596,0.134811368681022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.00378068264415964,0.00252818733260236,-0.00873592981606027,0.00117456452774098,0.134826494632637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,0.00401593161484073,0.00268646134155452,-0.00124953261460614,0.0092813958442876,0.13496961226657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.0252093966542831,0.0169081191032196,-0.0583493100965936,0.00793051678802728,0.13599107150357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00433744590420395,0.00292054303339955,-0.00138681844125916,0.0100617102496671,0.137524264815201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.0052080888466008,0.00351146870503689,-0.0120905675084731,0.00167438981527151,0.138054512843977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,-0.00823813534907656,0.00555909137834511,-0.019133954450633,0.00265768375247985,0.138385337534485
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,-0.00631990432369145,0.00426472494741089,-0.0146787652206168,0.00203895657323389,0.138386188021453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,0.00853477388123468,0.00577677160973788,-0.00278769847385156,0.0198572462363209,0.1395842388304
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,0.00502629703504222,0.00340938388219794,-0.00165609537406574,0.0117086894441502,0.140436583555395
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,-0.00321106999612529,0.0021801658725954,-0.00748419510641228,0.0010620551141617,0.140809769905142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,40355,-0.0262337231435821,0.0178165326242583,-0.0611541270871284,0.00868668079996413,0.140922677765104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37628,0.00406935824989263,0.00277517994191586,-0.00136999443626246,0.00950871093604771,0.142579460343487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,-0.00702092464818332,0.00480688831565585,-0.0164424257468688,0.00240057645050214,0.144150148590162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,0.00881906757309459,0.00604729434486569,-0.00303362934284217,0.0206717644890313,0.144768385849311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0113081729665441,0.00775959277005971,-0.00390062886277289,0.0265169747958612,0.145049517389065
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,-0.00908246654580372,0.00626133361320336,-0.0213546804276823,0.00318974733607487,0.146924893056591
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00512174964883041,0.00353493742808173,-0.0120502270078706,0.00180672771020979,0.147391249730886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,0.00523384246704875,0.00361253362954596,-0.00184672344686133,0.0123144083809588,0.147412979264225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39992,0.00669095099146148,0.00462539752111146,-0.00237482814991699,0.01575673013284,0.148038186728144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,0.00662628949904906,0.00459353301037212,-0.00237703520128029,0.0156296141993784,0.14917429174923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,0.00845420232203175,0.00586205596177236,-0.00303542736304206,0.0199438320071056,0.149268124687161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00437627580033081,0.00304184236868988,-0.00158573524230136,0.010338286842963,0.150261472291767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0030312620774065,0.00212357167523091,-0.00113093840604607,0.00719346256085908,0.153474035704907
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,0.00407291248994943,0.00285947043452109,-0.0015316495617119,0.00967747454161076,0.154365621616618
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37572,-0.00519090667398523,0.00365349109743794,-0.0123517492249636,0.00196993587699314,0.155396564719156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,0.00459538947031908,0.00323499965072441,-0.00174520984510076,0.0109359887857389,0.155475754901214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,-0.00625796698715191,0.00441196228302716,-0.0149054130618851,0.00238947908758132,0.156091003933538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37990,-0.00505154397137253,0.00356926674014501,-0.0120473067820568,0.0019442188393117,0.157006779749036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,40044,0.00444884542818297,0.00314638649532223,-0.00171807210264859,0.0106157629590145,0.157395406926373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,0.00461551352567208,0.00326477016718892,-0.0017834360020182,0.0110144630533624,0.157464020309833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37766,-0.00453171805371979,0.00320638150923438,-0.0108162258118192,0.0017527897043796,0.157578165681186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40489,-0.00611592548907882,0.00434569906146081,-0.014633495649542,0.00240164467138437,0.159342607175789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.00354169584447006,0.00251961466907513,-0.0013967489069172,0.00848014059585732,0.15985124215838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37572,-0.0047611768305451,0.00339789655690261,-0.0114210540820742,0.00189870042098403,0.161174040754753
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37900,0.00605048421796141,0.00432336563040715,-0.00242331241763661,0.0145242808535594,0.161690737516584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,0.00780224855839278,0.00558297694928038,-0.00314038626219677,0.0187448833789823,0.162284854798927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,0.00837254569356813,0.00601228073456981,-0.0034115245461887,0.020156615933325,0.163771680011445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,40341,0.0119237250646555,0.00858103821014991,-0.00489510982723835,0.0287425599565493,0.164687041275563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,40258,-0.00561506202462178,0.00405378380886899,-0.013560478290005,0.00233035424076145,0.166028915239217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,-0.00704451683002927,0.00509280212045876,-0.0170264089861284,0.0029373753260699,0.166617899375644
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40471,-0.00393129049162528,0.00284387604191783,-0.00950528753378423,0.00164270655053367,0.166877226053622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0083079964046529,0.00601495023789208,-0.00348130606161558,0.0200972988709214,0.16723353451662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,36179,0.0139128621780006,0.0101134371389422,-0.00590947461432622,0.0337351989703274,0.168946725573272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00510343845250878,0.00371919250136451,-0.00218617885016564,0.0123930557551832,0.170027800431918
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,37541,-0.00731172692394917,0.00533161073250524,-0.0177616839596594,0.0031382301117611,0.170276379771203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,0.00784115993028542,0.00574252481460726,-0.00341418870634481,0.0190965085669156,0.172129852326882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,-0.00831455301998267,0.0060961728635601,-0.0202630518325605,0.00363394579259513,0.172623224803643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,37541,-0.00657022248907958,0.00481804912848092,-0.0160135987809022,0.00287315380274303,0.172695330755677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.00398651069404113,0.00293571601082411,-0.00974051407525638,0.00176749268717412,0.174504052133585
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37562,-0.00594080120961451,0.00437899978322119,-0.014523640784728,0.00264203836549903,0.17491354502597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00387821841953805,0.00286516054044737,-0.0017374962397388,0.0094939330788149,0.175894351337122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,37482,-0.0055555053667629,0.00410503939387482,-0.0136013825787575,0.00249037184523175,0.175971185626676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37598,-0.00455328924365791,0.00337241326115662,-0.0111632192355249,0.00205664074820906,0.176988694227512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,-0.00834458408087804,0.00618579577358267,-0.0204687437971001,0.00377957563534399,0.177358944520924
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,0.0107530968058532,0.00797938505624986,-0.00488649790439655,0.0263926915161029,0.177806645423854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,-0.0107233012841658,0.00797106755039598,-0.026346593682942,0.00489999111461028,0.178558952946611
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,-0.00464512441476864,0.00345314987059627,-0.0114132981611373,0.00212304933160004,0.178588204065752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,37457,0.00458347241390579,0.00340951031987101,-0.0020991678130414,0.011266112640853,0.178868426386646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39871,-0.00908253620942206,0.00676526499931958,-0.0223424556080884,0.00417738318924431,0.179445651107861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,37482,-0.00544582409461655,0.00406481496368258,-0.0134128614234344,0.00252121323420131,0.180350940950318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39925,0.00442684148096858,0.00330435577204469,-0.002049695832239,0.0109033787941762,0.180362961322754
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,-0.00676830009037769,0.00505959853029674,-0.0166851132097593,0.00314851302900393,0.181012755293797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,40333,-0.00849810687219034,0.00635874687561715,-0.0209612507483999,0.00396503700401927,0.18142345459447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,0.0100591871824774,0.00754518556783732,-0.00472937653048377,0.0248477508954385,0.18249143685019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,40044,0.00498980142025774,0.00374592984480064,-0.00235222107555152,0.012331823916067,0.182860108448797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,0.00915963211403165,0.00687946267187752,-0.0043241147228483,0.0226433789509116,0.183065232008845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39602,0.0036038155642439,0.00270698786741204,-0.0017018806558837,0.00890951178437149,0.183110032260968
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.00883816954637642,0.00664472841355465,-0.00418549814419069,0.0218618372369435,0.183507540720821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00590842139822056,0.00445487782521518,-0.00282313913920118,0.0146399819356423,0.184765429056473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00381817304477362,0.00288420292126932,-0.00183486468091424,0.00947121077046148,0.185580878662845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00376938325623115,0.00285230383800619,-0.00182113226626099,0.00935989877872329,0.186350254975455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00545753899755127,0.00413403652018952,-0.0135602505771227,0.00264517258202018,0.186808163120898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0070549109803592,0.00535659819848385,-0.0175538434493876,0.00344402148866915,0.187844713973952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.00494019773715322,0.00375531903713862,-0.00242022757563847,0.0123006230499449,0.188354186019859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,-0.00522411526083927,0.00397420171627893,-0.013013550624746,0.00256532010306742,0.188698122362544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,37482,0.00935393613150704,0.00712343348944367,-0.00460799350780255,0.0233158657708166,0.189165017572963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,40044,0.0056420934429692,0.00429675265279137,-0.00277954175650189,0.0140637286424403,0.189166419028358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37598,0.0037846363063048,0.00288955292477658,-0.00187888742625729,0.00944816003886689,0.190298115273371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00999867287788078,0.00764398273540623,-0.024980879039277,0.00498353328351543,0.1908810406231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,0.00934127045605862,0.00714511560926872,-0.00466315613810808,0.0233456970502253,0.191111203585386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,0.00355407047400299,0.00273457966043724,-0.001805705660454,0.00891384660845999,0.193734336948611
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,37482,-0.00758187778080216,0.00584559523820572,-0.0190392444476854,0.00387548888608104,0.194645867463074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40536,0.00893629173778946,0.00691409711809254,-0.00461533861367192,0.0224879220892508,0.196211562619657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37942,0.00860405482535643,0.00665991248408509,-0.00444937364345035,0.0216574832941632,0.196407987057528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,-0.00452550084447153,0.0035033886473605,-0.0113921425932981,0.00234114090435505,0.196466632789134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_A,,37959,-0.00408290224156706,0.00316899618069616,-0.0102941347557315,0.00212833027259742,0.197632388938615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.00448752238314289,0.00349724826083375,-0.00236708420809126,0.011342128974377,0.199455768884394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00345921525179735,0.00270127954209735,-0.00875372315430815,0.00183529265071346,0.200358423358752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.0108586271095806,0.00848771089653549,-0.005777286247629,0.0274945404667901,0.200797650522083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37628,-0.00221390828443759,0.00173326297130509,-0.00561110370819557,0.00118328713932039,0.201516520515535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,-0.00481793907631435,0.00378918198881582,-0.0122447357743934,0.00260885762176466,0.203573930470009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00876877195490904,0.00690344630993841,-0.0222995267223883,0.00476198281257025,0.204035230771172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37959,0.0078521229037466,0.00618374395099869,-0.00426801524021084,0.019972261047704,0.20417747776108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0073980332738193,0.00586290955929504,-0.00409326946239898,0.0188893360100376,0.207026280894666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0108012290754621,0.0085771143707362,-0.00600991509118087,0.027612373242105,0.207937623644598
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00598290450920985,0.00475563347646525,-0.0153039461230817,0.00333813710466204,0.208390011112743
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37598,-0.0052210366415059,0.00417053843659795,-0.0133952919772379,0.00295321869422609,0.210633858568442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00447841129037926,0.00357860745359015,-0.00253565931865743,0.011492481899416,0.210796384023527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.00803700318432399,0.00645701699303811,-0.00461875012203071,0.0206927564906787,0.213266652924306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,-0.00903331972260095,0.00727454961894824,-0.0232914369757395,0.00522479753053759,0.214343571227077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,37482,-0.00543091291161424,0.0043763277736266,-0.0140085153479224,0.0031466895246939,0.21463736385508
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00324863089938212,0.00262521336248781,-0.00189678729109398,0.00839404908985823,0.215929704122254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00633710295616342,0.00512209560363806,-0.016376410339294,0.00370220442696717,0.216031648116342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37562,-0.00654448225952186,0.00530097636541769,-0.0169343959357405,0.00384543141669681,0.217008783112782
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37900,-0.00330151994029391,0.00268111842360886,-0.00855651205056728,0.00195347216997945,0.218196125167534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0106293459390041,0.0086343410832716,-0.00629396258420821,0.0275526544622165,0.218324636587182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.00814175940078162,0.00662179478448349,-0.00483695837680603,0.0211204771783693,0.218891043254091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,37429,0.00415903014441709,0.00338891782725379,-0.00248324879700033,0.0108013090858345,0.219753040052705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,-0.00768918258844514,0.0062816982947043,-0.0200013112460656,0.00462294606917529,0.220951207604253
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00831887222608013,0.00681175799237515,-0.0216699178911354,0.00503217343897516,0.222012612959464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37900,-0.00541949106194878,0.00444778090385317,-0.014137141633501,0.00329815950960343,0.22306649756216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,40042,0.00720574871714944,0.00591737446627614,-0.00439230523675179,0.0188038026710507,0.22334603099976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,0.015063833874464,0.0124166047932628,-0.00927271152033111,0.0394003792692592,0.225070977861606
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00760925707893817,0.00629231928353659,-0.00472368871679354,0.0199422028746699,0.226571594124394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00450487663617469,0.00372825466247904,-0.0118122557746336,0.00280250250228423,0.226950767331035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.00340347172339777,0.00282859330145993,-0.00214057114746369,0.00894751459425924,0.228901909510886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39961,0.00454466912872779,0.00378588541076179,-0.00287566627636532,0.0119650045338209,0.229992901943415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.00535588389489786,0.00447935084878232,-0.00342364376871549,0.0141354115585112,0.231838451310532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIM,Vimentin,40042,0.0136607880895974,0.0114655912748389,-0.00881177080908679,0.0361333469882816,0.233491369593019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00741481837956063,0.00623038012070291,-0.0196263634161383,0.00479672665701707,0.234026060936977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.004625961531496,0.00391759216398405,-0.0123044421729047,0.00305251910991275,0.237696461051908
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,-0.00555028344464159,0.00472821704846092,-0.014817588859625,0.00371702197034182,0.240471023580609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,-0.00249597462656222,0.00212805652226909,-0.00666696541020964,0.00167501615708519,0.240861471370889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,-0.00556626617215685,0.0047460422645661,-0.0148685090107064,0.00373597666639271,0.24088767943971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00442637120402882,0.00377851675442882,-0.0118322640427093,0.00297952163465166,0.241436283653565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39831,0.00667115797943859,0.00572744819945399,-0.00455464049149123,0.0178969564503684,0.244130303884317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,-0.00396356374598706,0.00341526817578826,-0.010657489370532,0.00273036187855793,0.245849089625201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39961,0.0053944958171267,0.00468170024252836,-0.00378163665822889,0.0145706282924823,0.249235528308458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37643,0.00927546415635363,0.00805012326385839,-0.00650277744080882,0.0250537057535161,0.249254056158087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37562,-0.00528967097978105,0.00460658310232096,-0.0143185738603301,0.00373923190076804,0.250871817939793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,-0.00471759197021582,0.00411678000583617,-0.0127864807816547,0.00335129684122308,0.251839981705798
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,0.00716668511226152,0.00626218540041633,-0.00510719827255447,0.0194405684970775,0.252462729032579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.00717810937024649,0.00630144752111377,-0.00517272777113649,0.0195289465116295,0.254670639354283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37598,0.0032679306600215,0.00286975905455176,-0.00235679708689995,0.00889265840694295,0.254829277443384
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0040281064166775,0.00354853632828901,-0.00292702478676896,0.010983237620124,0.256334935043789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37598,0.00565741939846436,0.00499827999033829,-0.00413920938259869,0.0154540481795274,0.25770837370416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.00531228456536503,0.00469971270655155,-0.0145237214702061,0.00389915233947601,0.258349046651078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,0.00505053143492408,0.00446957166647359,-0.00370982903136416,0.0138108919012123,0.258504203283616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37942,0.00422445903155637,0.00374802495354107,-0.00312166987738412,0.0115705879404969,0.259713471625198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.00783451107560101,0.00697163527103437,-0.00582989405562635,0.0214989162068284,0.261127664223496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00445993232213222,0.00396896849639072,-0.012239110575058,0.0033192459307936,0.261160397242097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,0.00857455540933058,0.00763133952864914,-0.00638287006682173,0.0235319808854829,0.261204257420368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,37541,0.00801371792586348,0.00714327586235311,-0.00598710276434861,0.0220145386160756,0.261944784502217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,0.00234068622252746,0.00208765444182794,-0.0017511164834553,0.00643248892851022,0.262221576590503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.00438841629472055,0.00391586120311992,-0.0032866716633945,0.0120635042528356,0.262442559298749
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40536,-0.0028655184863145,0.00256023999262382,-0.00788358887185719,0.00215255189922819,0.26305523266817
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,0.00442023364687279,0.00395395582766441,-0.00332951977534945,0.012169987069095,0.263618693058759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESPL1,Separin,37482,-0.00621827796989826,0.00556578922878719,-0.0171272248583211,0.00469066891852463,0.263915730785524
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.0101503944279452,0.00909285375509063,-0.0076715989320324,0.0279723877879229,0.264312178782035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.00304473809718852,0.00272874736070793,-0.00839308292417607,0.00230360672979902,0.264524375838734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37572,0.00706767671224549,0.00634576976780308,-0.00537003203264854,0.0195053854571395,0.26540174148149
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,-0.00751018562342625,0.00674419298882534,-0.0207288038815239,0.00570843263467141,0.265480407490359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37598,-0.0112980094534709,0.0101705096013075,-0.0312322082720335,0.00863618936509167,0.266649052654664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00307360314652238,0.002773203454254,-0.00236187562381546,0.00850908191686022,0.267740339624431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00396185604173031,0.00357762294085709,-0.00305028492234958,0.0109739970058102,0.268141181388506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00437173803138509,0.00401518972645267,-0.0122415098952323,0.00349803383246215,0.276262150275108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37572,0.00641893381407744,0.0059193924833951,-0.00518307545337696,0.0180209430815318,0.27821155717889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,-0.0102103825642476,0.00943115160260797,-0.0286954397053592,0.00827467457686399,0.278995662371343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,0.00935082209950455,0.00863936835702974,-0.00758233988027374,0.0262839840792828,0.279116853276319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,0.00486939671437816,0.00450412462078906,-0.00395868754236841,0.0136974809711247,0.279670648814204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,-0.00276672159573591,0.00256469109030815,-0.00779351613273989,0.00226007294126807,0.280707789650393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00817887129586718,0.00760238666203921,-0.00672180656172968,0.023079549153464,0.282022764323997
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,40044,-0.00308449294870323,0.00287472456811759,-0.0087189531022137,0.00254996720480725,0.283301224674719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,37541,-0.00656111447610552,0.00616973011452473,-0.018653785500574,0.00553155654836294,0.287603792808851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,-0.00601914543224082,0.0056784084454454,-0.0171488259853138,0.00511053512083217,0.289161471873064
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00267397075420662,0.00252575693926876,-0.0076244543551734,0.00227651284676016,0.289764062782752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37598,-0.0106259374102209,0.0100390009973576,-0.0303023793650418,0.00905050454460002,0.289862665234267
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,37541,-0.00460491401361638,0.00436739818788811,-0.0131650144618771,0.00395518643464432,0.291726686197265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,0.00622132245856486,0.00590061066469818,-0.00534387444424356,0.0177865193613733,0.291737989380294
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37562,-0.0063966729311075,0.00609638636856485,-0.0183455902134946,0.00555224435127962,0.294079429772877
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.00341447863880441,0.00325538035380648,-0.00296606685465628,0.00979502413226511,0.294252867072335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39961,0.00607846826336062,0.00585127354185149,-0.0053900278786683,0.0175469644053895,0.298900814757937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,-0.00279417660988773,0.00269100132023133,-0.00806853919754113,0.00248018597776567,0.299127115409987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40471,0.00259429883503821,0.00250615394044328,-0.00231776288823062,0.00750636055830703,0.300604508162072
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,-0.00437541681638165,0.00423310864175905,-0.0126723097542294,0.0039214761214661,0.30133401645312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37990,-0.00289926015063427,0.00282824889345672,-0.00844262798180945,0.00264410768054091,0.305330616628596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00492597620873713,0.00480811820976765,-0.0143498878998817,0.00449793548240746,0.305612387176123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,-0.0035770993132309,0.00350021052629509,-0.0104375119447693,0.00328331331830748,0.306815408200098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00408615182418962,0.00399944861228124,-0.0119250711042608,0.00375276745588161,0.306951588472547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,0.00292272140228592,0.00286113342550906,-0.00268510011171185,0.00853054291628368,0.307021182613649
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,-0.00289096135200283,0.00283043554084003,-0.00843861501204929,0.00265669230804363,0.307088426863986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37671,0.0033366765361784,0.00328166831854526,-0.00309539336817031,0.0097687464405271,0.30928514243021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,0.00778960505942719,0.00766781608540493,-0.00723931446796647,0.0228185245868209,0.309700440508566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,0.00837570761299117,0.00825600466829552,-0.00780606153686805,0.0245574767628504,0.310363008100977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,-0.00511172981725334,0.00505039369480969,-0.0150105014590803,0.00478704182457366,0.311487494434531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00500143673655249,0.00494292325092533,-0.0146895663083661,0.00468669283526116,0.311634258344767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,40332,-0.00471591137239207,0.00466703582142805,-0.0138633015823911,0.0044314788376069,0.312284362325043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,0.00363413169202001,0.00360569202823859,-0.00343302468332763,0.0107012880673677,0.313527105673697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40536,-0.0018747967602598,0.00187540022737495,-0.00555058120591471,0.0018009876853951,0.317481294923726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,-0.00357808880504595,0.00358014254041161,-0.0105951681842527,0.00343899057416081,0.317606630645543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.00371883238598764,0.00372709702943427,-0.0110239425636788,0.00358627779170353,0.31840004187537
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37562,-0.00715145450222267,0.00720504521531053,-0.0212733431242313,0.00697043411978597,0.320941741849947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.00581788730205582,0.00586869197975951,-0.00568474897827282,0.0173205235823845,0.321536320003887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,-0.00888343858200314,0.00897979501912959,-0.0264838368194971,0.00871695965549086,0.322549441683061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37874,-0.00545624015671043,0.00551571541947515,-0.0162670423788817,0.00535456206546087,0.322574753030236
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,-0.0082323159208841,0.00832474494823537,-0.0245488160194254,0.00808418417765723,0.322731782138159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,-0.00431710527019108,0.00437635072242077,-0.0128947526861358,0.00426054214575362,0.323924272542502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00705818618114527,0.00718224252037871,-0.00701900915879699,0.0211353815210875,0.32575980886196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,37482,-0.00681368428713631,0.00695641208645998,-0.0204482519765979,0.00682088340232524,0.327359788990932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00255382733378001,0.00262356941299748,-0.00258836871569505,0.00769602338325507,0.330361145509528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,0.00420253384614718,0.00431937185086133,-0.00426343498154102,0.0126685026738354,0.330595537115969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,40042,-0.00481368102115373,0.00494834756233048,-0.0145124422433215,0.00488508020101401,0.330674986973668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0051182522350737,0.00527431407247843,-0.00521940334698403,0.0154559078171314,0.331859380345028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00183994521754307,0.00189805188146668,-0.00556012690521776,0.00188023647013162,0.332369845498607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37714,0.00689411046234793,0.00711624363791877,-0.00705372706797285,0.0208419479926687,0.332670113318271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,0.00730487163171305,0.00754589903087537,-0.00748509046880268,0.0220948337322288,0.333030235923228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FST,Follistatin,40396,-0.00486247207291247,0.00502314597430677,-0.0147078381825537,0.0049828940367288,0.333052414402242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,-0.00530200787215226,0.00548126778596743,-0.0160452927326484,0.00544127698834392,0.333414084401489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,37482,-0.00883163323011436,0.00914673973932581,-0.0267592431191929,0.00909597665896422,0.334287397266661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00401240607016309,0.00417481149165163,-0.00417022445347411,0.0121950365938003,0.336517506072354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,0.00357971350325207,0.00374018456653566,-0.00375104824715782,0.010910475253662,0.338536302337076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37697,-0.00913821285018756,0.00956198523851219,-0.0278797039176715,0.00960327821729634,0.339250589843248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,40042,0.00450102109207604,0.00472724057481902,-0.00476437043456924,0.0137664126187213,0.341037930616826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37714,-0.00396213405303381,0.0041620005932826,-0.0121196552158677,0.00419538710980009,0.341125360373756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,0.00409690106150329,0.00430541697071719,-0.0043417162011024,0.012535518324109,0.341332741719678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37598,0.00437134388503464,0.004594458527801,-0.00463379482945533,0.0133764825995246,0.341399409446122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,40236,0.00635600258371001,0.00669517568294112,-0.00676654175485459,0.0194785469222746,0.342461908860195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,0.00300338592241228,0.00316680139992378,-0.00320354482143833,0.00921031666626289,0.342944129375008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39980,0.00374179132880072,0.00394801317267582,-0.00399631448964388,0.0114798971472453,0.343263512582662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00520370478049594,0.00551112057022658,-0.00559809153714816,0.01600550109814,0.345072072860716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,40228,0.00394828868713111,0.00418667047701548,-0.00425758544781924,0.0121541628220814,0.345663772546239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.00807683632598815,0.00857484895055385,-0.0087298676170974,0.0248835402690737,0.346246998828173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39961,0.00626286414884628,0.006660446465165,-0.00679161092287711,0.0193173392205697,0.347074776833262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.00203070354400702,0.002164084333335,-0.00221090174932958,0.00627230883734362,0.348072991749933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37598,-0.00239149605553746,0.00257995001093248,-0.00744819807696512,0.0026652059658902,0.353967219580762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.00371966416683105,0.00401958562969537,-0.011598052001034,0.00415872366737187,0.354780007197244
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37714,0.00205375268112186,0.00223186425545403,-0.00232070125956804,0.00642820662181177,0.357487053166505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,-0.00315144083852713,0.00344850520381077,-0.00991051103799625,0.00360762936094198,0.360806146654266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37714,-0.00508578368827246,0.00558305211478597,-0.016028565833253,0.00585699845670804,0.362347490203807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00219007079517257,0.00241716156576269,-0.00692770746406744,0.00254756587372231,0.364925162559775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,-0.00246222704502475,0.00272236122481995,-0.00779805504567186,0.00287360095562236,0.365775856078399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37959,0.00266647259171363,0.0029522877001537,-0.00312001130058762,0.00845295648401488,0.366441914556735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,0.00268526022121179,0.00297553378425279,-0.00314678599592368,0.00851730643834726,0.366833713691754
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40490,0.00233732291418204,0.00259985448565701,-0.0027583918777057,0.00743303770606977,0.368655149566168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,0.0042249756412679,0.00472508241635039,-0.00503618589477886,0.0134861371773147,0.371250624750949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,40406,-0.00347791180677169,0.00389206824117326,-0.0111063655594713,0.00415054194592791,0.371554977622237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00280089302823032,0.00313725729325083,-0.00894991732300196,0.00334813126654131,0.371986706419111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,40044,-0.00439738207534759,0.00494117255124903,-0.0140820802757957,0.0052873161251005,0.373508034034343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00373184888850978,0.00421161337189448,-0.00452291332040341,0.011986611097423,0.375587382444568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00250500502897446,0.00283922361095803,-0.0080698833064522,0.00305987324850329,0.37763577224256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00226114938563051,0.00257184325551968,-0.00277966339518806,0.00730196216644909,0.379312262490401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,-0.00218834324507737,0.00250642431634334,-0.0071009349051103,0.00272424841495557,0.382627491560975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,-0.00334399411815134,0.00386449616363782,-0.0109184065988815,0.00423041836257879,0.38688306549724
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37628,0.00570675038681657,0.00660727715779841,-0.00724351284246831,0.0186570136161014,0.387764684520752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37562,-0.00437975412018786,0.00511244660813639,-0.0144001494721352,0.00564064123175947,0.391634892062012
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37562,-0.00543484737358885,0.00635047457139297,-0.0178817775335191,0.00701208278634137,0.392114365843816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00373313604262753,0.00436615684650319,-0.00482453137651873,0.0122908034617738,0.392557471873718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,-0.0050176028044958,0.00586975613849364,-0.0165223248359433,0.00648711922695174,0.392664765108563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.00439761874050047,0.00515024035591973,-0.0056968523571022,0.0144920898381031,0.393194274218566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37572,0.00401510585842837,0.00470263505114977,-0.00520205884182519,0.0132322705586819,0.393231867698748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37998,0.0038676004874982,0.0045537938412452,-0.0050578354413424,0.0127930364163388,0.395721647776862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.0027615986405189,0.00325283951595509,-0.00913716409179087,0.00361396681075306,0.395907418506591
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.0047016161207082,0.00554337860668497,-0.00616340594839435,0.0155666381898107,0.396369956393921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37598,0.0013837717475475,0.00163469645266217,-0.00182023329967036,0.00458777679476535,0.397288873111538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39980,-0.0137917840922814,0.0163283805540197,-0.0457954099781601,0.0182118417935973,0.398318699736851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37987,0.00530767742055252,0.00630716012939609,-0.00705435643306381,0.0176697112741688,0.400064803025832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40489,0.00237427298848314,0.00283428186909164,-0.00318091947493648,0.00792946545190275,0.402212675167037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37934,-0.00377112116703894,0.00452248080381412,-0.0126351835425146,0.00509294120843674,0.404373989765118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.0038041768788919,0.00460510214658714,-0.00522182332841889,0.0128301770862027,0.408774471951951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARTN,Artemin,40044,0.00355234554238216,0.00431217223939085,-0.00489951204682392,0.0120042031315882,0.410068700553475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00507838713777285,0.00616529621631684,-0.0171623677217539,0.00700559344620815,0.410122106188931
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37959,0.0128381148361135,0.0155913036461024,-0.0177208403102471,0.0433970699824741,0.410286517411768
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,0.00313213732937129,0.00381230354745865,-0.00433997762364766,0.0106042522823902,0.411327185692504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00484502682171226,0.00590015601891887,-0.0164093326187932,0.00671927897536872,0.411564788694723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,40458,-0.00236982326723055,0.00289483132462641,-0.00804369266349833,0.00330404612903722,0.41300431146605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.00337182997805001,0.00413137419407962,-0.0114693233984461,0.00472566344234604,0.414427506552279
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00210698152508,0.00258647258030702,-0.00717646778248175,0.00296250473232175,0.415306965388745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37572,0.00274985150917939,0.00338567699803745,-0.00388607540697402,0.0093857784253328,0.416690827343579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,37482,-0.00243143290882055,0.00300899541767822,-0.00832906392746987,0.00346619810982876,0.419073841810405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,-0.00687157530946263,0.00850681978335279,-0.0235449420848341,0.00980179146590885,0.419233663514248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37572,0.00328719797908359,0.00407883783394688,-0.00470732417545228,0.0112817201336195,0.42030627209734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00474213422838262,0.00590047665601892,-0.0163070684741797,0.00682280001741447,0.421592569634086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37598,-0.00375315570862489,0.00467377867051112,-0.0129137619028267,0.0054074504855769,0.421975471724289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.00173639755409783,0.00218030164699898,-0.00600978878221584,0.00253699367402018,0.425812508605735
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,0.00635561018363741,0.0080113965274968,-0.00934672701025633,0.0220579473775311,0.427605031697715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,40042,-0.0082504726909346,0.0104100660025088,-0.0286542020558519,0.0121532566739827,0.428053515998311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,-0.00379277318063403,0.00481187652969544,-0.0132240511788371,0.00563850481756903,0.430587671305362
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,0.00178854339132877,0.00229049161795587,-0.00270082017986472,0.00627790696252227,0.434901065814063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,0.00381715258437892,0.00489624620430629,-0.00577948997606141,0.0134137951448192,0.435635820506363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,-0.00252046400807423,0.00323404758398821,-0.00885919727269113,0.00381826925654266,0.435785982838744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00375170514703235,0.00482320721553549,-0.0057017809954172,0.0132051912894819,0.436672501282662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,-0.00455921558153486,0.0058686408205224,-0.0160617515897588,0.00694332042668905,0.437242554741467
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,-0.00282987644048814,0.00365925179384636,-0.010002009956427,0.00434225707545073,0.439330015514518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00243083564825067,0.00315969941158147,-0.00862384649495036,0.00376217519844902,0.441714363862812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,40227,0.00391184463386122,0.00510040996031773,-0.00608495888836154,0.013908648156084,0.443112788072891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37572,-0.00199418757773253,0.00263700028366553,-0.00716270813371698,0.00317433297825192,0.449522874275661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,-0.00200898904241646,0.00267330799418757,-0.00724867271102409,0.00323069462619117,0.452365295250438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,-0.00639435418017191,0.00851924032787756,-0.0230920652228119,0.0103033568624681,0.45292018127927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,-0.0019544194001132,0.00260485842710088,-0.00705994191723093,0.00315110311700453,0.453088470559527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.00335497610710607,0.00447156170240184,-0.00540928482960153,0.0121192370438137,0.453092373756031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.00448233443784119,0.00598066090508248,-0.0162044298118029,0.00723976093612048,0.453584423785789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.00368056900942422,0.00491242161813584,-0.0133089153809705,0.00594777736212204,0.453727717051568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00381334425645105,0.00509846767327685,-0.0138063408960737,0.00617965238317158,0.454510069753915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37987,-0.00185275614186982,0.0024782138558426,-0.00671005529932132,0.00300454301558168,0.454703871303245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.00358243367007892,0.00479393034774183,-0.00581366981149507,0.0129785371516529,0.454902694205278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,0.00454727375627163,0.00608606286999672,-0.00738140946892194,0.0164759569814652,0.454978872020726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.00324372076722914,0.0043496655809864,-0.00528162377150421,0.0117690653059625,0.455835387187858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39961,0.0038349016359312,0.00514667584907337,-0.0062525830282526,0.013922386300115,0.45620923441078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,40044,0.00459677066327685,0.00618469018565495,-0.00752522210060685,0.0167187634271606,0.457341566477391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,40044,0.00354113646945692,0.00477783401690107,-0.00582341820366918,0.012905691142583,0.458607974823959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,-0.00233630087424793,0.00315223878734558,-0.00851468889744528,0.00384208714894941,0.458612098188181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37998,-0.00317852155620001,0.00431490528348191,-0.0116357359118246,0.00527869279942454,0.461355508219374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37998,0.00311060548050943,0.00423464124203509,-0.00518929135387935,0.0114105023148982,0.462619155581411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,-0.0045376880698355,0.00618420337890655,-0.0166587266924923,0.00758335055282133,0.4631114780762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,-0.00477952627162213,0.00652065146592197,-0.0175600031448292,0.00800095060158494,0.463581940923197
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,37482,0.0044315117353325,0.00604732439211572,-0.0074212440732143,0.0162842675438793,0.463690333053658
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,-0.00233302056674324,0.00320109269667203,-0.00860716225222042,0.00394112111873393,0.466122731631417
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00515536558064506,0.00710350102312099,-0.00876749642467209,0.0190782275859622,0.468004614113335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00237966971008632,0.00327920152089578,-0.00404756527086941,0.00880690469104205,0.468044032202619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,-0.00239437649869805,0.00330306226203641,-0.00886837853228942,0.00407962553489332,0.468528795176946
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00272302314217294,0.00376060639774054,-0.0100938116817444,0.00464776539739853,0.469020424146126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.00381426242464506,0.00529073160467707,-0.00655557152052199,0.0141840963698121,0.470963651225923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-0.00240309744846204,0.00334456598409029,-0.00895844677727901,0.00415225188035493,0.472456976606424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00294571102008796,0.00410689806332663,-0.0109952312242082,0.00510380918403223,0.473226855928652
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37572,0.00419678741108899,0.00592079383752094,-0.00740796851045205,0.01580154333263,0.478447696957336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,37482,-0.00288739381690745,0.00409147134541499,-0.0109066776539208,0.00513189002010593,0.480380877894174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,0.00578747689325063,0.00820257889015672,-0.0102895777314565,0.0218645315179578,0.480467394278633
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,0.00688874186091421,0.0097834831963154,-0.012286885203864,0.0260643689256924,0.481370700199728
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.00190234224279226,0.00273145392556391,-0.00725599193689751,0.003451307451313,0.486154524245926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,40305,0.0021667929610995,0.00312378314806981,-0.00395582200911732,0.00828940793131633,0.487915751672788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37598,-0.00391060174863715,0.0056441763401203,-0.0149731873752729,0.00715198387799864,0.488412129946393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,0.0052296234343454,0.00766078370655328,-0.00978551263049902,0.0202447594991898,0.494841038723607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00215662284050721,0.00317635362109236,-0.00406903025683383,0.00838227593784824,0.497173978337587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,40417,0.00739521131036968,0.010897646473776,-0.0139641757782313,0.0287545983989706,0.497397200313675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00300435549963984,0.00443250121048812,-0.00568334687291687,0.0116920578721966,0.497909588717956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00299313334546214,0.00442197247709028,-0.0116601994005591,0.00567393270963481,0.498495533949589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,-0.00220573735200359,0.00326158724997336,-0.00859844836195139,0.0041869736579442,0.498876618817219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,40341,0.00374884039869121,0.00557721564902121,-0.00718250227339036,0.0146801830707728,0.501484867886165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39953,-0.00574676984044094,0.00860738108151982,-0.0226172367602198,0.0111236970793379,0.50436312597757
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39903,0.00275932092399767,0.00413313602159554,-0.00534162567832959,0.0108602675263249,0.504392855046137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,0.00505132799221719,0.0076006020998735,-0.00984585212353487,0.0199485081079692,0.50632078465407
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,-0.00321282043496751,0.00484696322282659,-0.0127128683517076,0.00628722748177261,0.507436863767648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37857,0.0045873008986939,0.0069279529639211,-0.00899148691059147,0.0181660887079793,0.507890469032985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.00310653261348368,0.00470498097666345,-0.012328295327744,0.00611523010077668,0.509095579931641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,40044,0.00341347704987646,0.00517336068789705,-0.00672630989840177,0.0135532639981547,0.509380308736996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.00172309551818911,0.00261592887586947,-0.00685031611489327,0.00340412507851506,0.510102091810056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,-0.002868265878082,0.00438115679045528,-0.0114553331873743,0.00571880143121034,0.512683509374287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00493054790412825,0.00758738726560583,-0.00994073113645919,0.0198018269447157,0.5158103470519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.0031768484455509,0.00491261800530402,-0.0128055797359468,0.00645188284484498,0.517855998086778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00418483295805501,0.0064820005324854,-0.00851988808561638,0.0168895540017264,0.518544416530912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37998,-0.00568412970994519,0.00882013615014854,-0.0229715965642363,0.011603337144346,0.519295099815718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39980,-0.00891242711984079,0.0138514831466507,-0.0360613340872762,0.0182364798475946,0.519956154812977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37562,-0.00530452344483037,0.00824557613156878,-0.0214658526627052,0.0108568057730444,0.520029353646636
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.00430277174564811,0.00669471216597782,-0.0088188640996684,0.0174244075909646,0.520421912112043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00242303580218426,0.00377008045285033,-0.00981239348977092,0.00496632188540239,0.520429134857026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.00306625424327459,0.00478914560128097,-0.0124529796217853,0.00632047113523611,0.522020827288918
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37900,0.00496614624539068,0.00782404571183372,-0.0103689833498034,0.0203012758405848,0.525616179911021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37598,0.00161020813369327,0.00253714932567998,-0.0033626045446395,0.00658302081202604,0.52566613136898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,-0.00348292576964111,0.0055161728556124,-0.0142946245666414,0.0073287730273592,0.527788355905217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00306916632223998,0.00486836073307846,-0.00647282071459381,0.0126111533590738,0.528424032260777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.00256605130247589,0.00407509026847878,-0.00542112562374251,0.0105532282286943,0.528906885012602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,-0.00161631106253933,0.00257241374489161,-0.00665824200252688,0.00342561987744821,0.529800284340182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37942,-0.00141264423630482,0.00224961517089374,-0.00582188997125655,0.00299660149864691,0.530047793675716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,-0.00550904683769032,0.00879686833683415,-0.0227509087778852,0.0117328151025046,0.531161346941132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,40403,-0.00280827312657038,0.00449898080272445,-0.0116262754999103,0.00600972924676953,0.532503815085489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37572,-0.00237904067233662,0.00381744391936302,-0.00986123075428813,0.00510314940961489,0.533162278460742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00438040643146634,0.00704192740896511,-0.00942177129010528,0.018182584153038,0.533922089197765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37714,-0.00369438225225128,0.00598779119434242,-0.0154304529931624,0.00804168848865986,0.537254671399551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.0033381104463298,0.00541044922808098,-0.00726637004070893,0.0139425909333685,0.537262003519748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.00157562232194027,0.0025770849078898,-0.00662670874140428,0.00347546409752373,0.540945426873016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,-0.00279853110329285,0.00458005926808882,-0.0117754472687469,0.00617838506216124,0.541191643375576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00396215120815907,0.00652692071891728,-0.0167549158172369,0.00883061340091879,0.543829751271971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00301089199798141,0.00498950965039101,-0.0127903309127478,0.00676854691678497,0.546223571537261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,0.00499674140519335,0.00838089816259654,-0.0114298189934959,0.0214233018038826,0.551047957039531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37959,0.00220435749492381,0.00370337283078209,-0.00505425325340908,0.00946296824325671,0.551699912762496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.00260594578526344,0.00437976305697469,-0.0111902813769338,0.00597838980640695,0.55185388513717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.00508316800693638,0.0086183607183845,-0.02197515501497,0.0118088190010973,0.555330300566175
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37598,-0.00248049416824233,0.00421286137519664,-0.0107377024636277,0.00577671412714309,0.556011710836137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTN,Titin,37562,-0.00374609288307545,0.00636952676049826,-0.016230365333652,0.00873817956750114,0.556456948589499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,-0.00494420352245079,0.00841980703036634,-0.0214470253019688,0.0115586182570672,0.557072092965554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.0025354255878541,0.00433442005768471,-0.0110308889009161,0.00596003772520794,0.558590445916148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37714,0.00297479848808729,0.00509644588454809,-0.00701423544562697,0.0129638324218016,0.559431694539479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.0026487280867101,0.00454094688644288,-0.0115489839841381,0.00625152781071794,0.559702336118336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,-0.00315727632683437,0.00541882460318541,-0.0137781725490778,0.00746361989540904,0.560137636677127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00309013566712253,0.00532337293282195,-0.0135239466154536,0.00734367528120849,0.561597637815447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00407000695636112,0.00706685135011301,-0.00978102168986038,0.0179210356025826,0.564672828982306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,0.00356978442052281,0.00622492664031653,-0.00863107179449758,0.0157706406355432,0.566339041169996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,-0.00669607415302925,0.01171901223145,-0.0296653381266712,0.0162731898206127,0.567746597383983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37572,0.00376131106108211,0.00669544874923681,-0.00936176848742205,0.0168843906095863,0.574281433042935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00376949497418445,0.00671283490634713,-0.00938766144225591,0.0169266513906248,0.574440663899124
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00157842896123989,0.00281324897425868,-0.00393553902830712,0.0070923969507869,0.574759536844869
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.00293721783818967,0.0052362531927446,-0.00732583841958975,0.0132002740959691,0.574847319166188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37714,0.00929103425820415,0.0165892307411389,-0.0232238579944281,0.0418059265108364,0.575445107308862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.00170471663918898,0.00306630627249917,-0.00771467693328734,0.00430524365490939,0.578252037894565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39878,-0.00371774235488409,0.00679513315884797,-0.0170362033462261,0.00960071863645794,0.584305309151859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37598,-0.00287459603232049,0.00527875578695134,-0.0132209573747451,0.00747176531010415,0.586065828038545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,0.00408660932451955,0.00753370258718838,-0.0106794477463697,0.0188526663954088,0.587521887289441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00193603632846215,0.0035807516455803,-0.00508223689687524,0.00895430955379955,0.588736610229356
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,0.00154317149877473,0.00285419732591662,-0.00405105526002184,0.00713739825757131,0.588745755272037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00286726046248597,0.00533620150574187,-0.0075916944887681,0.01332621541374,0.591054087114314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37562,-0.00222990550946854,0.00417839308711251,-0.0104195559602091,0.00595974494127199,0.593575194934776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37598,0.00325957152421521,0.00614854976853561,-0.00879158602211459,0.015310729070545,0.59602614960042
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,0.00613690426489408,0.0116235857977097,-0.016645323898617,0.0289191324284052,0.597529128040176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,40398,0.00758209297528284,0.0144250409292332,-0.0206909872460143,0.03585517319658,0.599159423990325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,0.00278106131555204,0.00529753288443761,-0.00760210313794568,0.0131642257690498,0.59960947920424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,0.00276070078915812,0.00528229579889562,-0.0075925989766773,0.0131140005549935,0.601238574411549
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40475,0.00109884481530611,0.00210271755205171,-0.00302248158671525,0.00522017121732747,0.60127157634151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,-0.00239738341017971,0.00459324396624387,-0.0114001415840177,0.00660537476365828,0.601723075157163
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.0023641255098626,0.004529883832792,-0.0112426978221349,0.00651444680240971,0.601751975492147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00320395297032303,0.00615167841131913,-0.00885333671586246,0.0152612426565085,0.602495509542036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.00166542456910681,0.00319997406854372,-0.00460652460523887,0.0079373737434525,0.602757780649512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,0.0024409397949997,0.00469124827865604,-0.00675390683116615,0.0116357864211655,0.602850905871544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,-0.00714577929102545,0.0137416208788091,-0.0340793562134913,0.0197877976314404,0.603065489276993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37901,0.00566659519046589,0.0109750838721348,-0.0158445691989182,0.02717775957985,0.605643243555103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37671,-0.00216258063363202,0.00419461812078998,-0.0103840321503804,0.00605887088311635,0.606169823373259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37900,0.00246611317428653,0.00479208940913126,-0.00692638206761073,0.0118586084161838,0.606825859101841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,0.00155861437446151,0.00303831007246912,-0.00439647336757797,0.00751370211650098,0.607967364780414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.00588462859610088,0.0115955357237037,-0.0168426214223583,0.0286118786145601,0.611818972699492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00169825320475167,0.00339166995598476,-0.00494941990897845,0.0083459263184818,0.616581270682363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,0.00410087964722,0.0082109277481472,-0.0119925387391485,0.0201942980335885,0.617475338895358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00121866125704021,0.0024524032397283,-0.00358804909282726,0.00602537160690768,0.619250115716613
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.00180470966160633,0.00365035281797541,-0.00895940118483813,0.00534998186162548,0.621035508181464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,37482,0.00276262947889977,0.0055924601237201,-0.00819859236359162,0.0137238513213912,0.621320293106561
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,0.00126056736000037,0.00255677141310069,-0.00375070460967698,0.00627183932967773,0.621998790146245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37598,0.00229537086155753,0.00467711915088254,-0.00687178267417225,0.0114625243972873,0.623600181361638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37562,-0.00193201604441588,0.0039385603625565,-0.00965159435502662,0.00578756226619487,0.623761003902233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00607054901400707,0.0124740698782465,-0.018378627947356,0.0305197259753702,0.626511876199967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.000958059782080664,0.00199586690985266,-0.00295383936123054,0.00486995892539187,0.631218459347845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,40042,0.00128261383835633,0.00267995642238966,-0.0039701007495274,0.00653532842624007,0.632233462669597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,0.0120371413940467,0.0254800197918326,-0.0379036973979452,0.0619779801860387,0.636638484375376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40497,0.00136387868091702,0.00288763918424255,-0.00429589412019838,0.00702365148203242,0.636707553658008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,40044,-0.00227837117011893,0.00483331855967426,-0.0117516755470805,0.00719493320684262,0.637369865492607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40489,-0.00271810596398372,0.00577152812367314,-0.0140303010863831,0.00859408915841564,0.637682253527014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,37482,0.00247685105487116,0.00527717840912588,-0.00786641862701556,0.0128201207367579,0.638826336882189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39961,0.00160111434935682,0.00344903989502998,-0.00515900384490194,0.00836123254361558,0.642496431482915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,0.00315131603371875,0.00680901061471723,-0.010194344771127,0.0164969768385645,0.643504255721403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37562,-0.00209118684345613,0.00455616339913371,-0.0110212671057582,0.00683889341884594,0.64625630053707
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.00303345063763394,0.00661848811145011,-0.00993878606080827,0.0160056873360762,0.646723060827886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.0029185361353749,0.00637527950945564,-0.015414083973908,0.00957701170315816,0.647111253877364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37572,0.00257602854740181,0.00562712812033854,-0.00845314256846173,0.0136051996632653,0.647112745050185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.0018644508676297,0.00407683994358082,-0.00612615542178871,0.0098550571570481,0.647443090188733
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,40044,0.002372713981823,0.00521750547356552,-0.00785359674636543,0.0125990247100114,0.649288076855083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37572,-0.00190017145550057,0.00418211866431772,-0.0100971240375633,0.00629678112656216,0.649580003839093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,40419,-0.00146949619431216,0.00323440832855535,-0.00780893651828064,0.00486994412965631,0.649595843061924
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00217235267078085,0.00481833303862756,-0.0116162854264909,0.00727158008492918,0.652102877232201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00178815033566232,0.00397834801225739,-0.0095857124396868,0.00600941176836217,0.653099646133499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,37541,0.00501802229723273,0.0111880265094556,-0.0169105096613003,0.0269465542557658,0.653787401950956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,-0.00222511338375645,0.00497263319312871,-0.0119714744422887,0.00752124767477582,0.65454065654744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,0.00366473529741797,0.00821042658920914,-0.0124277008174319,0.0197571714122679,0.655350729850367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.002201877827414,0.00495134686601789,-0.0119065176848091,0.00750276202998106,0.65654188501593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.00299661171317332,0.00675869558281233,-0.0162436550554855,0.0102504316291389,0.657504480608571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37901,0.011074279925635,0.0251874907377426,-0.0382932019203405,0.0604417617716104,0.660180441140716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.00146998295642957,0.00334567355935595,-0.00802750313276723,0.00508753721990809,0.660400614792904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.00253685445178431,0.00577894961151051,-0.0138635956903449,0.0087898867867763,0.660680641868671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,0.00184437680705257,0.00422641470933257,-0.00643939602323925,0.0101281496373444,0.662558984110973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00147881050573881,0.00344736831960549,-0.00823565241216557,0.00527803140068795,0.667953600608705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37562,-0.00206048000558375,0.00486644084867513,-0.011598704068987,0.00747774405781951,0.672006050936154
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,40305,0.000780856631688885,0.00184892734837859,-0.00284304097113315,0.00440475423451092,0.6727902288695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.0015343367698949,0.00363440114346273,-0.00865776301108185,0.00558908947129205,0.67290642883355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37942,0.00217964461318904,0.00520107542988175,-0.00801446322937919,0.0123737524557573,0.675167441473274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,-0.00145669759760046,0.00351813573333,-0.00835224363492727,0.00543884843972635,0.678841434930495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,40359,0.00159977710038938,0.00386810519533044,-0.00598170908245828,0.00918126328323703,0.679186133013789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,0.00131608754159308,0.00318704450618385,-0.00493051969052726,0.00756269477371342,0.679650401979078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,-0.00162740852209177,0.00397741871218159,-0.00942314919796768,0.00616833215378414,0.682427517707422
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.00171633401687757,0.00423098766563894,-0.00657640180777475,0.0100090698415299,0.684999491573169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00154076658802092,0.00382061300382454,-0.00594763489947518,0.00902916807551702,0.686750591649494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_DRA,,40288,-0.00140211119062588,0.00348520193230479,-0.00823310697794328,0.00542888459669151,0.687465632881025
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,-0.00160931854435053,0.00406416625130517,-0.00957508439690866,0.00635644730820759,0.692128082680338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.001649146113469,0.0041680066401011,-0.00652014690112916,0.00981843912806716,0.692356529333262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,40042,0.00207552068449597,0.00527790719031359,-0.00826917740851868,0.0124202187775106,0.694142504215176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,40044,0.00180620306208475,0.00464629564725717,-0.0073005364065393,0.0109129425307088,0.697473464375287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00281024062972264,0.0072533696418402,-0.0114063638682841,0.0170268451277294,0.698437213845383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,-0.00208180149024708,0.00541968667533541,-0.0127043873739045,0.00854078439341033,0.700896946555305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00122932991953096,0.00320568390276808,-0.00505381052989448,0.0075124703689564,0.701366642949222
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,37482,-0.00433624933830418,0.0113404909986193,-0.0265636116955981,0.0178911130189897,0.702194104639973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,-0.00252628272641784,0.00662397359719396,-0.015509270976918,0.0104567055240823,0.702923969980461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37959,0.000938831633507051,0.00248160315893635,-0.0039251105580082,0.00580277382502231,0.705201371493465
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37562,-0.00265111113121354,0.00703509688049352,-0.0164399010169808,0.0111376787545538,0.706298060004872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.00181150692636416,0.00481532988176468,-0.0112495534946229,0.00762653964189461,0.706777221573661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,37541,-0.00168769433195354,0.00455245744173339,-0.010610510917751,0.0072351222538439,0.710850895641814
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,0.00349768389963045,0.0094569579684492,-0.01503795371853,0.0220333215177909,0.711498035969896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37572,0.00332367195275823,0.00899126648730366,-0.0142992103623569,0.0209465542678734,0.711645088731449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.0014149458424059,0.00386395207782881,-0.00615840023013857,0.00898829191495037,0.714228035996089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,37482,0.00259232162699547,0.00716321639911014,-0.0114475825152604,0.0166322257692514,0.717437467837095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37880,-0.00179044392813919,0.0049606072725556,-0.0115132341823482,0.00793234632606978,0.718155654044577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,40359,0.00268801399706534,0.00761755651627406,-0.0122423967748318,0.0176184247689625,0.724189905842781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,-0.00249514457658978,0.0071048292658205,-0.016420609937598,0.0114303207844184,0.725451507898076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,-0.00195080066443455,0.00556621628072954,-0.0128605845746644,0.00895898324579534,0.72599044825438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37572,-0.00223363129717267,0.0064268877880832,-0.0148303313618157,0.0103630687674704,0.728187658566185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0013845733904711,0.00399423455848977,-0.00921327312511105,0.00644412634416886,0.728865111890177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37714,0.00138714871673785,0.00401350427293399,-0.00647931965821276,0.00925361709168846,0.729633538790734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37572,0.00232610412346615,0.006773644895899,-0.0109502398724959,0.0156024481194282,0.731299234553765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37942,-0.00197455833999685,0.00578192208034991,-0.0133071256174827,0.00935800893748897,0.732728364858177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,-0.00141270071817857,0.0042089107571686,-0.00966216580222902,0.00683676436587188,0.737142907649062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.000776575631142473,0.00231393284648875,-0.00375873274797547,0.00531188401026042,0.737170522064605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,0.00154699722307213,0.00464435858927761,-0.00755594561191198,0.0106499400580562,0.739070403064807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37900,-0.00108928424361712,0.00328174359642908,-0.00752150169261812,0.00534293320538388,0.739953020800011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,0.00276498215999891,0.00835769933894471,-0.0136161085443327,0.0191460728643305,0.740777812917929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,-0.00117954855966921,0.00357541661684975,-0.00818736512869472,0.00582826800935629,0.741476704948794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.00540065075410238,0.0168014734171707,-0.038331538651757,0.0275302371435522,0.747882639864153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37562,-0.00344700806848292,0.0107365470503264,-0.0244906402871226,0.0175966241501568,0.748174820260633
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37598,0.00236520657867645,0.00739077128769879,-0.0121207051452132,0.0168511183025661,0.748957029463593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,0.00335523974840566,0.0105238088048345,-0.01727142550907,0.0239819050058813,0.749865286462617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00114322684297661,0.00364633376281693,-0.0082900410180978,0.00600358733214457,0.753884699519402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,-0.00537815134176975,0.0173813306972241,-0.0394455595083289,0.0286892568247894,0.757005254983739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37942,-0.00278275532175584,0.0091923720207449,-0.0207998044824158,0.0152342938389042,0.762104567422771
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00168601402252344,0.00557031572617536,-0.00923180480078028,0.0126038328458272,0.762139673115473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,0.00127619778163576,0.00422825513676512,-0.00701118228642387,0.00956357784969539,0.762788654933104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,-0.00144736165342742,0.00491170295969278,-0.0110742994544253,0.00817957614757043,0.76824598863008
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,-0.000539009005663504,0.00184319963953308,-0.00415168029914834,0.00307366228782133,0.769961461720755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,0.00159074435542661,0.00545167643527506,-0.00909454145771251,0.0122760301685657,0.770451880392872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.00060638203920363,0.0020787706842571,-0.00468077258034755,0.00346800850194029,0.770518097305348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.00160113508879583,0.00552164573229692,-0.00922129054650614,0.0124235607240978,0.771839728484967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,0.00187955070760886,0.00650471266415708,-0.010869686114139,0.0146287875293567,0.772622551479632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.00249116667050445,0.00864420925325401,-0.0194338168068823,0.0144514834658734,0.773205857332064
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37959,-0.00122206148184303,0.00424618404723931,-0.00954458221443207,0.00710045925074601,0.773502501821343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00113287630592897,0.00394624821790292,-0.0088675228130187,0.00660177020116076,0.774058030907157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37900,0.00111590894649654,0.00390084351583508,-0.00652974434454022,0.0087615622375333,0.774829966685857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,-0.00209002698719502,0.00736891486316659,-0.0165331001190015,0.0123530461446115,0.776700278610653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,40354,0.00106900675055691,0.00379095169545461,-0.00636125857253413,0.00849927207364796,0.777955599771985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.000877306290773928,0.00312217679643702,-0.00524216023024263,0.00699677281179049,0.778720251323938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,0.00131706536805169,0.00469605920274567,-0.00788721066932983,0.0105213414054332,0.779127629722416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00111302576255403,0.00403219875200146,-0.00679008379136883,0.00901613531647689,0.782525984545284
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37900,0.000988738767280333,0.00359581201532552,-0.00605905278275768,0.00803653031731835,0.783343866107756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,0.001075089134338,0.0039207993223979,-0.00660967753756188,0.00875985580623788,0.783933331290444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0012580667405162,0.00462558719984701,-0.00780808417118393,0.0103242176522163,0.785641091032171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,0.00216064431878339,0.00800720620656918,-0.0135334798460922,0.017854768483659,0.787289487960523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37562,0.000951451505373737,0.00353388871823558,-0.005974970382368,0.00787787339311547,0.787752001640858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,37541,-0.00167837549415172,0.00632514850544626,-0.0140756665648264,0.0107189155765229,0.790744353003219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00248818172630804,0.00937831763842484,-0.0208696842976207,0.0158933208450047,0.790773167851274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.00239990549867862,0.00918756989168408,-0.0156077314890222,0.0204075424863794,0.793932857430443
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.00318947761097251,0.0122422281938357,-0.0271842448708904,0.0208052896489454,0.794457808365923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,0.00110387181208549,0.00423808122659775,-0.00720276739204609,0.00941051101621707,0.794508489567032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,0.0010626099833561,0.00417105723438272,-0.00711266219603404,0.00923788216274623,0.798914049035718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,-0.00122349461793383,0.00485403047333789,-0.0107373943456761,0.00829040510980843,0.80100059454934
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,40042,0.000804322969177023,0.00320775411973075,-0.00548287510549525,0.0070915210438493,0.802015857770262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.000552875605070365,0.00221315168795468,-0.0037849017033208,0.00489065291346153,0.802734617238996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.000812262992197533,0.00326781468793532,-0.00721717978055075,0.00559265379615569,0.803700882227552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.00139725885155441,0.0056728701739262,-0.0125160843924498,0.00972156668934095,0.805449045619699
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00136304060577752,0.00562788479369011,-0.0123936948014101,0.00966761358985511,0.8086335393012
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,40042,0.00296939896072648,0.0124259763451531,-0.0213855146757736,0.0273243125972265,0.811134270898092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37598,-0.000891302596991782,0.00376394421897839,-0.00826863326618942,0.00648602807220586,0.812815516284496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00132886674887345,0.00562293241975374,-0.0123498142915908,0.00969208079384388,0.813180403104724
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37959,-0.000849274378956799,0.00363014163299717,-0.00796435197963126,0.00626580322171766,0.815026754567744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37572,-0.000966369959520303,0.00417423957115674,-0.00914787951898751,0.00721513959994691,0.816923761924534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.000644348958415368,0.00286690101007945,-0.0062634749381711,0.00497477702134036,0.822173136422653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,40228,-0.000762028128922368,0.00342281619448447,-0.00747074787011194,0.0059466916122672,0.82382487621866
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000863545350412817,0.00390920067028992,-0.00852557866418106,0.00679848796335542,0.825173160908787
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,-0.00135202823886288,0.00612734621816337,-0.0133616268264631,0.0106575703487373,0.825364639653315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.0011724060727085,0.00532385746339181,-0.0116071667009565,0.00926235455553945,0.825705262023074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,0.00199146085304036,0.00908103373715622,-0.0158073652717858,0.0197902869778666,0.826420611072354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,40044,0.000861075231887491,0.00398657554573188,-0.00695261283774699,0.00867476330152197,0.828995478032573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37598,-0.000635159891427843,0.00295436034760928,-0.00642570617274202,0.00515538638988634,0.829777932737981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,40044,-0.000978426126178328,0.00455388471190218,-0.00990404016150659,0.00794718790914994,0.82988297024369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.00282585761924321,0.0133292357517767,-0.0289511596927256,0.0232994444542392,0.832106733283992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37598,0.000645225846680554,0.0030933181146502,-0.00541767765803383,0.00670812935139494,0.834773916411762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.000885086970199236,0.00435037552361814,-0.00764164905609231,0.00941182299649078,0.838785881434394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,40044,0.00061188466841645,0.00303456841308931,-0.0053358694212386,0.0065596387580715,0.840202272615767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,0.00207630671042149,0.0104339396332732,-0.0183742149707939,0.0225268283916369,0.842269366422393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37572,0.000934567064396489,0.00474091599234037,-0.00835762828059063,0.0102267624093836,0.843730462925161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.00109375501842424,0.00562416609723575,-0.0121171205690063,0.00992961053215783,0.845807652914224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-0.000862460466863506,0.00451875516451799,-0.00971922058931876,0.00799429965559175,0.848636278265966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,-0.00101730302961882,0.00545509010700641,-0.0117092796393514,0.00967467358011375,0.852065776565929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.00100336338276952,0.0054857044350956,-0.0117553440755569,0.00974861731001785,0.854874799293253
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,40044,0.00138662436461704,0.00770505483597281,-0.0137152831138897,0.0164885318431238,0.857183996961319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,0.0014710932474037,0.00824419958214371,-0.014687537933598,0.0176297244284054,0.858380327870425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.000773642410097979,0.00435150423618563,-0.00775530589282585,0.00930259071302181,0.858892245508333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.000380693806609815,0.00214676580413327,-0.00458835478271103,0.0038269671694914,0.859248986106052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,37541,-0.000999607416294518,0.00566909837222455,-0.0121110402258546,0.0101118253932656,0.860040845267044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37714,-0.00143169944864904,0.00827650296150097,-0.0176536452531909,0.0147902463558929,0.862666942202572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,40379,-0.000394675616763212,0.00232838525763776,-0.00495831072173322,0.00416895948820679,0.865400689440186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37572,-0.000983893179364346,0.00582959005412436,-0.0124098896854481,0.0104421033267194,0.865975669408834
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.000576911739675229,0.00344974964418114,-0.00733842104227026,0.0061845975629198,0.867189289574257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.000566307810719508,0.00350462255732265,-0.00630275240163289,0.00743536802307191,0.871632126357605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37572,0.00135830450793778,0.00844227677831183,-0.0151885579775534,0.017905166993429,0.872180034342061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,-0.000769546333470174,0.0048229144650206,-0.0102224586849106,0.0086833660179702,0.873229803473182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.00088591079375228,0.0055541221897819,-0.0100001686982202,0.0117719902857248,0.873273009621785
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.000697485816544178,0.00446601808557389,-0.00805590963118064,0.00945088126426899,0.875896530095036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,-0.000632135940689967,0.00405832001304164,-0.00858644316625157,0.00732217128487164,0.876222263627037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,-0.00119574296282354,0.00785419459224377,-0.0165899643636213,0.0141984784379742,0.878997957044604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37671,0.000540637989903774,0.00370233198231252,-0.00671593269542876,0.00779720867523631,0.883902821360094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0005601021833954,0.00383593375048763,-0.00695832796756035,0.00807853233435115,0.883911791118488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.00116229664355323,0.00812532949073753,-0.0170879424453988,0.0147633491582923,0.886255974693089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.000609740303369787,0.00426360668649747,-0.00774692880216525,0.00896640940890482,0.88628407209162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.000679728125616045,0.00476061780220111,-0.00865108276669813,0.0100105390179302,0.886464940620085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.000836039892476819,0.0061960699014639,-0.0129803368993461,0.0113082571143924,0.89266873406508
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,37482,0.000672843658480375,0.00523662985128139,-0.00959095085003115,0.0109366381669919,0.897764843276085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37900,-0.00134293831998573,0.0104839184387192,-0.0218914184598754,0.0192055418199039,0.898075648809461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,37541,-0.000620252753865438,0.00492780521972593,-0.0102787509845283,0.00903824547679739,0.89983838416674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39934,0.000433416227696583,0.00347566799650893,-0.00637889304546092,0.00724572550085409,0.900762578766819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,37482,0.000737764476998376,0.00592347812878775,-0.0108722526554256,0.0123477816094224,0.900882366931598
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40516,-0.000477833125233054,0.00395780853169997,-0.008235137847365,0.00727947159689889,0.903905025020797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40453,0.000353949335746977,0.00300969632317108,-0.00554505545766834,0.0062529541291623,0.906383698852523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.000705596950095404,0.00610763697353693,-0.0126765654182278,0.011265371518037,0.908029193649224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,0.000498671155707473,0.00474377946907362,-0.00879913660367681,0.00979647891509176,0.916281347269731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000120670829791517,0.00117891958597145,-0.00219001155871252,0.00243135321829555,0.918474508099917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.000849661226607351,0.00860607043901963,-0.0160182368338711,0.0177175592870858,0.92135564421947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,40332,-0.000474460429612584,0.00490351253970308,-0.0100853450074306,0.00913642414820546,0.922918768986623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,0.000610252781576524,0.00647727055926454,-0.012085197514582,0.013305703077735,0.924940208505386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.00082836245253583,0.00906308963062492,-0.0185920181285607,0.016935293223489,0.927176286117147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.000594189612294512,0.0065256052715321,-0.0121959967199084,0.0133843759444974,0.927450202878621
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.000485849975881248,0.00540066818658342,-0.0110711596215848,0.0100994596698223,0.928319272076756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.000192476826529639,0.00216879470572137,-0.00405836079668424,0.00444331444974352,0.929283304084391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.000984812824208326,0.0114402294917734,-0.0214380369796675,0.0234076626280842,0.931401274333216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.000223391796718732,0.00269686968882341,-0.00550925638681262,0.00506247279337516,0.933985003562046
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37572,0.000184969501907733,0.00226905711437169,-0.00426238244226079,0.00463232144607625,0.935031077384939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37998,0.000450699640855952,0.00553597320551823,-0.0103998078419598,0.0113012071236717,0.935114792103978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000501955669827078,0.00635513012031847,-0.0119540993659971,0.0129580107056513,0.937046109085266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00026306670262154,0.00337131827338303,-0.00687085051845228,0.0063447171132092,0.937804515079084
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.000207848412929314,0.00277642372663776,-0.00564963891713932,0.00523394209128069,0.940325526321653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.000409543303141323,0.0054816577665088,-0.0103345059192159,0.0111535925254986,0.940445342211626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.000191166827617024,0.00261520821366422,-0.00493464127116485,0.0053169749263989,0.941729108506414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.000349228732932185,0.00483346576995955,-0.00982282164205291,0.00912436417618854,0.942402238923581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.000342441156613973,0.00480476712888913,-0.00975978472923667,0.00907490241600873,0.94318289387067
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,40042,-0.000485677946104822,0.00702323285476001,-0.0142512143414344,0.0132798584492248,0.944868684187542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,40387,0.000198088960146228,0.00294005834419034,-0.00556442539446685,0.0059606033147593,0.946283331534097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.000313768471311915,0.00481839994372517,-0.00975783236101325,0.00913029541838942,0.948080243157376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.000367924482051949,0.00582026280354091,-0.0110397906128882,0.0117756395769921,0.949596733540824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2,Prothrombin,38013,9.01199769011839e-05,0.00142597647727111,-0.0027047939185502,0.00288503387235256,0.949609145899577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.000258827613608071,0.00414147854187135,-0.00837612555567592,0.00785847032845978,0.950168454754434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37937,-0.000139571879528962,0.00226026521813654,-0.00456969170707657,0.00429054794801865,0.950762659830874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37598,0.000369995697803773,0.00606463911636231,-0.0115166969702664,0.0122566883658739,0.951353214443999
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-4.77683113985282e-05,0.000787683484063264,-0.00159162794016253,0.00149609131736547,0.95164360582748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.000369119935397263,0.00644222194225669,-0.0129958749422204,0.0122576350714259,0.954309351115864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.000160215807665514,0.00283981081179047,-0.0054058133834438,0.00572624499877483,0.955009700713528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.000570244870840937,0.0110386396825279,-0.0222059786485956,0.0210654889069138,0.958801186389746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,40228,0.000273626925745,0.00540807418133266,-0.010326198469667,0.010873452321157,0.959648090170376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.000286486350247863,0.00576820460004355,-0.0110191946658375,0.0115921673663332,0.960388939232027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.000156335547412484,0.00316531567523959,-0.00636035427088207,0.0060476831760571,0.960609098255058
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.000340905212379285,0.00710259053484346,-0.0142619826606725,0.0135801722359139,0.961719121806891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.000490359580184243,0.0103931403869955,-0.0208609147386954,0.019880195578327,0.962369514055115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,0.000241703417371346,0.0052058375471767,-0.009961738175095,0.0104451450098377,0.962968764391377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37671,-0.000139299879635308,0.00309894369795209,-0.00621322952762141,0.0059346297683508,0.964147234707431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.000162521459633265,0.00412042002763517,-0.0082385447137982,0.00791350179453167,0.968537742908447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.000242403000763925,0.00618979333065691,-0.0123743979288515,0.0118895919273236,0.968762042956263
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.00013871156113746,0.00370224532418413,-0.00739511239653836,0.00711768927426344,0.970113322240358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.000243077046441325,0.00655742404554324,-0.0130956281757061,0.0126094740828234,0.970430479368553
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.0004167588503992,0.0116328985856915,-0.0232172400783546,0.0223837223775562,0.971421654188883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37714,0.000200371258954065,0.00590274597492926,-0.0113690108519073,0.0117697533698154,0.972921175830493
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37714,-0.000171778476196359,0.00536433471645114,-0.0106858745204406,0.0103423175680479,0.974454728167789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.000157860002311947,0.00499882987360561,-0.00995556655457895,0.00963984654995506,0.974807955677887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,0.000306735276204003,0.00986653116347803,-0.0190316658042129,0.0196451363566209,0.975199464331449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.000173037869266524,0.00588698318172241,-0.0117115249054425,0.0113654491669094,0.976551365601366
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39980,0.000229155741732468,0.00820734093049332,-0.0158572324820344,0.0163155439654994,0.977725656618037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.000100699745822645,0.00471972513140257,-0.00914996151172639,0.00935136100337168,0.982978003546672
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,-6.69843766768239e-05,0.00323317907951129,-0.00640401537251896,0.00627004661916531,0.983471070319715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,-6.21021478434117e-05,0.0034359777378436,-0.00679661851401687,0.00667241421833004,0.985580027939818
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-8.57217607833748e-05,0.00535285490839533,-0.0105773173812382,0.0104058738596715,0.987223290044416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37562,-7.00441363180265e-05,0.00462955895219966,-0.00914397968262936,0.00900389140999331,0.987928885329835
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,0.000125854700263489,0.00862683347379986,-0.0167827389083842,0.0170344483089112,0.98836049938675
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37900,-4.96934576111199e-05,0.0034300998696322,-0.00677268920209022,0.00667330228686798,0.988441293256651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39980,-2.98893579450489e-05,0.00300110154711352,-0.00591204839028754,0.00585226967439745,0.992053758047999
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-2.2230675815076e-05,0.00376899393342385,-0.00740945878532583,0.00736499743369568,0.995293950458376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,1.68777728822401e-05,0.00660053742878538,-0.0129201755875371,0.0129539311333016,0.997959825844462
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,37482,1.95912212197057e-05,0.00786891243734342,-0.0154034771559734,0.0154426595984128,0.998013547996413
